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 RESUMÉ
Globalisering, internationale rejser og handel øger hastigt den globale udbredelse og overførsel af 
levnedsmiddelbårne patogener imellem lande. Allerede i dag er mere end halvdelen af alle 
humane 			 infektioner i Danmark forårsaget af internationale rejser og af importerede 
fødevarer. I store dele af verden har 			 
 serovar Enteritidis og  Typhimurium 
indtil nu tiltrukket sig mest opmærksomhed. Dog er andre 			 serotyper ofte mere 
udbredt i enkelte lande og resultere i flere alvorlige infektioner og udbrud. Det er således vigtigt 
at undersøge epidemiologien af 			 globalt.  
Det er vigtigt, at data fra forskellige lande er sammenlignelige. Vi har vurderet kvaliteten af 
			overvågningsdata fra laboratorier i hele verden samt deres evne til at serotype baseret 
på deltagelse i WHO's Globale Foodborne Infections Network (GFN) External Quality Assurance 
System (EQAS). Syv EQAS-runder blev gennemført mellem 2000 og 2007. Deltagende 
laboratorier indsendte serotypningsresultater for otte 			 isolater i hver runde. I alt deltog 
249 laboratorier i 96 lande i mindst én EQAS runde. Totalt set indsendte 76% af de deltagende 
laboratorier data for alle otte stammer og 82% af stammerne var korrekt serotypet. 
Præstationsmæssigt blev der observeret regionale forskelle blandt laboratorier fra Centralasien og 
Mellemøsten, som udførte testene mindre godt sammenlignet med de øvrige regioner. Fejl, som 
resulterede i forkert identifikation af serotypen, var typisk forårsaget af vanskeligheder med at 
detektere andenfasen af flagel antigenet eller differentiering indenfor antigen komplekser. Nogle 
af disse fejl er sandsynligvis relateret til kvaliteten af den antisera, som har været til rådighed (I).  
Baseret på data fra GFN Country Data Bank (CDB) i årene 2001 til 2007 sammenfattede vi den 
globale fordeling af 			 serotyper i udvalgte lande for at afdække de regionale og globale 
tendenser og mønstre i forekomsten af 			 serotyper. Sammendraget var baseret på 
kvalitetssikrede data fra 37 lande, som alle har bestået kvalitetssikringskravet til GFN EQAS. Vi 
har fundet betydelige forskelle imellem de mest almindeligt isolerede serotyper i forskellige 
geografiske områder, hvorimod flere lignende serotyper blev rapporteret i lande fra det samme 
område. Der blev også observeret en faldende tendens til at isolere og serotype i de lande som 
indgår i denne undersøgelse. Et par serotyper dominerede i hele verden, men var til stede med 
forskellig hyppighed i forskellige regioner. Vi bemærkede interessant nok, at globalt set er den 
relative betydning af . Enteritidis og . Typhimurium faldende, mens andre serotyper såsom  
Typhi,  Infantis,  Hadar,  Newport,  Virchow,  Agona og andre serovars er stigende (II).  
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 En række ”case-studies” blev udført for at undersøge den globale spredning af 			. Den 
genetiske diversitet og resistensprofilen blev undersøgt på 112  Rissen isolater fundet blandt 
mennesker, fødevarer og dyr i Danmark og Thailand. Derudover blev risikofaktorer såsom ”at 
rejse” og ”indtagelse af bestemte fødevarer” analyseret og evalueret. Der blev i alt observeret 63 
unikke &I pulsed field gel elektroforese (PFGE) mønstre, hvoraf det dominerende mønster blev 
delt af 22 stammer. Der blev observeret et begrænset niveau af antibiotikaresistens i de danske 
stammer, hvorimod der blev observeret en højere grad af resistens i stammer fra Thailand. 
Statistiske analyser og molekylær subtypning identificerede kombinationen af ”rejse til Thailand” 
og ”konsumering af importerede svin / svinekødsprodukter” samt ”konsumering af svin / 
svinekød produceret i Danmark”, som risikofaktorer for  Rissen-infektioner blandt danske 
patienter (III).  
Der er blevet rapporteret om multiresistente  Concord infektioner blandt børn adopteret fra 
Etiopien til Østrig, Danmark, England (og Wales), Irland, Holland og USA. Vi interviewede 
patienter, karakteriserede isolater og indsamlede oplysninger om adoptioner fra Etiopien for at 
vurdere konsekvenserne for folkesundheden. Isolaterne er blevet subtypet ved brug af PFGE og 
resistensprofiler; specifikke resistens-gener er blevet karakteriseret. Adoptionsstatus var 
tilgængelig for 44 patienter <3 år, hvoraf 98% var blevet adopteret fra Etiopien. De adopterede 
børn kom fra forskellige børnehjem i Etiopien. På de besøgte børnehjem var der dårlig hygiejne 
og sanitære forhold samt hyppig brug af antibiotika. Der var 53 PFGE mønstre blandt 64  
Concord isolater. Der blev udført resistensbestemmelser på 43 isolater, hvoraf 81% var 
multiresistente ( 3 stoffer). De multi-resistente isolater var fra etiopiske adoptivbørn og var 
resistente over for tredje og fjerde generations cephalosporiner. Herudover havde 14% nedsat 
følsomhed over for ciprofloxacin (IV).  
Vi har også karakteriseret 24 udvidet spektrum cefalosporinase-producerende isolater af  
Choleraesuis fra thailandske og danske patienter. Treogtyve af isolaterne var fra thailandske 
patienter fra år 2003, 2007 eller 2008. Yderligere var et af isolaterne fra en dansker, som havde 
været rejsende i Thailand. De 13 af isolaterne var fra blodprøver. MIC-bestemmelse, micro-array, 
PCR, plasmid-profilering og replikon-typning har afsløret forekomst af multiresistente isolater 
med plasmider der varierer i størrelse fra 75 -200 kb indeholdende enten 	CMY-2 inklusiv inc 
A/C eller 	CTX-M-14 inklusiv incFIIA / incFrepB. RFLP og replikon-typning fordelte isolaterne i 
fire adskilte grupper. PFGE afslørede 16 unikke mønstre og fem grupper. Isolatet fra den danske 
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 patient var identisk med to kliniske isolater fra Thailand. Undersøgelsen viste fremkomsten af 
	CTX-M-14 genet blandt adskillige kloner af Choleraesuis. Adskillige plasmider blev 
identificeret indeholdende op til to forskellige udvidet spektrum cefalosporinase gener og fire 
forskellige replikonner. En rejse-associeret spredning blev bekræftet (V).  
De fleste undersøgelser af epidemiologien af 			 er fra lande, hvor  Enteritidis og  
Typhimurium var dominerende. Der ses dog et andet mønster i Thailand, hvor vi har foretaget et 
retrospektivt observationsstudie fra 2002 til og med 2007 for at vurdere epidemiologiske 
tendenser og risikofaktorer forbundet med de ti mest almindelige 			 serotyper isoleret 
fra mennesker. Der blev inkluderet i alt 11.656 			 isolater i undersøgelsen dækkende alle 
seks år. De fleste af isolater var fra patienter <5 år (33%), isoleret i juni (13%), fra fæces (82%) 
og fra Bangkok (27%). Statistiske analyser viste, at . Enteritidis og . Choleraesuis blev isoleret 
fra blod med en højere frekvens end andre ikke-typhoide serotyper. Der var en tendens til at 
begge serotyper blev isoleret fra patienter ældre end 5 år.  Choleraesuis blev fundet med en 
højere frekvens i patienter fra Bangkok og den centrale region, mens Enteritidis overvejende 
blev fundet i patienter fra den sydlige region. Undersøgelsen viser også i forhold til tidligere 
undersøgelser et skift i forekomsten af de mest almindelige 			 serotyper forbundet med 
humane infektioner i Thailand. Der var blandt andet en stigning i humane infektioner med  
Stanley,  Corvallis, og . Choleraesuis, som tidligere har været forbundet med svin. Yderligere 
var der et fald i infektioner forårsaget af  Weltevreden og  Anatum (VI).  
Samlet set har denne Ph.D. afhandling vurderet kvaliteten af 			 serotypning foretaget på 
de nationale referencelaboratorier samt brugt disse data til at beskrive udviklingen i den globale 
distribution af 			. Desuden har den vist forbindelser imellem forskellige reservoirer og 
kilder til salmonellosis hos mennesker i forskellige områder af verden og anvendt thailandske 
overvågningsdata til at opstille risikofaktorer for salmonellose hos mennesker i Thailand. Den er 
kommet med flere anbefalinger til aktioner, hvad angår kontrol samt forebyggelse af infektioner i 
mennesker.  
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 SUMMARY
Globalization, international travel, and trade among countries facilitate the rapid global spread 
and transmission of food borne pathogens. Currently, more than half of all human 			 
infections in Denmark result from international travel and consumption of imported food. 
Worldwide,			 
 serovar Enteritidis and  Typhimurium cause the majority of 
human clinical cases. However, other 			 serovars are often more prevalent in specific 
countries, and result in more sever infections and outcome. It is, thus, important to study 
			 epidemiology globally.  
It is essential that data from different countries are comparable. We assessed the quality of the 
			 surveillance data worldwide, and the laboratories ability to accurately determine 
serotype, based on participation in the WHO Global Foodborne Infections Network (GFN) 
External Quality Assurance System (EQAS) for serotyping of 			 Seven EQAS 
iterations were conducted between 2000 and 2007. In each iteration, participating laboratories 
submitted serotyping results for eight 			isolates. A total of 249 laboratories in 96 
countries participated in at least one EQAS iteration. Cumulatively, 76% of participating 
laboratories submitted data for all eight strains and 82% of strains were correctly serotyped. 
Regional variations in performance were observed, with higher error rates in laboratories in 
Central Asia and the Middle East compared with other regions. Errors that resulted in incorrect 
serovar determinations were usually caused by difficulties either in the detection of the phase II 
flagellar antigen or differentiation within antigen complexes. Some of these errors likely were 
related to the quality of the antisera available (I).  
We summarised the global distribution of 			 serovars of selected countries, based on 
2001-2007 data from GFN Country Data Bank (CDB) to uncover regional and global trends in 
the occurrence of 			 serovars. The summary was based on quality-assured data from 37 
countries that passed the quality assurance threshold of the GFN EQAS. We found considerable 
differences in the most commonly isolated serovars in various geographical regions, and more 
similar serovars prevalences in countries from the same region. We observed a tendency among 
countries included in this study to isolate and serotype less compared to previous years. A few 
serovars predominated worldwide, but were present with different frequencies in different 
regions. Interestingly, we observed that the relative importance of  Enteritidis and  
 x
 Typhimurium is decreasing globally, while other serovars such as  Typhi,  Infantis,  Hadar, 
 Newport,  Virchow,  Agona and other serovars are increasing (II). 
A number of case studies were conducted to investigate the global spread of 			. The 
genetic diversity and antimicrobial resistance of 112  Rissen isolates recovered from humans, 
food products and animals in Denmark and Thailand were examined. Additionally, risk factors 
due to travel and consumption of specific food products were analyzed and evaluated. A total of 
63 unique &I pulsed field gel electrophoresis (PFGE) patterns were observed. The predominant 
pattern was shared by 22 strains. Limited antimicrobial resistance was observed in the Danish 
strains, whereas a higher degree of resistance was observed in strains originating from Thailand. 
Statistical analysis and molecular subtyping identified the combination of “travel to Thailand” 
and “consumption of imported pig / pork products” as well “consumption of as pig / pork 
products produced in Denmark” as risk factors for Rissen infection among the Danish patients 
(III).  
Multidrug-resistant  Concord infections have been reported from children adopted from 
Ethiopia to Austria, Denmark, England (and Wales), Ireland, the Netherlands and the United 
States. We interviewed patients, characterized the isolates, and gathered information about 
adoptions from Ethiopia to assess public health implications. Isolates were subtyped by PFGE 
and antimicrobial susceptibility; specific antimicrobial resistance genes were characterized. 
Adoption status was known for 44 patients <3 years of age; 98% were adopted from Ethiopia. 
The children adopted from Ethiopia were from several orphanages; visited orphanages had poor 
hygiene and sanitation and frequent use of antimicrobial agents. Sixty-four Concord isolates 
yielded 53 PFGE patterns. Antimicrobial susceptibility was performed on 43 isolates; 81% were 
multidrug-resistant (3 agents). Multidrug-resistant isolates were from Ethiopian adoptees and 
were resistant to third and fourth generation cephalosporins, with 14% showing decreased 
susceptibility to ciprofloxacin (IV).  
We also characterized 24 extended spectrum cephalosporinases (ESC) producing isolates of 
Choleraesuis recovered from patients in Thailand and Denmark. Twenty-three isolates were 
recovered from Thai patients in 2003, 2007, or 2008 and one isolate was recovered from a Danish 
traveler to Thailand, 13 of which were blood culture isolates. MIC determination, micro-array, 
PCR, plasmid profiling and replicon typing revealed the presence of multi-drug resistant isolates 
harboring either 	CMY-2 containing incA/C or 	CTX-M-14 containing incFIIA / incFrepB 
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 plasmids ranging in size from 75–200 kb. The RFLP and replicon typing clustered the isolates 
into four distinct groups. PFGE revealed 16 unique patterns and five clusters. The isolate from 
the Danish patient was indistinguishable from two Thai clinical isolates. This study revealed the 
emergence of the 	CTX-M-14 gene among several clones of  Choleraesuis. Numerous plasmids 
were identified containing up to two different ESC genes and four distinct replicons. A “travel 
associated” spread was confirmed (V).  
Most studies of 			 epidemiology have been in countries wereEnteritidis and 
Typhimurium predominated. In Thailand, a different pattern is observed. We conducted a 
retrospective observational study to assess epidemiological trends and risk factors associated with 
the ten most common 			 serovars isolated from humans in Thailand between 2002 and 
2007. A total of 11,656 			 isolates covering all six years were included in the study. 
Most isolates were from patients <5 years (33%), isolated during June (13%), recovered from 
stool (82%) and from Bangkok (27%). Statistical analysis revealed that Enteritidis and  
Choleraesuis were recovered from blood with a higher frequency than other non-typhoidal 
serovars. While both serovars tended to be isolated from patients older than 5 years; 
Choleraesuis was recovered with a higher frequency from patients in Bangkok and the Central 
Region, whereas Enteritidis was recovered predominantly from patients in the Southern 
Region.This study also indicates a shift in prevalence of the most common 			 serovars 
responsible for human infections in Thailand compared to previous studies. Notably, there was an 
increase in human infections with  Stanley,  Corvallis, and  Choleraesuis - three serovars 
which previously have been associated with swine - and a decrease in infections due to 
Weltevreden and  Anatum (VI).  
Overall, this Ph.D. thesis has assessed the quality of 			 serotyping conducted in national 
reference laboratories and used these data to describe trends in the global distribution of 
			. In addition, it has revealed links between different reservoirs and sources to human 
salmonellosis in different areas of the world and used Thai surveillance data to set up risk factors 
for human salmonellosis in Thailand. In several cases, this work has resulted in recommendations 
to help control and prevent infections in humans. 
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 BACKGROUND
Today, we are all residents of a global village. The expanding trade of food and livestock, and 
increased human travel and migration are means of spreading infectious disease irrespective of 
national borders. This makes infectious disease control and food safety important for all 
countries. In Denmark, it is expected that in a few years, around 2/3 of all food products will 
originate from other countries. Already today, more than half of all human 			 infections 
in Denmark are caused by international travel and consumption of imported food.  
In addition, the majority of the 			 isolates causing human infections in Denmark by 
consumption of imported food products are resistant to multiple antimicrobials, which has 
increased in many countries that export foods to Denmark.  
In Europe and North America, Enteritidis and  Typhimurium have, up until now, drawn most 
attention. However, other 			 serovars are often more prevalent in other parts of the 
world and result in more sever infections with higher morbidity. Thus, there is an urgent need to 
further investigate and elucidate the occurrence, international spread, and global epidemiology of 
			 serovars and specific clones so that evidence-based interventions can be taken 
worldwide. 
PURPOSE  
The purpose of the PhD project was to study the global epidemiology of NTS infections in 
humans. The term “epidemiology” is defined in the traditional way as the study of the occurrence 
and distribution of a disease in a population and the factors which influence disease occurrence. 
 
The PhD project integrated conventional and molecular microbiology used to characterise 
isolates with epidemiological and statistical tools needed to estimate trends and risk factors.  
 
RESEARCH APPROACH 
The projects were derived from the activities of the WHO Global Foodborne Infections Network 
(GFN), a network of institutions building capacity for laboratory-based surveillance of foodborne 
pathogens and disease (http://www.who.int/salmsurv/en/), to assess the global distribution of 
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			 serovars, investigate examples of international spread and identify regional and local 
risk factors for infection. 
 
The specific studies conducted during this PhD project focused on the following objectives: 
1. To assess the quality of the 			 surveillance data worldwide and the laboratories 
ability to serotype based on participation in the GFN EQAS. 
2. To estimate the global distribution and trends of 			 serovars from the GFN 
Country Data Bank (CDB). CDB data reliability was based on results from the GFN 
EQAS. 
3. To investigate the spread of  Rissen caused by international travel to Thailand and 
imported food from Spain and Germany. 
4. To investigate the spread of  Concord to Europe and United States through adopted 
children from Ethiopia. 
5. To characterise the extended spectrum cephalosporinases genes of the invasive serovar  
Choleraesuis. 
6. To identify risk factors in the epidemiology of 			 serovars in Thai patients and 
to use these findings to recommend strategies for control and prevention. 
 
 
 
 
 
 
 
 INTRODUCTION
			 is a genus of rod-shaped, Gram-negative, oxidase negative, non-spore forming, 
predominantly motile (peritrichous) bacteria belonging to the family '
. 
			 are approximately 0.7 to 1.5 m wide and 2.0 to 5.0 m in length (Giannella 	., 
1996). The bacterium ferments glucose and usually with production of gas. In addition, they are 
able to grow in a minimal media containing glucose as the sole carbon energy source and 
ammonium ion as a nitrogen source (prototrophic). Most serovars are phenotypically identified 
by urea hydrolysis, the absence of tryptophan deaminase, non-lactose fermentation, the 
production of hydrogen sulphide (H2S), decarboxylate lysine and ornithine and growth on 
Simmons citrate agar (Grimont 	., 2000).  
The genus 			, first known as 				
, was initially discovered in 1886 
by Theobald Smith and Daniel Elmer Salmon. The discovery of the genus originated from the 
work on swine fever (hog cholera) by Theobald Smith and he named the genus after his 
supervisor at the U.S. Department of Agriculture (USDA), Daniel E. Salmon (Grimont 	., 
2000).  
In the late 19th century, serological tests utilizing agglutination with antiserum were developed, 
and new serovars were discovered and named after either clinical conditions or hosts, e.g. 
			


,			
,					
,			



,and			

 (Grimont 	., 2000).  
In 1926, Bruce White developed the analysis of somatic and flagella antigens, which in 1961 was 
expanded by Fritz Kauffman to distinguish more than 2000 serovars. In 1980, the 			 
nomenclature of today (The Kauffman-White Scheme) was proposed, and is currently maintained 
by the World Health Organization (WHO) Collaborating Centre for Reference and Research on 
			 at the Pasteur Institute, Paris, France (Grimont 	., 2000; Grimont 	., 2007).  
Currently, 			 consists of 2.579 different serovars divided into two species – 			

 (n=2.557) replacing the old name 				
 (Hohmann 	., 2001) and 
			
(n=22) (Grimont 	., 2007). The species, 			 
 is further 
divided into six subspecies -			
subsp
(I), 			
subsp. 
	 (II), 			
subsp. 
( (IIIa), 			
subsp. 

( 
(IIIb), 			
subsp.  (IV), and 			
subsp. 

 (VI). 
Serovars of 			
subsp
(I), are primarily named by the geographical 
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 origin such as  Amsterdam,  Panama, and  Derby whereas the serovars of the remaining five 
subspecies all are named by antigenic formular (Grimont 	., 2000; Grimont 	., 2007). 
 
GLOBAL DISTRIBUTION OF SEROVARS AND TRENDS IN 
HUMANS
			 serotyping still serves as the predominately used surveillance tool for detection of 
outbreaks and corresponding sources, to monitor trends over time, and attribute different food 
and animal reservoirs to human infections. Despite this, there is today only limited knowledge of 
the global distribution of 			 serovars in humans. In the last decade, some countries have 
collected annual prevalence data on serovar distribution among humans, but very few 
publications have summarised the global distribution of the serovars responsible for human 
infections and further analysed the data (Herikstad 	., 2002; Galanis 	., 2006; II). An 
equally important feature for surveillance is quality assurance and quality control, which is 
necessary to ensure reliable data. Only a small number of international quality assurance systems 
exist to evaluate the quality of the serotyping conducted worldwide by national reference 
laboratories (Petersen 	., 2002; Anonymous, 2007b; I). 
In January 2000, the WHO launched WHO Global Foodborne Infections Network (GFN) 
(formerly known as Global Salm Surv (GSS)), a global effort to enhance laboratory-based 
surveillance of 			infections and other foodborne diseases, and to promote prevention 
and control activities. Enhancing worldwide serotyping of 			is a key objective of WHO 
GFN and is facilitated by bench training at international capacity building courses. 
To ascertain the performance of participating laboratories, and thereby promote enhanced 
laboratory-based surveillance, an External Quality Assurance System (EQAS) was established as 
a part of WHO GFN in 2000 (Petersen	., 2002; I). Each year, EQAS distributes a set of 
blinded bacterial cultures for identification, serotyping and antimicrobial susceptibility testing. A 
key component of this program is the Internet based Country Data Bank (CDB), to which 
member countries are encouraged to annually upload data on the 15 most common 			 
serovars (http://www.antimicrobialresistance.dk).  
The results of the WHO GFN EQAS data from 2000 to 2007 revealed that a total of  
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 249 laboratories in 96 countries participated in annual EQAS testing at least once (Figure 1) (I).  
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During the seven EQAS iterations, a total of 756 reports were received from the participating 
laboratories. Cumulatively, 76% of participating laboratories submitted data for all eight strains 
and 82% of the strains were correctly serotyped. The goal of the EQAS program is for all 
participating laboratories to perform 			serotyping with a maximum of one error. The 
percentage of laboratories reaching the threshold reporting one or zero errors increased 
significantly (=0.04), from 48% in 2000 to 68% in 2007. In each EQAS iteration, 84% to 96% 
of the laboratories correctly serotyped the Enteritidis isolate that was included in the panel of 
test strains as an internal quality control strain. Regional variations in performance were 
observed, with laboratories in Central Asia and the Middle East performing less well overall than 
other regions. Errors that resulted in incorrect serovar identification were usually caused by 
difficulties in the detection of the phase II flagellar antigen, or differentiation within antigen 
complexes. Some of these errors likely are related to the quality of the antisera available (I). The 
same conclusion, that the main problem existed in detecting the H antigens, was reached by the 
National Institute for Public Health and the Environment (RIVM) which served as the 
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community reference laboratory for 			 as designated by the European Commission. 
They evaluated 26 European national reference laboratories in 2007 and found that 98% and 96% 
of the laboratories correctly serotyped the isolates using O and H antigen, respectively 
(Anonymous, 2007b).  
In 2008, the global distribution of 			 serovars per country, based on data from the WHO 
GFN CDB, were summarised and analysed in search for trends from 2001 to 2007. All data 
included were based on reliable data from countries which managed the quality assurance 
threshold of the WHO GFN EQAS (Figure 1) (V).  
The data showed that, in all regions with exception of the Oceania and North American, 
Enteritidis and Typhimurium ranked as the first and second most common serovars, 
respectively. In the North American and the Oceania regions these two serovars ranked in the 
opposite order. Globally the 
overall proportion for both 
serovars decreased over time 
with  Enteritidis decreasing 
from 44.2% to 41.5% and  
Typhimurium decreasing from 
18.9% to 15.0% (Figure 2) (V). 
This was mainly due to a 
significant decreasing trend  )
1!		

23	

+V,
(p<0.01) in the proportion of  
Enteritidis in developing 
countries and a non-significant 
decreasing trend (p=0.16) in 
the proportion of  
Typhimurium in developed 
countries. 
In addition to Enteritidis and 
Typhimurium,  Infantis 
was among the serovars )
2!		

23	

+V,
 observed in all regions. Globally, the overall proportion of . Infantis increased over the years, 
from 1.5% to 2.2%. However, no statistically significant increasing trend was detected (p=0.76) 
(Figure 3). . Infantis ranked as the fifth most common serovar in the European region.  Agona 
was frequently observed in Asia and Latin America, ranking as the third most common serovar. 
 Agona also ranked as the top seven serovar in Europe and the top 13 in North America. 
Overall, the proportion of this serovar increased from 0.8% to 1.5% between 2001 and 2007.  
A slight decrease in the overall proportion over time was seen for  Heidelberg, from 2.5% to 
2.3% (Figure 3). This serovar was more common among developed countries. Heidelberg 
ranked in top four in North America. However, lower frequencies were seen in Europe (top 9) 
and Latin America (top 19).  
 Virchow was common only in Asia, Europe and the Oceania regions, but with a high 
proportion. The overall proportion oscillated over the years (Figure 3) and, since 2005, an 
increase was seen among developed countries while a similar proportionate decrease was 
reported by developing countries.  
High frequencies of  Thompson were seen in Europe and North America. Newport also was 
reported as a top serovar by these two regions, in addition to Latin America. Nevertheless, the 
overall proportion over time of  Newport, which was increasing in the initial years, decreased 
from 5.0% in 2005 to only 1.2% in 2007 (Figure 3).  
 Oranienburg was observed only in North and Latin America, ranked 10th and 15th, respectively. 
 Hadar and  Montevideo were reported by almost all regions, however, the frequencies varied 
considerably.  Hadar ranked 3rd in Europe, but lower in the other regions. In general, the overall 
proportion remained at similar levels over the years, with the exception of a slight decrease in 
2005 (Figure 3). Finally,  Montevideo was more common in North and Latin America while 
Saintpaul was more predominant in Oceania and North America. These two serovars exhibited 
similar trends over time, increasing from 2003 to 2005, followed by a decline in 2007 (Figure 3). 
The survey concluded large differences among the top 20 most commonly isolated serovars 
between regions but lesser differences between the top 15 most commonly isolated serovars 
between countries within the same region. Nevertheless, a few serovars are more frequent than 
others in many of the regions and countries.  
Several national surveillance reports and scientific articles support the observations described by 
Hendriksen 	. (II). In Europe, surveillance data from 23 countries between 2006 and 2007 
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 among humans showed that  Enteritidis was ranked first, but decreasing, and that  
Typhimurium was fairly consistent over time and ranked second (Anonymous, 2009b). In 
addition,  Infantis was ranked third followed by  Virchow (top 4),  Newport (top5), and  
Hadar (top 7). However, both  Thompson and  Heidelberg were not listed among top 10 
among the 23 countries in Europe (Anonymous, 2009b). In the United Kingdom, data from 1983 
to 2007 revealed the same ranking of  Enteritidis and  Typhimurium as for all Europe but 
with a decreasing tendency for both serovars (Anonymous, 2007f). In contrast, the Danish data 
from 2007 showed an opposite ranking of  Enteritidis and  Typhimurium (Anonymous, 
2009a). In South America,  Typhimuriumwas ranked first and  Enteritidis second in 2008 
(Anonymous, 2008c). In addition, the data also showed that  Isangi was highly frequent and 
ranked third followed by Dublin and  Virchow (Anonymous, 2008c).The same tendency of 
ranking  Enteritidis and  Typhimurium was observed since 1997 in the United States (Olsen 
	., 2001; Anonymous, 2008e), in China (Henan province) between 2006 and 2007 (Xia 	., 
2009), and Taiwan between 1998 to 2002 (Lauderdale 	., 2006). Also in India,  
Typhimurium was ranked before Enteritidis between 2001 to 2005 (Kumar 	., 2009) and in 
New Zealand in 2005 to 2008 (Anonymous, 2008a).  
In the United States, Newport was ranked third followed by Heidelberg (Anonymous, 
2008e). The distribution of serovars in Southeast Asia is slightly different from the global trend 
in general. In the Philippines, Hong Kong, and Sri Lanca,  Typhimurium was ranked before 
Enteritidis whereas it was the opposite in Singapore, South Korea, and Thailand (Lee 	., 2009; 
VI). However, in most of these countries another non-typhoidal			 (NTS) ranked either 
as the top serovar or in between  Enteritidis and  Typhimurium in prevalence. In general, the 
serovars following  Typhimurium and Enteritidis were  Weltevreden, Stanley,  
Choleraesuis,  London,  Agona,  Rissen,  Anatum,  Panama, and  Virchow (Lee 	., 
2009, VI). In Taiwan, the distribution of serovars revealed large similarities with Southeast Asia. 
Here, Stanley was listed as the third most common serovar followed by  Schwarzengrund,  
Newport, Albany, Virchow,  Weltevreden, and  Agona (Lauderdale 	., 2006). China 
(Henan province) did not share the same serovars as Taiwan. In Henan province, Derby ranked 
third followed by  Indiana,  Litchfield,  Thompson, and  Agona (Xia 	., 2009).  
The complexity of the global distribution of 			 serovars in humans is enormous as it is 
influenced by multiple factors such as animal and environmental reservoirs and complex route of 
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 transmission. It will be important for the future to extend the global understanding of the 
epidemiology of 			 in not only humans but also in all animal reservoirs. 
 
HUMAN EPIDEMIOLOGY 
	
				


Food-borne diseases have been estimated to infect up to 76 million people in the United States 
annually. This would equal one fourth of the people infected in the developed world per year if 
these data were extrapolated. The burden of salmonellosis is expected to be much greater in the 
developing parts of the world (Schlundt 	., 2004). 			 is overall the most common 
food-borne pathogen in the United States, however, in some states $	 is more 
prevalent than 			 (Anonymous, 2009c). In Europe, $	 are more frequent 
than 			 (Anonymous, 2008d)According to the WHO, humans NTS infections 
constitute a major public health burden on society and represent a huge cost for many countries 
(www.who.int). In 2000, it was estimated that in the United States, NTS resulted in 1.4 million 
infections annually in a population of about 293 million inhabitants with approximately 168.000 
visits to the general practitioner (GP). A total of 16.430 people were hospitalized resulting in 582 
deaths (Mead 	., 1999; McDermott 	., 2006). A similar study was conducted the same year 
in the United Kingdom. This revealed that 41.616 NTS cases occurred each year with 15.036 
laboratory confirmations among a population of 60 million people, resulting in 1.516 
hospitalization and 119 deaths (Adak 	., 2002; McDermott 	.,2006). This was 
approximately twice as many hospitalizations and deaths in the United States compared to the 
United Kingdom. 
Recently, the financial burden of NTS was estimated in the United States based on FoodNet data. 
The data revealed that costs of medical care, lost productivity, and mortality exceeded more that 
$ 3.6 billion annually (Voetsch 	., 2004; McDermott 	., 2006). In comparison, the annually 
costs of NTS in Denmark are estimated to be $ 15.5 million which was approximately four time 
less that in the United States (www.who.int).  
A few countries around the world have an established laboratory-based surveillance of NTS, or 
have recently improved the data quality and reporting to implement programmes measuring the 
burden of salmonellosis. One of the measurements in the surveillance reports are the notification, 
incidence, or isolation rate per 100.000 inhabitants all estimating the burden on the society 
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 caused by salmonellosis (Figure 4) (Bangtrakulnonth and Tishyadhigame; 2006; Aissa 	., 
2007; Anonymous, 2008c; Anonymous, 2008d; Anonymous, 2008e). 
In the United States, the National 			 Surveillance System reported in 2006 an increase 
of 12.3% of NTS compared with 2005 due to increased reporting. In general, the level decreased 
compared with data from 1996 (Anonymous, 2008e). The number of human 			 cases 
also seems to have declined in Tunisia based on data collected from 1994 to 2004 with the lowest 
isolation rate monitored in 2004 for the entire surveillance period (Aissa 	., 2007). The 2008 
Annual Surveillance Report from New Zealand showed, as many other country reports, a 
decreasing notification rate of NTS (Anonymous, 2008a). Based on data from 29 countries, the 
number of salmonellosis cases in Europe decreased by 8% between 2005 and 2006 (Anonymous, 
2008d). In 2006, the National 			 and 
		 Center in Thailand found 3.758 NTS 
cases, representing a decrease compared with previously published data showing the number of 
human cases from 1993 to 2002 (Bangtrakulnonth 	., 2004). 
The worldwide reported trend of decreasing human cases caused by NTS seems to be in 
agreement with what have been observed elsewhere. A decreasing number of 			 isolates 
were serotyped from 2001 to 2007 when assessing the global distribution of 			 serovars 
in 37 countries worldwide. The data were based on quality data submitted to CDB of the WHO 
Notification rate in the US, 2006: 
13.6 / 100.000 inhabitants Notification rate in the EU,  2006: 34 / 100.000 inhabitants 
Isolation rate in Tunisia, 2004 : 
1.9 / 100.000 inhabitants 
Incident rate in South Africa 2008: 
1.9 / 100.000 inhabitants 
Isolation rate in Thailand 006:  2
5.7 / 100.000 inhabitants 
Notification rate in New Zealand 2008: 
31.5 / 100.000 inhabitants 
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 GFN (II). Despite the decreasing occurrence of NTS infections in human, the problem is still 
large and is largely preventable and therefore an unnecessary burden on public health. 




The symptoms of 			 infections usually appear 12 to 72 hours after ingestions of the 
organism, and include diarrhea, fever, abdominal cramps, nausea, and sometimes vomiting but 
asymptomatic infections may also occur. The illness usually lasts from 4 to 7 days but are in most 
cases self limiting (www.cdc.gov; www.who.int; McDermott 	., 2006; Anonymous, 2007f).  
NTS gastroenteritis will develop into bacteremia in about 5% of cases. Bacteremia often requires 
hospitalization with a prolonged course of illness and could potentially result in a fatal outcome 
(Hohmann 	., 2001; Jones 	., 2008). A cohort study with almost 49.000 participants 
showed that people with gastrointestinal infections caused by NTS have an excess mortality with 
a relative risk of 13.31 up to a month after being infected (Helms 	., 2003). Several studies 
have described certain serovars such as  Dublin and Choleraesuis often being associated with 
invasiveness (Hohmann 	., 2001; Helms 	., 2002; Chiu 	., 2004; Jones 	., 2008; V;
VI).  
An observational study based on patient data from 11.656 isolates (2002 – 2007) estimated the 
risk factors of the ten most common 			 serovars from Thai patients. The data showed 
that 87.4% of 681  Cholereasuis isolates originated from blood samples with a significant 
increased odds ratio of 44.00 (95% CI 34.3 – 56.5) when compared to other NTS serovars.  
Enteritidis,  I [1],4,[5],12:i:-, Typhimurium, and  Panama did also seem to be highly 
invasive when compared to other NTS serovars (VI). These data correspond well with an 
investigation describing the differences in the outcome of salmonellosis based on the various 
serovars (Jones 	., 2008). Sixty percent and 67% of all  Choleraesuis and  Dublin 
infections, respectively, require hospitalization compared with other serovars. However, 
Heidelberg,  Poona,  Panama, Virchow,  Paratyphi B var. Java and  Sandiago also 
seemed to more frequently cause invasive diseases (Jones 	., 2008).  
Several studies have shown that invasive NST is endemic in sub-Saharan Africa (Morpeth 	., 
2009; Vandenberg 	., 2009). In some of those countries the mortality in children caused by 
NST bacteremia exceeds the burden of childhood malaria (Morpeth 	., 2009). In the 
Democratic Republic of Congo, a retrospective study from 2002 to 2006 in one hospital showed 
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 that 59% of all bloodstream infections in children were caused by NTS. The data revealed that  
Enteritidis and  Typhimurium were responsible for up to 82.8% of the cases (Vandenberg 	., 
2009). The study highlighted that many NTS invasive infections were nosocomial and resulted in 
prolonged hospitalization, posing a significant problem in developing countries. Little is known 
about human NTS infections in Africa and many other developing countries, but the limited data 
have shown that NTS infection often are associated with invasiveness and severe outcome. There 
is an urgent need to address this problem in order to elucidate the mechanisms responsible for the 
severe outcomes.  
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Human			 infections are age specific and affect mostly children, elderly people and 
immunological compromised patients (Hohmann et al., 2001; Anonymous, 2008c; Anonymous, 
2008d; Anonymous, 2008e; Jafari et al, 2009; VI).  
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The reason for the typical age pattern is believed to be a result of children acquiring immunity to 
			, and deteriorating 
immune status in the elderly. This 
observation was supported by 
Hendriksen 	 who showed that 
from 2002 to 2007 in Thailand, 
32.6% of all 			 cases were 
observed among children from 0 to 5 
years of age and peaked again with 
14.0% of all cases in people older 
than 60 years in Thailand (Figure 5) (VI). The previously mentioned risk factor analysis from 
Thailand showing an odds ratio between 1.63 (95% CI 1.1-2.5) and 1.51 (95% CI 1.1-2.0) in the 
age group of 6-20 and 21-40 years for being infected withCholeraesuis compared to other 
NTS infections (VI). In the risk factor analysis, additional serovars seemed to be age specific 
such as Anatum,  Enteritidis, and Weltevreden, which mainly affected people older than 6 
years. In contrast, Stanley,  Panama, and  I [1],4,[5],12:i:- predominately infected children 
less than 6 years of age (VI).  
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Several surveillance reports have illustrated the general infection pattern of human salmonellosis 
associated with yearly seasonality, with the summer months being the season having the highest 
incidence of infections (Anonymous, 2008a; Anonymous, 2008c; Anonymous, 2008d; Cho 	., 
2008; VI). In Tunisia, however, this general pattern of infection seemed not to be consistent with 
the hypothesis that most infections occur in the summer months.  Enteritidis infections peaked 
in January followed by Livingstone peaking in April, whereas  Corvallis peaked in October 
(Ben-Aissa 	., 2007). Ben-Aissa 	. did not indicate a reason for the skewed seasonal 
pattern but one possibility could 
be that this was the same time of 
the year when the serovar peaked 
in the animal reservoir. In 
Thailand, the seasonality of 
			 infections were in 
general in agreement with other 
studies having most infections in 
the summer period (Figure 6) (VI). 
Nevertheless, Hendriksen 	. 
describe that infections caused by 
Enteritidis had the highest 
odds ratio of 1.2 (95% CI 1.0-
1.5) during the winter time. For infections caused by  I [1],4,[5],12:i:- and Panama, however, 
spring time seemed to constitute the highest risk with an odds ratio of 1.8 (95% CI 1.5-2.3) and 
1.5 (95% CI 1.2-2.0). Choleraesuis was observed to pose the highest risk with an odd ration of 
1.4 (95% CI 1.1-1.9) during autumn (VI) which was supported by another study (V). 
The use of available surveillance data for descriptive analysis and source attribution, or even 
more advanced analysis, should be of a high priority of all countries in order to facilitate a more 
direct and targeted effort to minimize the burden of salmonellosis in high risk populations.  
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Antimicrobial treatment is not routinely recommended for empiric treatment of gastrointestinal 
infections caused by NTS in healthy people as the infection often is self limiting. Antimicrobial 
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 treatment should be given to patients with severe illness, immunosuppression or patients 
suffering from bacteraemia (Hohmann 	., 2001). Treatment with first line antimicrobials 
should include ampicillin, chloramphenicol or trimethoprim + sulfamethoxazole (Hohmann 	., 
2001; McDermott 	., 2006). The choice differs by region and chloramphenicol is not used in 
most developed countries, but is common in developing countries. Ampicillin and trimethoprim + 
sulfamethoxazole are good choices, but many do not even considering them and choose in stead 
fluoroquinolone or 3rd generation cephalosporins.  
Unfortunately, the recent increased development of resistance to many antimicrobials often 
leaves the GP with no alternative than to treat the infection with either a fluoroquinolone or 3rd 
generation cephalosporins. These antimicrobials are routinely used for empiric treatment if the 
susceptibility of the isolates is unknown or if the patient suffers from bacteremia (Hohmann 
	., 2001). For paediatric patients, treatment with a fluoroquinolone is contraindicated, and 
practitioners will rely on ceftriaxone or another 3rd generation cephalosporin (Hohmann 	., 
2001).  
Several studies from the United States, Canada and Denmark have shown an increased risk of 
hospitalization or even death associated with multi-drug resistant NTS compared with 
pansusceptible NTS. (Holmberg 	., 1987; Lee 	., 1994; Mølbak 	., 1999; Helms 	., 
2002; Martin 	., 2004; Helms 	., 2004; Varma 	., 2005a; Varma 	., 2005b). In a 
Danish study, an increased risk of invasive illness has been observed with 3.5% of the patients 
investigated being hospitalized. An increased mortality was recorded in 1.2% of the patients in up 
to two years after the infection. In both cases the infections were associated with quinolone or 
multi-drug resistant  Typhimurium (Helms 	., 2002; Helms 	., 2004).  
Recently, multi-drug resistant NTS have increased and have reached an alarming level 
worldwide. While the extent varies, the increased level of multi-drug resistant NTS has become a 
problem in all countries. Data have revealed that countries in Southeast Asia and Africa tend to 
have a high level of resistant NTS (Collard 	., 2007; Lee 	., 2009; Vanderberg 	., 
2009). Several publications have described the increasing occurrence of multi-drug resistant NTS 
and isolates resistant to both fluoroquinolone and 3rd generation cephalosporins in Southeast Asia 
and Africa (Archambault 	., 2006; Lauderdale 	., 2006; Aarestrup et al., 2007; Collard 
	., 2007; Vandenberg 	, 2009; Lee 	., 2009; III; IV; V). Lee 	. recently described the 
level of antimicrobial resistance from 2003 to 2005 in seven Southeast Asia countries. They 
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 found that Taiwan and Thailand demonstrated an alarming high frequency of resistance to 
fluoroquinolones and 3rd generation cephalosporins. These findings were also supported by 
Sirichote 	. who found cephalosporinases producing  Choleraesuis from Thai patients and a 
Danish traveler to Thailand harbouring both 	CTX-M-14 gene and 	CMY-2 gene (V). Hendriksen 
	. showed that among 33 Thai patients infected with Rissen 36%, 27%, 33%, 30%, 27%, 
and 88% of the isolates were resistant to ampicillin, chloramphenicol, spectinomycin, 
streptomycin, sulfamethoxazole, trimethoprim, and tetracycline, respectively (III). Another study 
highlights the same worrisome frequency of multi-drug resistance in children from Ethiopia (IV). 
The investigation revealed that among 43  Concord isolates, all isolates were resistant to 
ampicillin, chloramphenicol, streptomycin, sulfamethoxazole, and trimethoprim. In addition, 
97%, 97%, 69%, and 14% of the isolates showed resistant or decreased susceptibility to 
ceftriaxone, gentamicin, tetracycline, and ciprofloxacin, respectively. All of the isolates resistant 
to ceftriaxone harboured the 	CTX-M-15 gene and 13 of the isolates also the 	SHV-12 gene (IV). 
In response to worldwide increases in multi-drug resistance among human bacterial pathogens, 
the WHO has developed a list ranking the critically important antimicrobials. This categorization 
of antimicrobials is prioritized according to their importance in human medicine, and is intended 
to help assess the risks associated with resistance (Anonymous, 2007e; Collignon 	., 2009). In 
addition, individual countries without a strict antimicrobial policy should consider lowering the 
consumption of antimicrobials, ban antimicrobial growth promoters and enforce prescription-
only policies to accommodate the increasing frequency of multidrug resistant pathogens 
worldwide. 

MAIN RESERVOIRS
As a zoonotic foodborne bacterium, 			 has reservoirs in various animals. The most 
common domesticated animal hosts are chickens, pigs, and cattle; but many other domestic 
animals as well as a wide range of wild animals can also harbour this organism. Because of the 
ability of 			 to contaminate meat during slaughter and to survive in fresh meats and 
meat products that are not thoroughly heated, animal products constitute a main vehicle of 
transmission. Another important vehicle of transmission is eggs that are contaminated on the 
surface or in the interior of the egg. Finally, produce and other vegetables that are contaminated 
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 with animal manure during growing or processing are increasingly recognized as an important 
source of human 			 infections  
 
 

NTS have a wide range of hosts and reservoirs which mostly have been associated with 
agricultural product. Some of the NTS are host adapted or host restricted while others are non-
specific and cause infections in various hosts, leading to their division into two separate groups 
(Uzzau 	., 2000; Cray 	., 2000). 
The host restricted serovars cause disease in a limited number of animal species such as  
Abortusequi (horses),  Gallinarum (poultry),  Pullorum (poultry),  Typhisuis (swine), and  
Abortusovis (sheep). The host adapted serovars are most prevalent in one animal species, but are 
also able to cause severe illness in a limited number of other hosts. These serovars include  
Choleraesuis (predominantly in swine and human) and  Dublin (predominantly in cattle and 
human) (Uzzau 	., 2000; Chiu 	., 2004). There are limited data describing the reasons 
these serovars only affect a limited number of hosts compared to non-specific serovars which 
colonize a broad range of animals and humans (Uzzau 	., 2000). 
Some decades ago, Choleraesuis was in many countries one of the most predominant serovars 
isolated from swine (Cray 	., 2000). Recently, the prevalence decreased in Europe and is not 
presently listed among the top serovars isolated from swine (Uzzau 	., 2000; Anonymous, 
2007f; Anonymous, 2009a; Anonymous, 2009b). In many countries,  Choleraesuis is now 
believed to be eradicated. However, the incidence in the United States does not seem to have 
followed the same path as in Europe and Choleraesuis have not decreased to a similar level. 
Thus,  Choleraesuis represent a major swine pathogen in the United States and costs the 
producers an estimated $100 million annually (Gray 	., 1996; Uzzau 	., 2000). Despite the 
high prevalence in animals, it rarely causes human illness in the United States, with 
approximately 40 cases annually (Foley 	., 2008). Today,  Choleraesuis is mainly a problem 
in Southeast Asia, especially in Taiwan and Thailand, with high frequencies of human illness. 
This may be due to little effort to prevent and control this serovar, but also as a consequence of 
local small scale farming where infection control is difficult (Chiu 	., 2004; Foley 	., 2008; 
Lee 	., 2009; V; VI). 
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 In many European countries, surveillance shows that  Dublin is the most commonly isolated 
serovar from bovine meat, exceeding the level of  Typhimurium (Anonymous, 2009b). In 2007, 
it was the most common serovar in bovine meat from both Denmark and the Netherlands with 
68.2% and 63.3% of isolates, respectively. In the same year,  Dublin was also ranked as the 
most common serovar isolated from cattle herds in Austria (33.3%), Belgium (66.3%), Denmark 
(52.3%), Ireland (82.5%), the Netherlands (63.6%), Sweden (34.8%), and the United Kingdom 
(65.1%) among 15 European countries including Norway (Anonymous, 2009b).  
It is difficult to estimate the frequency of Dublin among cattle isolates from outside of Europe 
due to limited data.  Dublin is not listed among the most common serovars in cattle from either 
the Unites States, Canada or New Zealand (Wray 	., 2000; Anonymous, 2007c; Anonymous, 
2007d; Anonymous, 2008b). 
Because the reservoirs of the host adapted serovars are known, and limited in number, countries 
with a high number of human infections caused by these serovars could implement control 
strategies to eradicate the serovars among the reservoir in order to limit the transmission to man. 




The non-specific serovars are not restricted to a single host but able to colonize, and on occasion, 
cause severe illness or gastroenteritis in a wide range of animal species (Uzzau 	., 2000). 
Today, more than 2.579 different serovars are known to man (Grimont 	., 2007) but only a 
limited number of approximately 50 serovars are predominantly found in domestic animals. The 
primary reservoirs for the majority of the remaining serovars remain obscure. 
Several factors complicate a clear picture of the true link between the serovars and the animal 
reservoir such as the production systems (intensive / free range), irrigation (manure) and 
contamination of food sources (cross contamination). In addition, only a limited number of 
countries have established a systematic integrated laboratory-based surveillance system, which 
includes data from both food and animals. Despite these factors, some serovars appear to be more 
frequently associated with certain animal species and / or production systems than others.  
In Figure 7, the most commonly isolated serovars in 2007 from pig meat in eight European 
countries are illustrated (Anonymous, 2009b). Only two serovars; Typhimurium and  Derby 
were common for all nine countries. The same distribution of serovars was observed for pig herds 
for 17 European countries. A comparison with the incidents data from the United Kingdom 
 15
 Canada 
Swine, Abattoir 2007 
Serovars Percentages 
S. Typhimurium 30.4% 
S. Brandenburg 5.7% 
S. Infantis 5.7% 
S. London 4.8% 
S. Mbandaka 3.8% 
S. Agona 2.9% 
S. California 2.9% 
S. Heidelberg 2.9% 
S. Krefeld 2.9% 
Nine European countries 
Pig Meat 2007 
Serovars Percentages
S. Typhimurium 37.6% 
S. Derby 21.0% 
S. I [1],4,[5],12:i:- 4.4% 
S. Infantis 4.0% 
S. Rissen 3.4% 
S. Bredeney 2.8% 
S. London 1.6% 
S. Brandenburg 1.6% 
S. Enteritidis 1.3% 
The United States 
Pork Chop 2007
Serovars Percentages 
S. Infantis 27.8% 
S. Derby 22.2% 
S. Typhimurium 16.7% 
S. Mbandaka 11.% 
S. Hadar 5.6% 
S. Saintpaul 5.6% 
S. Montevideo 5.6% 
The United Kingdom 
Pigs, livestock 2007 
Serovars Percentages
S. Typhimurium 69.7% 
S. Derby 7.9% 
S. London 3.6% 
S. Anatum 2.4% 
S. Bovismorbificans 2.4% 
S. Kedougou 2.4% 
S. Reading 1.8% 
Thailand 
Pork 2003 
Serovars Percentages
S. Anatum 36.8% 
S. Rissen 15.8% 
S. Derby 14.0% 
S. Corvallis 8.8% 
S. Stanley 7.0% 
S. Panama 7.0% 
S. Bovismorbificans 5.3% 
S. Kedougou 5.3% 
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reveals the same complexity in pigs (livestock). In 2007, only three of the serovars described i
the overall prevalence of pig meat from the nine European countries were listed among the top
seven serovars isolated from pigs in the United Kingdom (Anonymous, 2007f). These data 
revealed that even within small geographical area huge changes may be present. Differences w
also revealed when compared with 2007 data from the United States  
n 
 
ere 
and Canada (Anonymous, 2008b; Anonymous, 2007c; Anonymous, 2007d). The top three most 
common serovars from pork chops in the United States were the same as observed in pig meat 
from Europe (Anonymous, 2007c). However, the list revealed additional serovars when surveyed 
marked hogs;  Johannesburg (9.9%),  Saintpaul (6.4%),  Adelaide (4.9%),  Agona (4.4%), 
and  Hadar (3.9%) (Anonymous, 2007c). The list was further expanded when assessing the data 
from Canada from swine abattoirs (Anonymous, 2008b). In Thailand, a different set of serovars 
were reported from pork isolated in 2004 (Figure 7) (Vindigni 	., 2007). It is still unknown if 
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 the huge number of serovars isolated from swine is a result of a better surveillance or if other 
factors contribute to the increase of serovars (Lee 	., 2009). 
It appears as the number of different serovars associated with cattle are just as diverse as for 
swine. In the European surveillance of bovine meat in 2007, three of the five countries have 
reported only two to three serovars (Figure 8) (Anonymous, 2009b).  
Canada
In the Netherlands and Denmark,  Dublin was the most prevalent serovar in bovine meat. 
However, in Ireland and Italy numerous serovars were isolated from bovine meat thus in both 
countries  Typhimurium was the most frequent serovar observed. The distribution of serovars 
in cattle herds from 15 European countries including Norway is quite different from the serovars 
in bovine meat from the five European countries. The only serovars ranked similarly in cattle 
herds compared to bovine meat are Typhimurium and . Dublin whereas several serovars, such 
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Bovine 2007 
Serovars Percentages 
S. Typhimurium 32.6% 
S. Kentucky 21.2% 
S. Cerro 9.8% 
S. I 6,14,18:-:- 8.3% 
S. Thompson 4.5% 
S. I 4:i 3.8% 
S. Schwarzengrund 3.0% 
S. Anatum 2.3% 
S. Montevideo 2.3% 
Five European countries 
Bovine Meat 2007 
Country data in Percentages Serovars 
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S. Typhimurium 38.9% 9.1% 34.3% 27.3% 9.1%
S. Dublin  68.2% 20.0%  63.6%
S. Enteritidis 22.2%  2.9% 5.5% 9.1%
S. Derby   8.6% 9.1%  
S. Infantis    1.8%  
S. Rissen   5.7% 3.6%  
S. I [1],4,[5],12:i:-    5.5%  
S. Bredeney    5.5%  
S. Kentucky   8.6%   
S. London 16.7%     
The United States 
Ground beef 2007 
Serovars Percentages 
S. Montevideo 23.4% 
S. Dublin 9.8% 
S. Muenster 7.6% 
S. Mbandaka 6.3% 
S. Newport 6.0% 
S. Typhimuriuml 5.2% 
S. Cerro 4.9% 
S. Meleagridis 4.4% 
S. Agona 4.1% 
S. Anatum 3.8 
S. Infantis 2.7% 
S. Kentucky 2.7% 
The United Kingdom 
Cattle 2007 
Serovars Percentages
S. Dublin 59.0% 
S. Typhimurium  14.3% 
S. Anatum  5.5% 
S. Mbandaka 4.2% 
S. Monetvideo 2.8% 
S. Newport 1.9% 
S. Agama 1.5% 
S. Ohio 1.0% 
Tunisia 
Cattle 1994-2004 
Serovars Percentages
S. Enteritidis 69.0% 
S. Amsterdam 7.7% 
S. Corvallis 7.0% 
S. Hadar 3.0% 
S. Anatum 2.6% 
S. Typhimurium 2.3% 
S. Livingstone 1.0% 
S. Infantis 0.5% 
S. Cerro 0.5% 
S. Braenderup 0.5% 
S. Mbandaka 0.5% 
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 as . Anatum, . Havana, . Goldcoast, . Give, . Bovismorbificants, are not listed among the 10 
most frequently isolated serovars in bovine meat (Anonymous, 2009b). The distribution of 
serovars in cattle based on livestock incidents data was for the United Kingdom different from 
the overall European data in 2007 (Anonymous, 2007f). In Tunisia, the prevalence of serovars in 
cattle was quite different from Europe. Between 1994 to 2004,  Enteritidis was ranked as the 
most common followed by Amsterdam and Corvallis (Ben-Aissa 	., 2007). In the United 
States,  Montevideo was the most common isolated serovar among ground beef followed by  
Dublin (Anonymous, 2007d).  Cerro seemed to be frequent in Canada where it was ranked as 
the third most common serovar in cattle (Anonymous, 2008b).  
 Enteritidis is probably best known for its association with poultry (>				) and egg. 
Today,  Enteritidis no longer ranks among the most common serovars in chickens in many 
countries and the prevalence is decreasing in both egg and chicken. In 2007,  Kentucky was 
listed as the most common serovar in broiler meat from Europe. However, this included only four 
(Austria, Czech Republic, Ireland, and Slovakia) out of 11 countries. All of the 11 countries in 
the European survey have rankedEnteritidis second (Figure 9) (Anonymous, 2009b). In 2007, 
Enteritidis is still ranked as the most common serovar isolated from flocks of >				 
among 14 European countries with exception of Germany where Livingstone is the most 
predominant serovar. Interestingly, a comparison of predominant serovars between chicken meat 
(>				, and flocks of >				 among European countries reveal some differences in 
the ranking of serovars shared by both reservoirs. In addition, frequently isolated serovars present 
in chicken meat such as . Kentucky, . Agona,  Ohio, and . Indiana are not ranked among the 
10 most common serovars in flocks of >				 whereas the opposite is the case with . 
Livingstone, . Mbandaka, . Seftenberg, and . Bredeney (Anonymous, 2009b). In the United 
Kingdom, additional serovars were observed being highly frequent mong chickens in 2007 
(Anonymous, 2007f). The same tendency of  Enteritidis decreasing was observed in 2007 
among broilers in the United States (Anonymous, 2007d). The exact same pattern as observed in 
the United States was seen in Canada where the same two serovars were listed first and second 
with approximately the same percentages (Figure 9) (Anonymous, 2008b). There is a need to 
regularly survey the primary animal reservoirs in order to detect the emergence of new and 
emerging serovars or sub-types such as for instance  Typhimurium DT 104, to elucidate their 
epidemiology, and epidemic potential, and to conduct targeted interventions to avoid 
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The United States 
Broiler 2007 
Serovars Percentages
S. Kentucky 47.1% 
S. Heidelberg 13.4% 
S. Enteritidis 10.8% 
S. Typhimurium 9.0% 
S. I [1],4,[5],12:i:- 4.6% 
S.Montevideo 2.2% 
S. Berta 1.5% 
S. Infantis 1.5% 
S. Mbandaka 1.1% 
 
Canada 
Chicken 2007 
Serovars Percentages
S. Kentucky 43.1% 
S. Heidelberg 17.8% 
S. Enteritidis 9.9% 
S. Hadar 5.0% 
S. I 4:i 3.5% 
S. Kiambu 3.0% 
S. Typhimurium 3.0% 
The United Kingdom 
Chicken 2007 
Serovars Percentages
S. Enteritidis 18.8% 
S. Livingstone 13.0% 
S. Senftenberg 8.9% 
S. Agama 8.3% 
S. Kedougou 7.3% 
S. Mbandaka 7.3% 
S. Gallinarum 3.1% 
S. Typhimurium 3.1% 
S. Ohio 3.1% 
 
Eleven European countries 
Broiler Meat 2007 
Serovars Percentages
S. Kentucky 17.5% 
S. Enteritidis 16.5% 
S. Paratyphi B (Java) 10.2% 
S. Typhimurium 7.2% 
S. Infantis 7.0% 
S. Hadar 4.7% 
S. Virchow 4.6% 
S. Agona 3.3% 
S. Ohio 1.9% 
S. Indiana 1.8% 
transmission to humans if necessary. In some countries, the primary animal reservoir might not 
be cattle, swine or poultry but reptiles or seafood. Several studies have shown that reptiles are 
reservoirs for 			 that are able to affect humans (Cooke 	., 2009; Pedersen 	., 
2009). Similarly, rare serovars have been suggested to be associated with seafood (Aarestrup 
	, 2003) and other serovars have found niches in small production settlements (Raufu 	., 
2009). 
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The primary reservoirs of NTS are the intestinal tracts of colonised food- and wild animals. In 
most industrialised countries, food of animal origin is the primary vehicle for human 
salmonellosis, however multiple routes of transmission has been documented including vector- 
and waterborne, animal-, human- and environmental contact, as well as many others. In the 
Netherlands,  Typhimurium isolated from a pig, a calf, and a child on a farm were identical, 
indicating animal-to-animal and animal-to-human transmission (Hendriksen 	., 2004). 
			 is passed on from the intestinal tract of the host to meat products during slaughter, 
where faecal contamination often occurs. Human infections are acquired from contaminated 
meats due to inadequate cooking or poor kitchen hygiene, the latter of which can result in cross-
contamination of uncooked foods such as vegetables (Figure 10).  
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 In 2007, 26.3% of human infections in Denmark were associated with domestically produced 
meat products, 11.7% were associated with imported meat, and 48.2% were associated with 
international travel (Anonymous, 2009a). Waste/manure from the production of food animals or 
from abattoirs often contains 			, which can survive for years outside its host in the 
environment, sewage, or slurry tanks. Faecally contaminated water from these reservoirs is a 
major route of 			 
transmission to vegetables and fruits, 
and can results in human infections. 
The increased demand from 
consumers for fresh vegetables and 
fruits year round has also resulted in 
an increased level of NTS outbreaks 
caused by these commodities. 
Several environmental factors 
contribute to produce contamination 
by NTS, such as irrigation and rinse 
of the crops in polluted fresh and 
waste water, some of which originated from animal production systems (Figure 11) 
(Sivapalasingam 	., 2003; Hanning 	., 2009). A recent review highlights examples of 
human outbreaks in the United States from 1950 to 2007 associated with vegetables and fruits. At 
least 25 different NTS in at least 15 different vegetable or fruit products were responsible for the 
outbreaks in this time period (Hanning 	., 2009). In 2004, an international outbreak associated 
with imported Italian rucola letters occurred in Sweden, Norway, and the United Kingdom 
(Nygård 	., 2008). This outbreak was caused by  Thompson and resulted in 21 reported 
cases, but was believed to be much larger in magnitude. In 2008, a multi-state outbreak in the 
United States was caused by  Saintpaul. A total of 1.442 persons from 43 states in the United 
States and Canada were infected, 286 of which were hospitalized and two died. The responsible 
vehicle was jalapeño peppers imported from Mexico, but Serrano peppers and tomatoes also were 
believed to have contributed to the outbreak. All of these products were contaminated with 
			 from irrigation water polluted by an animal source (Anonymous, 2008f). A large 
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 number of 			 infections caused by contaminated vegetables or inadequate cooking could 
probably be prevented if consumers followed basic kitchen hygiene regimes, such as frequent 
hand washing, thorough cleaning of raw vegetables, keeping hot items hot and cold items cold, 
and by the separation of raw meat and vegetables on the cutting board. 

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Recently, several countries have initiated the development of systems to attribute sporadic cases 
of human salmonellosis to specific sources, in the quest to control and prevent salmonellosis.  
In Denmark, a source attribution model was applied to retrospectively assess sources of 
salmonellosis between 
1988 and 2004. In 2000 
to 2001, 53.1% of all 
cases were linked to 
domestically produced 
food products – mainly 
table eggs (37.6%). 
However, the data also 
showed that 19% of all 
cases were travel 
related and 9.5% were 
associated with 
imported food products – dominated by chickens (Hald 	., 2007). In 2007, the travel 
associated cases increased considerably to 46% of all cases compared to the 2001 data, due in 
part to a substantial improvement in reporting travel information, and in part to a reduction in the 
number of domestically acquired infections (Anonymous, 2009a). Consequently, the infections 
acquired from domestically produced food items decreased to 19% in 2007. Similarly, a 
reduction in 			 cases that could be attributed to imported food products was observed in 
the 2007 data due to a huge decrease in the number of cases associated to imported chickens, 
probably due to enhanced control of imported food products. The overall results of the Danish 
source attribution system revealed that travel associated sources and imported food products were 
far more important risk factors of human 			 infections than was consumption of 
Travel (44.4-48.2%)
Unknown (20.0-26.8%)
Outbreak, source 
unknown (4.6%)
Pork (3.6-9.7%)
Chicken (0.1-1.8%)
Beef (0.2-1.6%)
Layers (8.9-13.2%)
Imported turkey (1.2-
1.8%) Imported chicken (2.1-
5.3%)
Imported beef (0.6-1.8%)
Imported pork (0.2-2.8%)
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 domestically produced products in 2007 (Figure 13) (Anonymous, 2009a). Countries with 
integrated laboratory-based surveillance systems could benefit from attributing the human 
infections to specific food categories, and other sources, and by this approach, gain knowledge 
that can enable them to target control, intervention, and prevention strategies to the most 
important sources.  
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In the last decade, the international trade of food has increased resulting in increasing import of 
cheaper food products from countries with little or no control programmes of foodborne 
pathogens. In addition, many of the imported food products contain multi-drug resistant 
foodborne pathogens (Aarestrup 	., 2007). Today, international trade of food products 
contaminated with not only NTS but all foodborne pathogens poses a threat to the public health. 
A retrospective study investigated the association between imported pig and pork from Germany 
and Spain and Thai food products and Thai patients with Danish patients all containing or 
infected with  Rissen (I). The data revealed that six out of nine isolates from imported pork had 
the same genetic Pulsed 
Field Gel Electrophoresis 
(PFGE) pattern as a Danish 
patient. Aarestrup 	
described the spread of 
Schwarzengrund resistant to 
nalidixic acid from 
imported Thai chicken to 
Denmark (Figure 12). The 
data showed that  
Schwarzengrund from 
Danish pigs were 
susceptible to nalidixic acid, 
in contrast to isolates from 
the Thai chicken. However, Danish patients were infected with both nalidixic acid resistant and 
susceptible  Schwarzengrund isolates, suggesting that Danish patients were affected by 
International travel 
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 consumption of Thai chickens imported to Denmark or consumed in Thailand, and domestically 
produced pigs (Aarestrup 	., 2007).  
The import of live animals is a means by which NTS can disseminate between countries. In 2003, 
the first case of NTS resistant to extended spectrum cephalosporins (ESC) occurred in a pig 
intended for breeding, which was imported into Denmark from Canada (Aarestrup 	., 2004). 
Microbiological study of the intestinal contents of this animal revealed the presence of a  
Heidelberg strain harboring the 	CMY-2 gene. While rare or absent in most regions of the globe, 
 Heidelberg ranks amongst the most prevalent causes of human salmonellosis in Canada and 
the United States. In addition, an increase in ESC resistance has been observed both by the 
Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) (Andrysiak 
	., 2008) and the U.S. National Antimicrobial Resistance Monitoring System (NARMS) (Folster 
	., 2009).  
			 infections caused by imported food and food animals represent an increasingly 
important cause of human infections in some countries, highlighting the need for better import 
control and testing. The approach could help limit the number of human infections, but result in 
considerable challenges for exporting countries and eventually limited the volume of infected 
food products.  
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In 2004, global travel reached a record of 763 million arrivals, an increase of 11% compared to 
2003 (www.world-tourism.org). The increase was observed in all regions but was most profound 
in Asia (28%) and the Middle East (18%). The intensity of international travel is a public health 
concern since an increasing number of travellers return home with mild or severe infections 
(Archambault 	 ., 2006; III; V). In 2008, 3,022 confirmed human salmonellosis cases were 
reported to Statens Serum Institute. Of these, 706 (23.3%) were confirmed to be travel associated 
and 95 (13.4%) of these cases were linked to travelling to Thailand (unpublished data). In the 
same year, 149.570 Danes visited Thailand (http://www.tourism.go.th/). The number of infected 
Danes returning back from Thailand might be underestimated and may have been 10-20 times 
higher (Wheeler 	., 1999). Taking this underestimation into consideration, 0.6% of the Danes 
visiting Thailand may have brought back a 			 infection in 2008 (V). The Swedish 
database on notifiable communicable diseases identified 24.803 NTS cases associated with 
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 international travel from 1997 to 2003. High risk of disease was seen in travellers returning from 
Africa, India, and Southeast Asia (Ekdahl 	., 2004). 
Three recent studies have linked Danish patients, suffering from either gastrointestinal infections 
or bacteremia, with travel to Thailand (Archambault  	., 2006; III; V). One investigation 
linked six  Rissen isolates recovered from Danish patients with travel to Thailand, where 
genetically identical  Rissen isolates were found. In addition, several of the isolates shared the 
same phenotypic and genotypic antimicrobial susceptibility patterns (III). Similarly, sporadic 
cases of travel associated salmonellosis have been frequently described (Collard 	 .; 2007; 
Kasper 	.; 2009). Recently, an outbreak of travel associated  Enteritidis illness was detected 
in Finland. Petrov 	. linked Finnish outbreak strains with strains from Sunny Beach, Bulgaria 
where employees at a hotel were also infected. The outbreak likely included tourists from the 
United Kingdom, Norway, Sweden, and Germany (Petrov 	., 2009). 
Multiple studies have revealed that international travel to certain destinations is associated with a 
relatively high risk of human salmonellosis. However, little has been done to avoid it. The best 
way to prevent it is ensure an adequate level of food safety globally, and by educating the general 
population about food borne disease prevention under different circumstances.  
 
 
	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The international adoption of children carrying and transmitting infectious diseases is probably a 
minor but clearly an overlooked problem. Since 1986, nearly 220.000 children have been adopted 
by North American families (Miller 	., 2005). In 2007, the most common countries of origin 
for Danish adoptions were China, Vietnam, South Africa and Ethiopia. For U.S. adoptions, most 
were from China, Guatemala, Russia and Ethiopia (IV). Today, international adoption medicine 
is a relatively new specialization in paediatrics that has emerged to address the specific health 
care needs of children and their adoptive families (Miller 	., 2005). Common infectious 
diseases in adopted children include tuberculosis, hepatitis B and C, HIV, syphilis, parasites and 
enteric infectious diseases (Miller 	., 2005). In 1997 and 1998, a study determined the 
prevalence of infectious diseases among 504 adoptees. The data revealed that 90% of the stools 
were abnormal and that two of the children carried a 			 species (Saiman 	., 2001).  
 25
 In France, fourteen  Babelsberg harbouring the 	SHV-12-like gene and six  Enteritidis isolates 
were detected in 2002 and 2003 from international adoptees. All of the children were traced back 
to one orphanage in Mali (Weill 	., 2004).  
Figure A
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In 2007, infections caused by  Concord were reported in several countries among children 
adopted from Ethiopia. A total of 3.419 children were adopted from Ethiopia from 2003 to 2007 
and brought to Denmark, England and 
Wales, Ireland, the Netherlands and the 
United States. 
During this period, the number of children 
adopted from Ethiopia increased from 221 
adoptions in 2003 to 1.385 in 2007. The 
five countries including Austria reported 
78 laboratory confirmed cases of  
Concord from 2003 to 2007 (Figure 14) 
(IV). Simultaneously, another study 
reported 35 French and 27 Norwegian 
cases of  Concord of which 28 and 26, 
respectively, originated in children from 
Ethiopia (Fabre 	., 2009). In a study 
by Hendriksen 	. where adoption 
status was known for 44 (79%) of the 
patients  3 years of age, 43 were adopted from Ethiopia. One patient  3 years of age and two 
patients 18 years of age were either a sibling or mothers to Ethiopia adoptees (IV). Six adoptees 
were asymptomatic at the time of adoption. In addition, the data showed that among 35 isolates, 
all from or associated with a child adopted from Ethiopia, were multi-drug resistant including 
resistance to third generation cephalosporins. Six (14%) also showed reduced susceptibility to 
ciprofloxacin. All of the 35 isolates harbored the 	CTX-M-15 gene and 17 of them also the 	SHV-
12 gene. Of the six ciprofloxacin resistant isolates three harbored a B gene (IV).This work 
indicates the need for mandatory screening of adoptees, not only for foodborne pathogens but 
also for viruses and parasites, for the benefit of the children and respectively new families. In 
)
*4@
	'

+

,	

			$+
0,
'
A
17721773+IV,

 26
 addition, the findings should be disseminated to the orphanages along with assistance to resolve 
the problem of infections. 
SURVEILLANCE

		
Surveillance is defined by the WHO as a systematic ongoing collection, collation, analysis, and 
interpretation of data and a timely 
dissemination of information to those 
who need to know so that public health 
actions can be taken (Figure 15). 
Surveillance is conducted to facilitate a 
better control of diseases and lead to 
public health actions such as outbreak 
detection, to measure the magnitude, the 
burden, and trends of disease, to 
improve the knowledge of the disease (causes, sources, reservoirs, risks, morbidity, and 
mortality), guide programmes to measure the effectiveness of interventions, and to assist 
policymakers in setting priorities. To date, four generic types of enteric disease surveillance 
systems exist; no formal (occasional) surveillance, syndromic surveillance, laboratory-based 
surveillance, and integrated laboratory-based surveillance. The last two types are mostly 
associated with foodborne pathogens and stand out from the first two types of surveillance 
systems by being based on laboratory results. Integrated foodborne surveillance refers to 
concomitant testing of isolates from humans, animals and foods, and may include environmental 
and animal feed samples.  
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Surveillance of NTS infections in humans is conducted in a hierarchical structure from local to 
global. Since 2000, the WHO has volunteered to collect data and facilitate a global surveillance 
of 			 by establishing the CDB. Global surveillance is relative important as it render 
analysis of the major trends worldwide limiting the influence of local outbreaks and other 
elements which complicate interpretation (II, Galanis 	., 2006). Ongoing overall trend 
analysis may provide crucial knowledge of emerging serovars on global level which might result 
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 in pandemic proportions and millions of cases or pin out regional endemic serovars. In addition, 
global surveillance may also identify problems of global importance which may be difficult to 
detect due to the limitations in national surveillance such as occurrences of important rare 
serovars in low frequencies present in several countries (IV). Regional or national surveillance 
are mostly governed by the individual countries and conducted by national or regional public 
health institutes. Regional or national surveillance allows the scientists to narrow the focus on 
specific national emerging or rare serovars. The focus offers the opportunity to initiate detailed 
epidemiological and molecular studies and set priorities for intervention strategies and elucidate 
associated risk factors (III, V, VI, Bangtrakulnonth 	., 2004, Archambault 		., 2006, 
Tapalski 	., 2007, Petrov 	., 2009). Local surveillance is often restricted to a confined 
geographical area such as a large city compared to rural areas. This often results in detection of 
local minor outbreaks. 

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In the last decade, our ability to distinguish in a rapid and reliable way between 
epidemiologically unrelated isolates from the same bacterial species has increased, thereby 
enhancing our capacity to detect outbreaks, conduct surveillance and understand or elucidate the 
epidemiology of certain types or clones. Thus, bacterial typing techniques have been developed 
to measure genetic relatedness among emerging pathogenic strains, clones or clusters of bacteria 
from a single species.  
In the beginning of the bacterial typing era, typing systems were based solely on phenotypic 
methods such as serotyping (Grimont 	., 2007), phage typing (Smith 	., 1951; Guinee and 
Scholtens, 1967; Sechter and Gerichter, 1968; Petrow 	., 1974; Rowe 	., 1980; Tyc 	., 
1980; Scarlata 	., 1982; Sharma 	., 1984; Sood and Basu, 1984; Ward 	., 1987) 
and antibiogram typing (Figure 16). These methods are currently in use in many countries as part 
of national surveillance programmes. The results obtained by these phenotypic tests, particularly 
serotyping, have been the basis for the elucidation of the epidemiology of NTS for decades. In 
addition, conventional serotyping and antimicrobial susceptibility testing are excellent 
surveillance tools and also used as first line methods in outbreak detection caused by NTS. 
Recently, several DNA fingerprinting and array techniques have been developed serving as an 
alternative to the conventional serotyping method (McQuiston 	., 2004; Fitzgerald 	., 
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 2007). By merging these two 
methods one should be able to 
identify the major serotypes 
(McQuiston 	., 2004). The 
method has proved its worth in 
the characterization of a 
monophasic variant of  
Goettingen where conventional 
serotyping was insufficient 
(Petrov 	., 2009).  
Phenotypic methods may not have sufficient discriminatory power in an outbreak situation, and 
may need to be supplemented with molecular techniques such as PFGE (Raufu 	., 2009; III; 
IV; V). The number of genotyping methods and their discriminatory power has increased and 
several methods have been implemented to meet public health needs. The most commonly used 
genotyping method for surveillance and outbreak detections is PFGE (Tenover 	., 1995; Ribot 
	., 2006; van Belkum 	., 2007), however Multi Locus Sequence Typing (MLST) and 
Multiple Locus Variable Number Tandom Repeat Analysis (MLVA) (Lindstedt 	., 2003; 
Tapalski 	., 2007; van Belkum 	., 2007; Lindstedt 	., 2008) are also commonly used. In 
the near future, these methods will likely be superceded by microarray technologies and full 
genome sequencing (Maslow 	., 1993; Foxman 	., 2005; van Belkum 	., 2007).  
Since 1984, PFGE has been standardized for 			 testing, allowing comparison of patterns 
between laboratories around the world (Ribot 	., 2006). Similarity indexes have partly 
replaced the criteria by Tenover 
	 by implementation of the 
BioNumerics software (Applied 
Maths, Sint-Martens-Latem, 
Belgium) for interpretation of the 
PFGE profiles. In the United States, 
the preferred subtyping method is 
currently PFGE used by PulseNet 
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 USA for outbreak detection (Gerner-Smidt 	., 2006) and it has also shown to be useful in 
epidemiological studies of NTS worldwide (III; IV; V).  
Scientists in PulseNet USA are currently developing a MLVA scheme for both . Typhimurium 
and  Enteritidis. The strategy is to first integrate these new methods into the PulseNet platform 
to complement PFGE data (Gerner-Smidt 	., 2006). There is still a need for a common MLVA 
nomenclature in order to compare results among laboratories. However, a recent publication 
proposes such a nomenclature that is independent of equipment and primers used (Larsson 	., 
2009). Before applying a typing technique, it is important to understand and evaluate the 
strengths and weaknesses of the methods. Certain criteria are normally used to assess this such as  
the discriminatory power, 
reproducibility, typeability, 
and repeatability (Figure 17). 
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A good typing method should 
give the same result each time 
tested in the same laboratory 
(repeatability) but also when 
tested in different 
laboratories (reproducibility). Typically, sequence-based methods are more repeatable and 
reproducible than gel based methods (Table 1). At the same time the methods should be able to 
assign a specific type to all tested isolates (typeability) and furthermore, be able to assign a 
different type to two epidemiologically unrelated isolates sampled randomly from a population of 
the same bacterial species (discriminatory power) (Foxman 	., 2005; van Belkum 	., 
2007). In addition, several other aspects also affect the choice of typing techniques such as the 
costs, accessibility, and workload.  
Typing technique Discriminating 
power 
Repeatability Reproducibility Comment 
Whole genome 
sequencing Very High High Medium / High  
MLST Medium / High High Medium / High Depends on gene choice 
MLVA High High High  
PFGE Medium / High Medium Medium 
Depends on 
type and 
number of 
enzyme used.  
Conventional 
serotyping Medium Medium Medium  
 

		
In February 1997, a global survey of the 191 WHO member states was initiated to estimate the 
number of countries conducting public health surveillance of 			. Only 76 (73%) of 104 
countries reported conducting 			 surveillance ranging from all countries in Europe to 
40% of the countries in the Western Pacific region. A total of 69 countries among the 76 
countries conducting surveillance of 			 included serotyping (Herikstad 	., 2002). 
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 This number is quite low considering that 			 in many countries is either the first or 
second most common foodborne bacterial pathogen.  
Despite the low number of countries conducting surveillance based on serotyping, some countries 
have a long tradition for 			 surveillance or have recently initiated the programmes. One 
of the countries that stand out as having conducted laboratory-based surveillance for at least 15 
years is Thailand. Each year, the National Institute of Health publishes an annual report of 
laboratory-confirmed 			 and 
		 in Thailand (Bangtrakulnonth 	., 2006). This is 
one among many reasons why many international 			 studies have been based on or 
included Thai data (Bangtrakulnonth 	., 2004; Archambault 	., 2006; Aarestrup 	., 
2007; Vindigni 	., 2007; III; V; VI). In addition to the Thai program, several other countries 
conduct annual 			 surveillance including New Zealand (Anonymous, 2008a), South 
Africa (Anonymous, 2008c), the United States (Anonymous, 2008e), Canada (Anonymous, 
2008b), Korea, Denmark, Norway, and Sweden. 
In the United States, several institutes independently conduct 			 surveillance in humans, 
food and animals (Jones 	., 2007). The Centers for Disease Control and Prevention (CDC) 
collect data on reported laboratory confirmed 			 cases of human origin to the National 
			 Surveillance System (NSSS) through the Public Health Laboratory Information 
System (PHLIS). The PHLIS database contains data from all state and territorial public health 
laboratories (Anonymous, 2008e). The United States Department of Agriculture, Food and Safety 
Inspection Service (USDA-FSIS) and the United States Food and Drug Administration Center for 
Veterinary Medicine (FDA-CVM) collect 			 data from food animals and retail meats, 
respectively. 
Integrated laboratory-based 			 surveillance systems are established in a small number of 
countries such as the United Kingdom (Anonymous, 2007f), Australia (OzFoodNet Working 
Group, 2003), and Denmark (Anonymous, 2009a). In the United States, the surveillance in 
humans is from all 50 states in contrast to animals, which are from all federally inspected 
abattoirs (Jones 	., 2007). However, in Canada an integrated surveillance programme for 
antimicrobial resistance has been established (Anonymous, 2008b) which also includes serovar 
distribution. 
In contrast, only a few developing countries have a 			 surveillance system implemented 
and none of these systematically integrates data from humans, food, and animals.  
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 In developing countries, information on foodborne pathogens is limited due to several factors 
such as patients who do not seek medical care, samples that are not processed and/or reported 
data to central public health institutes. In Mexico, syndromic surveillance was replaced in 2002 
by an integrated laboratory-based surveillance system in four states. The sampling scheme was 
designed to follow the food chain in a temporal mode. In a test week, food animal intestines were 
collected on the first sampling day, followed by raw retail meats on the second to the fourth day. 
From day 7 to 14, fecal samples from asymptomatic children were collected. This surveillance 
revealed high rates of contaminated meat and ceftriaxone resistant salmonellae. Genotyping data 
showed 14 PFGE clusters with indistinguishable patterns associated with human, retail meat, and 
food animals (Zaidi 	., 2008). This approach could be technical feasible for many developing 
countries for future surveillance efforts. Unfortunately, it is too expensive why the described 
study is currently not operating.  
One could wish that WHO had the power and authority to strengthen through Codex 
Alimentarius mandatory laboratory-based surveillance of foodborne pathogens in food animals, 
food and humans in order to gain detailed data for initiating action to prevent human 
salmonellosis.  
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In 2003, the European Parliament and Council, adopted; Directive 2003/99/EC on the monitoring 
of zoonoses and zoonotic agents (Anonymous, 2003a; O’Brien et al., 2005) amending Decision 
90/424/EEC (Anonymous, 1990) and repealing Council Directive 92/117/EEC (Anonymous, 
1992). The purpose of the Directive 2003/99/EC was, among other things, to ensure a proper and 
harmonised surveillance of zoonoses including 			. The Directive was supplemented later 
the same years with the Regulation 2160/2003 on the control of 			 and other specified 
foodborne zoonotic agents, which in principle should cover the whole food chain, from farm to 
table (breeding flocks of Gallus gallus, laying hens, broilers, turkeys, herds of slaughter, pigs, 
breeding herds of pigs) (Anonymous, 2003b; O’Brien 	., 2005). The sampling should take 
place over a three year period with the possibility of extension. The surveillance should take 
place on a harmonised basis by all member states according the detailed rules laid down in the 
regulation. In addition, all national reference laboratories should participate in proficiency testing 
arranged by the Community Reference Laboratory (CRL) to insure a high quality of the results 
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submitted. The data are 
complied and published 
annually by the European 
Food Safety Authority 
(EFSA) (Anonymous, 
2009b) including human 
data collected by European 
Centre for Disease 
Prevention and Control 
(ECDC) and through the 
European Surveillance 
System.  
Others (1)
S. Enteritidis (2)
S. Stanley (3)
S. Weltevreden (4)
S. Rissen (5)
S. I 4, 12:i:- (6)
S. Choleraesuis (7)
S. Anatum (8)
S. Typhimurium (9)
S. Corvallis (10)
S. Panama (11)
S. Kedougou (12)
S. Hvittingfoss (13)
S. Derby (14)
S. Albany (15)
S. Virchow (16)
The experience from the 
European Union has 
proven how important it is 
to design the surveillance 
program to include as 
many of the countries and 
the population as possible and to ensure a high quality of the data. Nevertheless, the overall 
serovar distribution and frequencies in the EFSA report does not necessarily reflect the 
distribution of serovars in a single country. Several studies have shown large differences in the 
distribution of NTSbetween countries but also among regions within a country (V; VI). 
Hendriksen 	. revealed that the serovar distribution varied considerably among five regions 
within Thailand as 15 serovars were listed among the top 10 most common serovars in the 
regions (Figure 18). In Thailand, the distribution of serovars seemed to be culturally linked, and 
was for instance influenced by differences in pork and poultry consumption between the 
Buddhist North and the Muslim population in Southern Thailand (VI). 
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In Thailand, a large amount of data has been generated, but it is not easily accessible. 
Nevertheless, harmonizing surveillance programmes will in the future be of high priority in order 
to have comparable data on occurrence and frequencies between countries and regions, and to 
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 facilitate joint actions directed towards the most important sources of human infections in a 
region or country.  
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
Sporadic cases and outbreaks caused by NTS is often linked to consumption of meat, egg and 
recently also to contaminated fruits and vegetables (Nygård 	., 2008; Hanning 	., 2009). In 
the United States, 121 			 outbreaks were recorded to the CDC Foodborne Outbreak 
Reporting System in 2006. The outbreak consisted of more than 3.300 cases and the most 
common serovars responsible for the outbreaks were  Enteritidis (n=26),  Typhimurium 
(n=26),  Newport (n=10), and  Heidelberg (n=10) (Anonymous, 2008e). In comparison, there 
were in 2007 observed six outbreaks caused by 			 which accounted for 12% of all 
outbreaks in Denmark. The serovars involved in these outbreaks were  Typhimurium (n=27), . 
Weltevreden (n=19), . Heidelberg (n=13),  Enteritidis (n=9), and Senftenberg (n=3) 
(Anonymous, 2009a). In 2007, a total of 2.201 outbreaks were reported in 22 European countries 
ranging from five in Ireland and Romania to 843 in Germany.. Enteritidis was by far the most 
common serovar responsible for the outbreaks (n=355) infecting 5.940 humans. The second most 
common serovar was . Typhimurium with 63 outbreak (Anonnymous, 2009d). 
In recognition that infections, including outbreaks, may originate in different countries, the Salm-
net project was established in 1993 under the leadership of the Health Protection Agency (HPA). 
A main goal of Salm-net was to harmonise the 			 phage typing schemes used in Europe 
(Fisher 	., 2004; Hald 	., 2004). Participants in the Salm-net project were public health 
reference laboratories in the European Union, Norway, Switzerland, Australia, Canada, Japan, 
and South Africa. Salm-gene, another European network established by HPA, began in 2001 to 
build a database based for 			 PFGE profiles among European countries. By the end of 
2004, the Salm-gene database contained approximately 20.000 profiles of primarily  Enteritidis 
and  Typhimurium (Swaminathan 	., 2006). In 2004, the Salm-gene network merged with 
Enter-Net which later became PulseNet Europe in 2004 (O’Brien 	., 2005; Fisher 	., 
2005). 
In the United States, PulseNet USA was established in 1996 as the national molecular 
surveillance network for foodborne infections (Gerner-Smidt 	., 2006). The aim of the 
network was to rapidly detect outbreaks caused by foodborne pathogens by the use of the PFGE. 
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 In 2001, full national participation by all 50 states was achieved. By 2005 the network consisted 
of 65 participating public health laboratories, four countries, three cities and eight food safety 
regulatory laboratories. All PFGE profiles are uploaded to the national database where local or 
multi-state outbreaks are investigated. In 1999, PulseNet USA harmonised protocols with 
PulseNet Canada forming PulseNet International (Swaminathan 	., 2006). PulseNet USA and 
PulseNet Canada have investigated numerous multi-national outbreaks, showing the advantage of 
international collaboration in food safety surveillance. In addition to PulseNet USA and PulseNet 
Canada, PulseNet networks have been established in the Asia Pacific region, Latin America, 
Europe, and China.  Surveillance by PulseNet Europe ceased in 2007 due to lack of funding, but 
it is expected that funding from the ECDC will resume in 2010. 
 
CONTROL, INTERVENTION, AND PREVENTION 
	
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Surveillance of NTS is not only about collecting data, but also analyzing the data to identify 
critical points of intervention. Many types of analyses are possible. Case control studies to 
identify risk factors can be sufficient to focus interventions and prevention measurements. Source 
attribution modelling can provide detailed information about the nature and magnitude of 
different reservoirs contributing to infection. Source attribution is partitioning of the human 
disease burden of one or more foodborne infections to specific sources, guiding authorities to 
prioritise intervention and control efforts and measuring the impact (Pires 	., 2009). Several 
factors need to be known to attribute burden to specific sources. A laboratory-based surveillance 
system must be in place, and the burden of illness determined. In addition, the proportion of 
foodborne disease due to international travel should be estimated and food items categorised. In 
2004, a Danish mathematical model was published for quantifying the number of domestic and 
sporadic cases caused by different serovars and phage types as a function of the prevalence of the 
same serovars in each major animal or food sources (Hald 	., 2004). In the following years, 
the model was enhanced to include information on antimicrobial susceptibility. Using this model, 
researchers in Denmark were able to quantify the contribution of various animals, foods, and 
international travel to human infections with resistant NTS(Hald 	., 2007). In the United 
States, the Foodborne Diseases Active Surveillance Network (FoodNet) adopted the same model 
to attribute the human 			 cases to various sources (Gerner-Smidt 	., 2006).  
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Denmark has one of the best national programs in the world for controlling and preventing 
			, and other nations look to Denmark for leadership in this area. In the 1980s, the 
incidence of salmonellosis in Denmark steadily increased, and was linked to the consumption of 
broiler chicken and pork. This led to a targeted national control programme (Wegener 	., 
2003; Mousing 	., 1997) based on the general prevention strategy known as Hazard Analysis 
and Critical Control Points (HACCP). HACCP is a systematic preventive approach to food safety 
that addresses physical, chemical and biological hazards as a means of prevention, rather than 
finished product inspections. The HACCP strategy is to identify key steps (critical control points) 
in the chain from farm to fork (Busani 	., 2006) where interventions will have the most impact 
in reducing or eliminating food safety hazards.  
In 1995, the most extensive nation-wide control programme ever attempted was launched in 
Danish finishing swine herds. All swine herds were tested and categorized based on their 
			 prevalence. Herds were assigned to three categories: herds with low and acceptable 
prevalence, moderate prevalence, and clearly unsatisfactory prevalence (Wegener 	., 2003). 
Swine herds belonging to the unsatisfactory category were slaughtered using special hygienic 
precautions according to the inherent risk. In 2001, the classification scheme was extended to 
include a fourth category, namely, herds being negative in serological tests (Alban 	., 2002).  
A similar approach was implemented for poultry. All shell eggs from layer flocks should be free 
from  
Enteritidis and  
Typhimurium, 
and suspected or 
confirmed 
positive eggs 
should be 
pasteurized prior 
to marketing. In 
addition, )
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 infected flocks either were eliminated or slaughtered separately or late in the day to avoid cross-
contamination (Wegener 	., 2003; Hald 	., 2005). These control programmes and targeted 
interventions resulted in a major reduction in the incidence of human salmonellosis in Denmark. 
The broiler, pork, and egg associated salmonellosis incidences were reduced by 95% (1988 to 
2001), 85% (1993 to 2001), and 75% (1997 to 2001), respectively (Figure 19) (Wegener 	., 
2003). The benefit of implementing the control programmes by eliminating infected animals and 
diversifying slaughter were estimated to save the taxpayers in Denmark $25.5 million annually. 
In 2003, the European Parliament and Council issued, in combination with the harmonised 
surveillance system, Regulation 2160 on the control of 			 and other specified food-
borne zoonotic agents. This regulation was intented to control 			 and other specified 
foodborne zoonotic agents by reducing transmission from poultry and pigs (Anonymous, 2003b). 
The regulation enforced strict rules for all Member States to reduce the prevalence of 			 
in primary production. The control programmes target breeding flocks of >			in 2004, 
followed by laying hens, broilers, turkeys, slaughter pigs and breeding pigs over the subsequent 
four years (Anonymous, 2003b). 
The increased number of human infections caused by international travel is in many countries a 
major concern. Currently, there is no vaccine to prevent infections caused by NTS for travellers. 
Thus, in many countries, public health authorities have initiated campaigns to educate the public 
on steps to reduce the risk of salmonellosis. Consumers are advised not to eat raw or 
undercooked eggs, poultry or meat, not to consume raw and unpasteurised dairy products, and to 
clean vegetables before consumption. The WHO instituted a similar communication programme 
as part of their global strategy to decrease the burden of foodborne diseases. This lead to the 
WHO report “The Five Keys to Safer Food”, which was published in 2001, and included and 
associated training materials developed to provide countries with materials that are easy to use, 
reproduce and adapt to different target audiences (www.who.int/foodsafety/consumer/5keys/en/). 
Several publications have shown that adopted children carrying 			 is an overlooked 
problem (Saiman 	., 2001; Weill 	., 2004; Fabre 	., 2009; IV). The American Academy 
of Paediatrics recommends that a stool specimen be collected from all adopted children entering 
the United States and cultured for the presence of bacterial pathogens such as 			 
(Hostetter 	., 1991; Nicholson 	., 1992; Stauffer 	., 2002). The utility of this 
recommendation was highlighted to all countries in a study where family members were infected 
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 with  Concord which was introduced by adopted children (IV). Another approach in preventing 
travel associated salmonellosis is by publishing data on the burden of salmonellosis, and routes of 
transmission, in different countries. Thus, urging the country to take action to limit the sources of 
infections among the general population and travelers by improving the food safety. (Aarestrup 
	., 2007; V; VI). However, this might be a challenge due to the limited knowledge of the 
epidemiology of 			 in developing countries and the circumstances associated with the 
production systems, which often are many small operations where animals are reared with 
minimal oversight such as free range.  
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To date, only a few studies describe effective serovars-specific control programmes that do not 
rely on vaccination. Multidrug resistant . Typhimurium DT104 appeared in the 1980s and 
became a major cause of salmonellosis around the world. In Denmark, a component to control 
and prevent . Typhimurium DT104 to spread and cause infections in humans was incorporated 
into the existing control program for pig herds (Alban 	., 2002). Farmers with . 
Typhimurium DT104 infected herds had to follow a herd intervention plan which included 
restrictions on livestock trade and special slurry management. Carcasses of infected pigs had to 
be heat treated or decontaminated before leaving the abattoir (Nielsen 	., 2001). Likewise, a 
Danish control programme for Dublin was launched in 2002 attempting to reduce the 
increasing number of human infections and the economic losses for the cattle industry, where this 
serovars was a problem. In contrast to the control programme in pigs, this programme sought to 
identify cattle herds free of infection by periodic measurement of  Dublin antibody titres in bulk 
milk and by modelling the spread between herds (Hald 	., 2005; Jordan 	., 2008). The 
outcome of the modelled control programme showed that restricting the movement of herds 
between regions was more important that attempting control within herds. However, a 
combination seems to be more effective but needs to be further explored (Jordan 	., 2008). 
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To date, all attempts to develop a comprehensive vaccine for humans and animals that will cover 
all important serovars of 			 have failed. Today, only vaccines for humans against  
Typhi exist. One study revealed that a Vi Typhi vaccine did not protect against . Paratyphi A 
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 or B since these serovars do not express the Vi polysaccharide. However, a Ty21a  Typhi 
vaccine conferred substantial cross protection against  Paretyphi B but not to  Paratyphi A 
(Levine 	., 2009). This example highlights the difficulties in developing 			 vaccines. 
A major problem is that both serovar-dependent and host-dependent factors, as well as the 
attributes influencing serovar host specificity, are unknown among the more than 2.500 serovars 
(Barrow 	., 2007). Some success has been seen with . Enteritidis, which is associated with 
chickens and is mainly transmitted in eggs. In the United Kingdom, a widespread vaccination 
program was implemented for egg-laying hens to reduce transmission of  Enteritidis. The 
programme was successful in achieving a significant decrease of human infections caused solely 
by  Enteritidis (Gast 	., 2007). 
FUTURE PREDICTIONS AND PERSPECTIVES 
Zoonotic infections are responsible for a large and growing proportion of the mortality and 
morbidity throughout the world. Foodborne zoonoses will likely continue to be important in the 
future as the global population moves more toward meat products as a source of protein 
(Merianos 	., 2007; Murphy 	., 2008). In general, the human infections caused by NTS 
will most likely not significantly decrease in the future unless the global intervention towards 
eggs succeeds. However, the serovar distribution will probably on a global scale be influenced by 
increased trade, travel and consumption of exotic food or food produced to low costs (III; IV; 
V;VI ). 
Most of the research conducted in the last decades has been focused on  Enteritidis and  
Typhimurium, while relatively little is know about the epidemiology of rare serovars with the 
potential to increase globally.  
Recently focus on NTS in the African region revealed that serovars causing gastrointestinal 
infections also are invasive (Morpeth 	., 2009). We predict to see stronger evidence of NTS 
causing bacteremia in humans from Africa in time due to the efforts by WHO to implement and 
enhance 			 surveillance and burden of illness studies in this area. Another alarming 
development which lay ahead is the increasing frequency of antimicrobial resistance in NTS. In 
the last decade, the Western world has tried to minimise the usage of fluoroquinolones and third 
and fourth generation cephalosporins in both the human and veterinary medicine. These two drug 
classes are paramount in treating salmonellosis caused my multi-drug resistant strains. Recently, 
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 the WHO has stated that antimicrobial resistance is a global public health concern and has top 
priority. Evidence shows extensive usage and resistance to fluoroquinolones and third and fourth 
generation cephalosporins from developing countries, driven in part by low prices and weak or 
absent use restrictions (Archambault 	., 2006; Aarestrup 	., 2007; Fabre 	., 2009; Lee 
	., 2009; II; IV).  
In the past two decades, our understanding of 			 biology and epidemiology has grown 
tremendously. Advances in technology are moving toward rapid, high-throughput, 
comprehensive analytical methods. It is highly likely that many, if not all, phenotyping 
techniques will be supplanted by platforms based on DNA sequence and gene expression tools. 
To make this transition, it will be necessary to validate the sequenced-based methods to the older 
phenotypic methods in order to avoid the loss of knowledge and the ability to compare with 
“historical” data (Hyytiä-Trees 	., 2007). It is expected that within the next decade, microbial 
genomic sequencing will become inexpensive and routine worldwide. Currently, the technique is 
faced with a limiting factor of how to assemble, process and handle the large amount of data full 
genome sequencing will create. Despite of this limitation, software to resolve this problem will 
most likely be developed in the future making rapid tools for analysis available for extraction of 
biological and epidemiological data. The data could be applied in multiple ways for typing, 
genetic comparison or even non-specific vaccines. 
Over the past decade, the WHO GFN has promoted capacity building for integrated, laboratory-
based surveillance through training courses and activities around the world. The network consists 
of more than 1200 researchers in more than 700 institutes in 158 member states and 64 training 
courses have been conducted to date. It is expected that more countries will establish 			 
laboratory-based or integrated laboratory-based surveillance. One challenge is to ensure 
international harmonization of surveillance systems so that data can be directly compared. 
Despite of the good intention for conducting surveillance in a global context the benefit for 
developing countries might be controversial. 			 infections in developing countries are 
frequently endemic resulting in a high incidence of symptomatic infections primarily in children 
causing immunity. Food consumption is often based on locally produced food and with the 
acquired immunity it is likely to result in much fewer outbreaks compared to e.g. the United 
States. It will require huge investments in sanitation infrastructure as a whole to decrease the 
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 burden of 			 in these countries in contrast to a recall of a specific food product in a 
developed country (Zaidi 	., 2009). 
The recent development of source attribution models and the increased number of developed 
countries conducting integrated laboratory-based surveillance will most certainly results in more 
countries attributing human infections to various sources. An increased number of countries 
performing source attribution will probably enable epidemiologists to target control and 
prevention programmes to the principal reservoirs and serovars responsible for the majority of 
salmonellosis cases in a global context to avoid a new pandemic. In addition, applied research 
linking across the human, livestock and food products is needed to increase preparedness 
planning and the development of evidence-based approaches to zoonotic disease prevention and 
control (Merianos 	., 2007). Therefore, long term planning that takes into consideration the 
unique nature of zoonosis is needed.  
 
CONCLUSIONS AND RECOMMENDATIONS  
The studies included in this thesis have confirmed the importance of international travel and 
consumption of imported food for NTS infections in humans. Globally, the serovars . Enteritidis 
and . Typhimurium seems to decrease in relative importance whereas a large diversity of other 
non-specific serovars are increasing; indicating that serovar specific interventions for . 
Enteritidis and . Typhimurium are ineffective against other NTS. Reliable serotyping data 
revealed large differences among commonly isolated serovars between continents and less 
difference between countries within the same continent. Global surveillance identified common 
problems in several countries, which then was elucidated by detailed epidemiological and 
molecular studies. Country specific studies have also revealed differences between regions within 
a country associated with specific risk factors. The thesis illustrates the value of global 
harmonised surveillance in detecting global trends and identifying local and global problems 
which then were elucidated. The thesis also illustrates the great value of combining epidemiology 
and molecular microbiology. There is still a huge lack of knowledge regarding the global 
epidemiology of 			. There is a global need for implementing timely systematic 
integrated laboratory-based surveillance for 			 in combination with extensive collection 
of epidemiological data to target prevention and intervention strategies to diminish the worldwide 
burden of human salmonellosis.  
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An international external quality assurance system (EQAS) for the serotyping of Salmonella species was
initiated in 2000 by WHO Global Salm-Surv to enhance the capacity of national reference laboratories to
obtain reliable data for surveillance purposes worldwide. Seven EQAS iterations were conducted between 2000
and 2007. In each iteration, participating laboratories submitted serotyping results for eight Salmonella
isolates. A total of 249 laboratories in 96 countries participated in at least one EQAS iteration. A total of 756
reports were received from the participating laboratories during the seven EQAS iterations. Cumulatively, 76%
of participating laboratories submitted data for all eight strains, and 82% of strains were correctly serotyped.
In each iteration, 84% to 96% of the laboratories correctly serotyped the Salmonella enterica serovar Enteritidis
isolate that was included as an internal quality control strain. Regional differences in performance were
observed, with laboratories in Central Asia and the Middle East performing less well overall than those in
other regions. Errors that resulted in incorrect serovar identiﬁcation were typically caused by difﬁculties in the
detection of the phase two ﬂagellar antigen or in differentiation within antigen complexes; some of these errors
are likely related to the quality of the antisera available. The results from the WHO Global Salm-Surv EQAS,
the largest of its kind in the world, show that most laboratories worldwide are capable of correctly serotyping
Salmonella species. However, this study also indicates a continuing need for improvement. Future training
efforts should be aimed at enhancing the ability to detect the phase two ﬂagellar antigen and at disseminating
information on where to purchase high-quality antisera.
Salmonella species are among the most important food-
borne pathogens, leading to millions of cases of diarrheal ill-
ness and thousands of hospitalizations and deaths worldwide
each year (3, 7).
More than 2,500 serovars of Salmonella enterica have been
identiﬁed; most human infections are caused by a limited num-
ber of serovars. In many developed countries, Salmonella en-
terica serovars Typhimurium and Enteritidis are the most com-
mon causes of human salmonellosis (5, 6, 8).
In other regions, however, other serovars have been re-
ported to be more prevalent (1, 3, 5). Changes in the preva-
lences of speciﬁc serovars can result from the movements of
people, animals, and food. Correct serotyping is essential for
discerning such changes and therefore is essential for efﬁcient
outbreak detection and response resulting from laboratory-
based surveillance.
In January 2000, the World Health Organization (WHO)
launched WHO Global Salm-Surv, a global effort to enhance
the laboratory-based surveillance of Salmonella infections and
other food-borne diseases and to promote prevention and con-
trol activities. Enhancing worldwide serotyping of Salmonella
species is a key objective of WHO Global Salm-Surv and is
facilitated by bench training at international training courses.
To ascertain the performance of participating laboratories
and thereby promote enhanced laboratory-based surveillance,
an external quality assurance system (EQAS) was established
as a part of the WHO Global Salm-Surv program in 2000.
Since then, the WHO Global Salm-Surv EQAS has grown to
be the largest of its kind worldwide (4, 9). Among other activ-
ities, the EQAS conducts an assessment of the capacities of
laboratories to correctly serotype Salmonella species by ship-
ping eight blinded Salmonella isolates for serotyping. Iterations
of the EQAS are organized yearly by Denmark’s National
Food Institute (DTU Food) in collaboration with WHO, the
U.S. Centers for Disease Control and Prevention (CDC), and
France’s Institut Pasteur. The WHO Global Salm-Surv EQAS
is a self-evaluating system: after submitting their results to the
EQAS Web-based reporting system via a secured individual
log-in pass code, participants receive a report that itemizes
errors relative to the expected results. The report is intended
to be used by the participants for evaluating the accuracy of
current techniques and the quality of antisera. The goal is to
have all laboratories perform serotyping of Salmonella with a
* Corresponding author. Mailing address: National Food Institute,
Bu¨lowsvej 27, DK-1790 Copenhagen V, Denmark. Phone: 45 35 88 70
00. Fax: 45 35 88 60 01. E-mail: rshe@food.dtu.dk.
 Published ahead of print on 1 July 2009.
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maximum of one error out of eight isolates. Here we report the
results of the ﬁrst seven iterations of the WHO Global Salm-
Surv EQAS Salmonella serotyping procedures, conducted
from 2000 to 2007. In 2005, no iteration was conducted, due to
an internal assessment of the system.
MATERIALS AND METHODS
Participation in the WHO Global Salm-Surv EQAS is open to all laboratories
free of charge. An invitation to participate in each EQAS iteration was an-
nounced through Electronic Discussion Group messages, which are received by
WHO Global Salm-Surv members. All members receive these messages by
e-mail or by fax. Previous messages are archived on the WHO Global Salm-Surv
website (http://www.who.int/salmsurv/activities/bulletin_board/en/). In 2007,
WHO Global Salm-Surv membership included 1,000 microbiologists and epi-
demiologists from 152 countries representing 140 national reference laborato-
ries (animal, food, or public health). Scientists who attended WHO Global
Salm-Surv international training courses were automatically registered as WHO
Global Salm-Surv members. Through 2008, 56 training courses were held at 17
training sites worldwide. The training curricula provided in these courses typi-
cally include both classroom and laboratory instructional modules on the iden-
tiﬁcation and serotyping of Salmonella species.
Eight Salmonella strains, based on the global prevalence of the serotypes, were
selected for each EQAS iteration (3). Strains were obtained from the isolate
collection of DTU Food. The same strain of Salmonella serovar Enteritidis was
included as an internal quality control in 2000, 2001, 2004, 2006, and 2007. For
the 2002 iteration, an alternate but phenotypically identical strain of Salmonella
serovar Enteritidis was chosen. All other strains were included only once in the
EQAS iterations. Some serovars (e.g., Salmonella serovar Typhimurium) were
utilized in multiple iterations; however, these strains had different antimicrobial
resistance proﬁles (Table 1).
All Salmonella isolates included in the EQAS were serotyped at DTU Food,
the CDC, and Institut Pasteur; the serotypes obtained served as the reference
standard. O (somatic) and H (ﬂagellar) antigens were characterized by aggluti-
nation with hyperimmune sera, and serotypes were assigned according to the
Kauffmann-White scheme (11).
Testing instructions and a “participating laboratory record sheet” (PLRS)
were copied to a compact disc, enclosed with the Salmonella agar stab cultures in
double-pack containers (class UN 6.2), and sent to the participating laboratories
according to the International Air Transport Association regulations as “Biolog-
ical Substance Category B,” classiﬁed as UN 3373. Prior to shipping, each
participating laboratory was notiﬁed of the shipping arrangements that had been
made for the parcels and was given the airway bill number to enable it to track
the package and pick it up from the airport. Import permits were necessary for
shipping the parcels to several countries.
WHO Global Salm-Surv EQAS participation was free of charge, but each
participating laboratory was expected to cover the expenses associated with its
testing of the strains in its facility. Participating laboratories were provided with
instructions for the initial subculture of the Salmonella strains. Participating
laboratories serotyped the isolates using protocols routinely utilized in their
institutions; therefore, instructions for serotyping the isolates were not provided.
Laboratories were required to submit results by uploading the PLRS onto the
WHO Global Salm-Surv website or by submitting the completed PLRS by fax to
DTU Food.
After submitting results, each participating laboratory received an individual
report. Laboratories that submitted results via the website received an instant
report via the secure website, and laboratories that sent the results by fax or
e-mail received the report using media. The individual reports included all errors
and suggestions on how to either solve or investigate the problem. Errors are
deﬁned as results that are different from the expected serotypes. Errors were
reported as incorrect results only, and no attempt was made to quantify their
severity. Fisher exact tests were performed to assess the signiﬁcance of the
observed changes in correct serotyping results and reported errors. Laboratory
participation over the years was assessed by logistic regression, and a P value
of0.05 was regarded as signiﬁcant for all statistical tests. SAS Enterprise Guide
software (version 3.0; SAS Institute, Cary, NC) was used for the statistical
analyses.
RESULTS
A total of 249 laboratories in 97 countries participated in at
least one of the seven iterations of EQAS from 2000 to 2007;
44 laboratories in 35 countries participated in 2000, 96 labo-
ratories in 55 countries in 2001, 99 laboratories in 61 countries
in 2002, 127 laboratories in 72 countries in 2003, 127 labora-
tories in 71 countries in 2004, 130 laboratories in 66 countries
in 2006, and 140 laboratories in 68 countries in 2007. The
average number of participating laboratories per EQAS itera-
tion between 2000 and 2007 was 102. One hundred twenty-ﬁve
laboratories participated in three or more iterations, and 92
laboratories participated in four or more iterations. The par-
ticipating laboratories included national reference laborato-
ries; veterinary, food, and regional public health laboratories;
and clinical laboratories. One or more institutions from the
countries listed in Table 2 participated in at least one of the
EQAS iterations.
The percentage of participating laboratories that performed
serotyping on all eight strains during the seven iterations
ranged from 54% to 92%, with an average of 76% (Table 3).
The percentage of participating laboratories that correctly se-
rotyped the Salmonella serovar Enteritidis isolate that was
included in six of the seven iterations increased over the years,
although the increase was not statistically signiﬁcant (P 
0.37), from 92% (2000) to 96% (2007).
The percentage of correct serotyping results oscillated in the
initial years, decreasing from 76% in 2000 to 72% in 2001 and
rising to 91% in 2002. In the 2003 cycle, the percentage of
correct serotyping results was 80%, and since then it has in-
creased annually, reaching 88% in 2007. Overall, logistic re-
gression indicates a signiﬁcant increase in the percentage of
correct serotyping results over the years (P  0.01), and the
average percentage of correctly serotyped isolates across all 7
years was 82% (Table 3).
The goal of the EQAS program is for all participating lab-
oratories to perform Salmonella serotyping with a maximum of
one error. A total of 756 PLRSs were received during the seven
EQAS iterations. The percentage of laboratories reaching the
threshold of reporting one or zero errors increased signiﬁ-
cantly (P  0.04), from 48% in 2000 to 68% in 2007 (data not
shown). In addition, the 2007 iteration was the ﬁrst in which
every participating laboratory correctly identiﬁed at least one
strain.
A wide range of incorrect results was observed across the
seven-cycle study period. The rate of errors ranged from 3.6%
(2007) to 41.0% (2006). The rate of errors also differed widely
between the different isolates within a single year. For exam-
ple, in 2001, rates of incorrect results for a single isolate ranged
from 9.6% for the Salmonella serovar Typhimurium isolate to
38.0% for a Salmonella serovar Kottbus isolate.
A Salmonella enterica subsp. enterica serovar 4,5,12:i: iso-
late included in the 2006 iteration accounted for the greatest
number of incorrect results (Table 1). A total of 38 laborato-
ries (31.1%) incorrectly serotyped this isolate as Salmonella
serovar Typhimurium. Salmonella enterica subsp. enterica ser-
ovar 4,5,12:i: is a common monophasic variant in both Eu-
rope and North America. Characterization of other Salmonella
enterica subsp. enterica serovar 4,5,12:i: strains suggests that
these strains are most likely variants of Salmonella serovar
2730 HENDRIKSEN ET AL. J. CLIN. MICROBIOL.
 by on A
ugust 31, 2009 
jcm
.asm
.org
D
ow
nloaded from
 
TABLE 1. List of Salmonella serotypes and errors (EQAS, 2000 to 2007)
Yr WHOno. Correct serotype Correct formula
No. of labs
serotyping
%
Errors Deviating serotype (formula) (no. of labs)
a
2007 7.1 Concord 6,7:l,v:1,2 125 19.2 Mkamba (I 6,7:l,v:1,6) (5), Potsdam (I 6,7,14:l,v:e,n,z15) (4), Colorado
(I 6,7:l,w:1,5), Bonn (I 6,7:l,v:e,n,x), Gabon (I 6,7:l,w:1,2), Kortrijk
(I 6,7:l,v:1,7), Langeveld (I 6,7:l,w:e,n, z15), Nessziona (I 6,7:l,z13:1,5),
Ohio (I 6,7,14:b:l,w), Oakland (I 6,7:z:1,6,7), Panama (I 1,9,12:l,v:1,5),
Richmond (I 6,7:y:1,2), Strathcona (I 6,7:l,z13, z28:1,7), Thompson
(I 6,7,14:k:1,5), Virchow (I 6,7,14:r:1,2), Wil (I 6,7:d: l,z13, z28),
Salmonella spp.
2007 7.2 Enteritidis 9,12:g,m: 140 3.6 Blegdam (I 9,12:g,m,q:), Dublin (I 1,9,12;Vi:g,p:), Potsdam
(I 6,7,14:l,v:e,n,z15), Rissen (I 6,7,14:f,g:), Warragul (I 1,6,14,25:g,m:)
2007 7.3 Livingstone 6,7,d:l,w 128 10.9 Kambole (I 6,7:d:1;2,7) (3), Gabon (I 6,7:l,w:1,2) (2), Paratyphi C
(I 6,7,Vi:c:1,5) (2), Gombe (I 6,7,14:d:e,n,z15), Herston (I 6,8:d:
e,n,z15), Isangi (I 6,7,14:d:1,5), Kisii (I 6,7:d:1,2), Nievkerk (I 6,7,14:d:z6),
Ohio (I 6,7,14:b:l,w), Typhi (I 9,12,Vi:d:)
2007 7.4 Montevideo 6,7:g,m,s: 131 6.9 Salmonella enterica subsp. II (3), Chincol (I 6,8:g,m,s:e,n,x), Eboko
(I 6,8:b:1,7), Menston (I 6,7:g,s,t:1,6), Othmarschen
(I 6,7,14:g,m,t:), Rissen (I 6,7,14:f,g:)
2007 7.5 Mbandaka var. 14 6,7,14:z10:e,n,z15 131 14.5 Braenderup (I 6,7,14:e,h:e,n,z15) (6), Djugu (I 6,7:z10:e,n,x) (2), Aequatoria
(I 6,7:z4,z23:e,n,z15), Denver (I 6,7:a:e,n,z15), Georgia (I 6,7:b:e,n,z15),
Glostrup (I 6,8:z10:e,n,z15), Gombe (I 6,7,14:d:e,n,z15), Kaduna
(I 6,7,14:c:e,n,z15), Kastrup (I 6,7:e,n,z15:1,6), Larose (I 6,7:g,z51:e,n,z15),
Lockleaze (I 6,7,14:b:e,n,x), Montevideo (I 6,7,14:g,m,p,s:1,2,7),
Papuana (I 6,7:r:e,n,z15)
2007 7.6 Elisabethville 3,10:r:1,7 130 10.0 Weltevreden (I 3,10,15:r:z6) (5), Simi (I 3,10:r:e,n,z15) (2), Salmonella
spp. (2),Give (I 3,10,15, 15,34:d,l,v:1,7), Montevideo
(I 6,7,14:g,m,p,s:1,2,7), Seegefeld (I 3,10:r,i:1,2), Westhampton
(I 3,10,15, 15,34:g,s,t:)
2007 7.7 Poona 13,22:z:1,6 121 14.0 Bristol (I 13,22:z:1,7) (2), Farmsen (I 13,23:z:1,6) (2), Salmonella spp. (2),
Borbeck (I 13,22:l,v:1,6), Derby (I 1,4,5,12:f,g:1,2), Durban
(I 9,12:a:e,n,z15), Gabon (I 6,7:l,w:1,2), Kuru (I 6,8:z:l,w), Manhattan
(I 6,8:d:1,5), Marburg (I 13,23:k:), Montevideo (I 6,7,14:g,m,p,s:1,2,7),
Nyanza (I 11:z:z6:z83), Saugus (I 40:b:1,7), Salmonella subsp. II
2007 7.8 Isangi 6,7:d:1,5 136 13.2 Kisii (I 6,7:d:1,2) (4), Kambole (I 6,7:d:1;2,7) (2), Livingstone
(I 6,7,14:d:l,w) (2), Paratyphi C (I 6,7,Vi:c:1,5) (2), Wil
(I 6,7:d:l,z13,z28) (2), Choleraesuis (I 6,7:c:1,5), Herston (I 6,8:d:e,n,z15),
Manhattan (I 6,8:d:1,5), Nievkerk (I 6,7,14:d:z6), Poitiers (I 6,7:z:1,5),
Salmonella spp.
2006 6.1 Salmonella I
4,5,12:i:
1,4,12:i: 122 41.0 Typhimurium (I 1,4,5,12:i:1,2) (38), Farsta (I 4,5:i:e,n,x) (3), Gloucester
(I 1,4,12,27:i:l,w) (2), Agama (I 4,12:i:1,6), Lagos (I 1,4,5,12:i:1,5),
Mathura (I 9,46:i:e,n,z15), Paratyphi B (I 1,4,5,12:b:1,2), Tsevie
(I 4,12:i:e,n,z15), Tumodi (I 1,4,12,27:l,z15,z28:1,5), Salmonella subsp. V
2006 6.2 Saintpaul 1,4,12:e,h:1,2 119 11.8 Sandiego (I 4;5,12:e,h:e,n,z15) (6), Chester (I 1,4,5,12:e,h:e,n,x) (2),
Reading (I 1,4,5,12:e,h:1,5), Bardo (I 8,e,h:1,2), Typhimurium
(I 1,4,5,12:i:1,2), Paratyphi B (I 1,4,5,12:b:1,2), Chartres
(I 1,4,12:e,h:l,w), I 4,12::b
2006 6.3 Virchow 6,7:r:1,2 121 9.9 Nigeria (I 6,7:r:1,6) (4), I 6,7:r: (3), Bsilla (I 6,8:r:1,2), Infantis
(I 6,7,14:r:1,5), Lomita (I 6,7:e,h:1,5), Papuana (I 6,7:r:e,n,z15), Ngili
(I 6,7:z10:1,7)
2006 6.4 Rissen 6,7:f,g: 118 11.0 Montevideo (I 6,7,14:g,m,p,s:1,2,7) (5), Eingedi (I 6,7:f,g,t:1,2,7) (2),
Othmarschen (I 6,7,14:g,m,t:) (2), Blegdam (I 9,12:g,m,q:), Derby
(I 1,4,5,12:f,g:1,2), Oranienburg (I 6,7,14:m,t:z57), Sandow
(I 6,8:f,g:e,n,z15)
2006 6.5 Reading 4,5,12:e,h:1,5 121 16.5 Saintpaul (I 1,4,5,12:e,h:1,2) (6), Sandiego (I 4;5,12:e,h:e,n,z15) (3),
Chester (I 1,4,5,12:e,h:e,n,x) (2), Bradford (I 4,12,27:r:1,5), Derby
(I 1,4,5,12:f,g:1,2), Enteritidis (I 1,9,12:f,g,m,p:1,7), Eppendorf
(I 1,4,12,27:d:1,5), Hato (I 1,4,5,12:g,m,s:), Mono (I 4,12:l,w:1,5),
Paratyphi B (I 1,4,5,12:b:1,2), Typhimurium (I 1,4,5,12:i:1,2),
I 4,5,12::b
2006 6.6 Enteritidis 9,12:g,m: 124 6.5 Gallinarum (I 1,9,12:,) (2), Berta (I 1,9,12:f,g,t:), Blegdam
(I 9,12:g,m,q:), Bournemount (I 9,12:e,h:1,2), London (I 3,10,15:l,v:1,6),
Montevideo (I 6,7,14:g,m,p,s:1,2,7), Typhi (I 9,12,Vi:d:)
2006 6.7 London 3,10:l,v:1,6 111 9.9 Amherstiana (I 8:l,v:1,6) (2), Give (I 3,10,1515,34:d,l,v:1,7) (2),
Birmingham (I 3,10:d:l,w), Clackamas (I 4,12:l,v:1,6), Nchanga
(I 3,10,15,l,v:1,2), Ruzizi (I 3,10:l,v:e,n,z15), Sinstorf (I 3,10:l,v:1,5),
Stockholm (I 3,10,15:y:z6), Suberu (I 3,10:g,m:)
2006 6.8 Give 3,10:l,v:1,7 114 9.6 London (I 3,10,15:l,v:1,6) (4), Nchanga (I 3,10,15,l,v:1,2) (2),
Amsterdam (I 3,10,1515,34:g,m,s:), Bredeney (I 1,4,12,27:l,v:1,7),
Kortrijk (I 6,7:l,v:1,7), Mokola (I 3,10:y:1,7), Stormont (I 3,10:d:1,2)
2004 5.1 Give 3,10:l,v:1,7 111 26.1 London (I 3,10,15:l,v:1,6) (9), Parkroyal (I 1,3,19:l,v:1,7) (3), Meleagridis
(I 3,10,1515,34:e,h:l,w) (3), Joal (I 3,10:l,z28:1,7) (2), Nchanga
(I 3,10,15,l,v:1,2) (2), Anatum (I 3,10,1515,34:e,h:1,6),
Assinie (I 3,10:l,w:z6), Cannonhill (I 3,10,15,19:y:e,n,x), Elisabethville
(I 3,10:r:1,7), Litchﬁeld (I 6,8:l,v:1,2), Newbrunswick,b Nyborg
(I 3,10,15:e,h:1,7) Ruzizi (I 3,10:l,v:e,n,z15), Sinchew (I 3,10:l,v:z35),
Sinstorf (I 3,10:l,v:1,5)
2004 5.2 Braenderup var. 14 6,7,14:eh:enz15 110 6.8 Larochelle (I 6,7:e,h:1,2) (2), Norwich (I 6,7:e,h:1,6) (2), Larose
(I 6,7:g,z51:e,n,z15), Lomita (I 6,7:e,h:1,5), Sanjuan (I 6,7:a:1,5)
Continued on following page
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TABLE 1—Continued
Yr WHOno. Correct serotype Correct formula
No. of labs
serotyping
%
Errors Deviating serotype (formula) (no. of labs)
a
2004 5.3 Corvallis 8,20:z4z23: 88 20.5 Chailey (I 6,8:z4,z23:e,n,z15) (5), Dabou (I 8,20,z4,z23:l,w) (4), Albany
(I 8,20,z4,z23:) (3), Ackwepe (I 9,46:l,w:), Breda (I 6,8:z4,z23:e,n,x),
Hindmarsh (I 8,20:r:1,5), Kallo (I 6,8:k:1,2), Kentucky (I 8,20:i:z6), Noya
(I 8:r:1,7)
2004 5.4 Heidelberg 4,12:r:1,2 116 16.3 Magumeri (I 1,6,14,25:e,h:1,6) (2), Remo (I 1,4,12,27:r:1,7) (2), Typhimurium
(I 1,4,5,12:i:1,2) (2), Winneba (I 4,12:r:1,6) (2), Africana (I 4,12:r,i:l,w),
Agona (I 1,4,5,12:f,g,s:1,2), Fayed (I 6,8:l,w:1,2), Hidalgo
(I 6,8:r,i:e,n,z15), Kalamu (I 1,5,512:z4,z24:1,5), Kiel (I 1,2,12:g,p:),
Ljubljana (I 4,12,27:k:e,n,x), Paratyphi B (I 1,4,5,12:b:1,2), Saintpaul
(I 1,4,5,12:e,h:1,2), Sandiego (I 4;5,12:e,h:e,n,z15), Schwarzengrund
(I 1,4,12,27:d:1,7)
2004 5.5 Chester 4,5,12:eh:enx 110 40.0 Sandiego (I 4;5,12:e,h:e,n,z15) (26), Saintpaul (I 1,4,5,12:e,h:1,2) (5),
Abortusequi (I 4,12::e,n,x) (3), Agona (I 1,4;5,12:f,g,s:1,2), Goldcoast
(I 6,8:r:l,w), Haıˆfa (I 1,4,5,12:z10:1,2), Kaapstad (I 4,12:e,h:1,7), Magumeri
(I 1,6,14,25:e,h:1,6), Paratyphi B (I 1,4,5,12:b:1,2), Sarajane
(I 1,4,5,12,27:d:e,n,x) Texas (I 4,5,12:k:e,n,z15)
2004 5.6 Corvallis 8,20:z4z23: 87 23.0 Albany (I 8,20,z4,z23:) (5), Dabou (I 8,20,z4,z23:l,w) (4), Hailey
(I 6,8:z4,z23:e,n,z15) (3), Bellevue (I 8:z4,z23:1,7) (2), Rechovot
(I 8,20:e,h:z6) (2), Newport (I 6,8,20:e,h:1,2:z67) (2), Bardo (I 8:e,h:1,2),
Bovismorbiﬁcans (I 6,8,20:r,i:1,5)
2004 5.7 Mbandaka 6,7,:z10:enz15 104 20.2 Djugu (I 6,7:z10:e,n,x) (7), Menden (I 6,7:z10:1,2) (4), Redba (I 6,7:z10:z6)
(2), Gabon (I 6,7:l,w:1,2), Infantis (I 6,7,14:r:1,5), Lindenburg
(I 6,8:i:1,2), Lockleaze (I 6,7,14:b:e,n,x), Namibia (I 6,7:c:e,n,x), Omuna
(I 6,7:z10:z35), Paratyphi C (I 6,7,Vi:c:1,5), Thompson (I 6,7,14:k:1,5)
2004 5.8 Enteritidis 9,12:gm: 120 5.8 Blegdam (I 9,12:g,m,q:) (3), Berta (I 1,9,12:f,g,t:), Gallinarum
(I 1,9,12:,), Goverdhan (I 9,12:k:1,6), Typhi (I 9,12,Vi:d:)
2003 4.1 Montevideo 6,7:g,m,s: 119 10.9 Salmonella subsp. II (4), Menston (I 6,7:g,s,t:1,6) (3), Oakland
(I 6,7:z:1,6,7), Oranienburg (I 6,7,14:m,t:z57), Riggil (I 6,7:g,t:),
Rissen (I 6,7,14:f,g:), Sanjuan (I 6,7:a:1,5), Schwarzengrund
(I 1,4,12,27:d:1,7)
2003 4.2 Schwarzengrund 4,12:d:1,7 119 15.1 Stanley (I 1,4,5,12,27:d:1,2) (5), Ayinde (I 1,4,12,27:d:z6) (2), Ahmadi
(I 1,3,19:d:1,5), Brezany (I 1,4,12,27:d:1,6), Duisburg (I 1,4,12,27:d:e,n,z15),
Eppendorf (I 1,4,12,27:d:1,5), Kambala (I 1,42:c:z6), Magumeri
(I 1,6,14,25:e,h:1,6), Mons (I 1,4,12,27:d:l,w), Montevideo
(I 6,7,14:g,m,p,s:1,2,7), Sarajane (I 1,4,5,12,27:d:e,n,x), Southampton
(I 4,12,27:r:z6), Typhimurium (I 1,4,5,12:i:1,2)
2003 4.3 Paratyphi B (var.
Java)
1,4,5,12:b:1,2 118 23.7 Abony (I 1,4,5,12,27:b:e,n,x) (3), Typhimurium (I 1,4,5,12:i:1,2) (3),
Derby (I 1,4,5,12:f,g:1,2) (2), Schleissheim (I 4,12,27:b:) (2),
Saintpaul (I 1,4,5,12:e,h:1,2) (2), Salmonella subsp. (2), Uppsala
(I 1,4,12,27:b:1,7) (2), Athinai (I 6,7:i:e,n,z15), Agona
(I 1,4,5,12:f,g,s:1,2), Brandenburg (I 4,5,12:l,v:e,n,z15), Fortune
(I 1,4,12,27:z10:z6), Hato (I 1,4,5,12:g,m,s:), Indiana (I 1,4,12:z:1,7),
Lagos (I 1,4,5,12:i:1,5), Onarimon (I 1,9,12:b:1,2) Sandiego
(I 4;5,12:e,h:e,n,z15), Wagenia (I 1,4,12,27:b:e,n,z15), II Chartres
(I 4,12: e,n,x:1,2,7), Abony (I 1,4,12,27:b:e,n,x), Salmonella subsp. II
2003 4.4 Panama 9,12:l,v:1,5 120 14.2 Enteritidis (I 1,9,12:f,g,m,p:1,7) (2), Javiana (I 1,9,12:l,z26:1,5) (2),
Kapemba (I 9,12:l,v:1,7) (2), Lawndale (1,9,12:z:1,5) (2), Dublin
(I 1,9,12,Vi:g,p:), Goettingen (9,12:l,v:e,n,z15), London
(I 3,10,15:l,v:1,6), Irumu (I 6,7:l,v:1,5), Italiana,b Itami (I 9,12:l,z13:1,5),
Paratyphi C (I 6,7,Vi:c:1,5), Sarajane (I 1,4,5,12,27:d:e,n,x), Victoria
(I 1,9,12:l,w:1,5)
2003 4.5 Cerro 18:z4,z23: 91 35.2 Aarhus (I 18:z4,z23:z64) (9), Bousso (I 1,6,14,25:z4,z23:e,n,z15) (5),
Salmonella subsp. III (3), Salmonella subsp. IV (3), Arapahoe
(I 6,14:z4,z23:1,5), Blukwa (I 6,14,18:z4,z24:), Chailey
(I 6,8:z4,z23:e,n,z15), Chichiri (I 6,14,24:z4,z24:), Corvallis
(I 8,20:z4,z23:z4), Memphis (I 18:k:1,5), Obogu (I 6,7:z4,z23:1,5)
Siegburg,b Tallahassee (I 6,8:z4,z32:), Usumbura (I 6,14,18:d:1,7),
Virchow (I 6,7,14:r:1,2), I 6,7:z4,z23:, Salmonella subsp. II
2003 4.6 Havana 13,23:f,g: 96 19.8 Raus (I 13,22:f,g:e,n,x) (6), Okatie (I 13,23:g,s,t:) (2), Afula
(I 6,7:f,g,t:e,n,x), Agbeni (I 1,13,23:g,m,s,t:) Berta (I 1,9,12:f,g,t:),
Bron (I 13,23:g,m:e,n,z15) Chagoua (I 1,13,23:a:1,5), NewYork
(I 13,22:g,s,t:), Poona (I 1,13,22:z:1,6:z44), Rissen (I 6,7,14:f,g:), Tees
(I 16:f,g:), Tschangu (I 1,13,23:e,h:1,5), Worthington (I 1,13,23:z:l,w)
2003 4.7 Vinohrady 28:m,t: 75 29.3 Abadina (I 28:g,m:e,n,z15) (4), Morillons (I 28:m,t:1,6) (4), Salmonella
subsp. II (3), Croft (I 28:g,m,s:e,n,z15) (2), Hatﬁeld (I 28:d:1,6), Nitra
(I 2,12:g,m:), Othmarschen (I 6,7,14:g,m,t:), Panama
(I 1,9,12:l,v:1,5), Pomona (I 28:y:1,7:z60), Southbank
(I 3,10,15,15,34:m,t:1,6) Techimani (I 28:c:z6), Tennessee
(I 6,7,14:z29:1,2,7), II 28.9,m,s,t:1,5
2003 4.8 Singapore 6,7:k:enx 113 15.0 Thompson (I 6,7,14:k:1,5) (5), Escanaba (I 6,7:k:e,n,z15) (2), Salmonella
subsp. II (3), Braenderup (I 6,7,14:e,h:e,n,z15). Kastrup (I 6,7:e,n,z15:1,6)
Ljubljana (I 4,12,27:k:e,n,x), Mbandaka (I 6,7,14:z10:e,n,z15), Norwich
(I 6,7:e,h:1,6), Paratyphi C (I 6,7,Vi:c:1,5), Rissen (I 6,7,14:f,g:)
2002 3.1 Virchow 6,7:r:1,2 93 18.3 Infantis (I 6,7,14:r:1,5) (9), Colindale (I 6,7:r:1,7) (5), Galiema
(I 6,7,14:k:1,2), Senegal (I 11:r:1,5), Thompson (I 6,7,14:k:1,5)
Continued on following page
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Typhimurium that arose following loss of the phase two ﬂagel-
lin gene ﬂjB (2).
Incorrect serovar identiﬁcation was often caused by incor-
rect detection of the phase two ﬂagellar antigen. In many
instances, erroneous serotyping results differed from the ex-
pected serovar only by the phase two ﬂagellar antigen (Table
1). Discrimination within the H antigen complexes (E, G, and
L) also accounted for a signiﬁcant number of errors.
TABLE 1—Continued
Yr WHOno. Correct serotype Correct formula
No. of labs
serotyping
%
Errors Deviating serotype (formula) (no. of labs)
a
2002 3.2 Derby 4,12:f,g: 91 7.1 Agona (I 1,4,5,12:f,g,s:1,2) (3), Essen (I 4,12:g,m:), Fyris
(I 4,5,12:l,v:1,2), Kiel (I 1,2,12:,p:)
2002 3.3 Weltevreden 3,10:r:z6 91 7.7 Elisabethville (I 3,10:r:1,7) (3), Seegefeld (I 3,10:r,i:1,2), Ughelli
(I 3,10:r:1,5), Weltevreden (I 3,10,15:r:z6), Wilmington (I 3,10:b:z6)
2002 3.4 Senftenberg 1,3,19:g,t: 89 17.1 Westhampton (I 3,10,15,15,34:g,s,t:) (6), Rideau (I 1,3,19:f,g:) (2),
Catanzaro (I 6,14:g,s,t:), Kingston (I 1,4,5,12,27:g,s,t:1,2), Maiduguri
(I 1,3,19:f,g,t:e,n,z15), Suberu (I 3,10:g,m:), Salmonella spp.
2002 3.5 Typhimurium var. 5

4,12:i:1,2 96 4.3 Agona (I 1,4,5,12:f,g,s:1,2), Choleraesuis (I 6,7:c:1,5), Kingston
(I 1,4,5,12,27:g,s,t:1,2), Lagos (I 1,4,5,12:i:1,5)
2002 3.6 Manhattan 6,8:d:1,5 90 15.4 Dunkwa (I 6,8:d:1,7) (2), Isangi (I 6,7,14:d:1,5) (2), Muenchen
(I 6,8:d:1,2:z15) (2), Blockley (I 6,8:k:1,5), Bovismorbiﬁcans
(I 6,8,20:r,i:1,5), Duesseldorf (I 6,8:z4,z24:), Kottbus (I 6,8:e,h:1,5),
Newport (I 6,8,20:e,h:1,2:z67), Yovokome (I 8,20:d:1,5)c
2002 3.7 Enteritidis 9,12:g,m: 95 9.2 Dublin (I 1,9,12;Vi:g,p:) (2), Essen (I 4,12:g,m:), Kapemba
(I 9,12:l,v:1,7), Nitra (I 2,12:g,m:), Seftenberg (I 1,3,19:g,s,t:),
Typhimurium (I 1,4,5,12:i:1,2), Salmonella spp.
2002 3.8 Bovismorbiﬁcans 6,8:r:1,5 91 4.4 Hindmarsh (I 8,20:r:1,5)b (4), Infantis (I 6,7,14:r:1,5), Hidalgo
(I 6,8:r,i:e,n,z15), Kentucky (I 8,20:i:z6) Tallahassee (I 6,8:z4,z32:)
2001 2.1 Agona 4,12:f,g,s: 80 18.8 Derby (I 1,4,5,12:f,g:1,2) (7), Salmonella spp. (4), Kingston
(I 1,4,5,12,27:g,s,t:1,2), California (I 4,12:g,m,t:), Enteritidis
(I 1,9,12:f,g,m,p:1,7), Essen (I 4,12:g,m:)
2001 2.2 Dublin 1,4,12:f,g: 79 34.2 Enteritidis (I 1,9,12:f,g,m,p:1,7) (14), Rostock (I 1,9,12:g,p,u:) (3),
Agona (I 1,45,12:f,g,s:1,2) (2), Salmonella spp. (2), Derby
(I 1,4,5,12:f,g:1,2), Moscow (I 1,9,12:g,q:), Regent (I 3,10:f,g,s,1,6),
Togo (I 4,12:l,w:1,6), Typhi (I 9,12,Vi:d:), II Neasdenb
2001 2.3 Infantis 6,7:r:1,5 83 13.3 Virchow (I 6,7,14:r:1,2) (3), Salmonella spp. (3), Colindale (I 6,7:r:1,7),
Lomita (I 6,7:e,h:1,5), Oritamerin (I 6,7:i:1,5), Thompson (I 6,7,14:k:1,5),
Typhimurium (I 1,4,5,12:i:1,2)
2001 2.4 Kottbus 6,8:eh:1,5 78 38.0 Newport (I 6,8,20:e,h:1,2:z67) (12), Tshiongwe (I 6,8:e,h:e,n,z15) (11),
Salmonella spp. (4), Ferruch (I 8:e,h:1,5)b (3), Hidalgo
(I 6,8:r,i:e,n,z15), Kalumburu (I 6,8:z:e,n,z15), Stourbridge (I 6,8:b:1,6)
2001 2.5 Typhimurium 4,12:i:1,2 80 9.6 Salmonella spp. (2), Gloucester (I 1,4,12,27:i:l,w), Kiel (I 1,2,12:g,p:),
Lagos (I 1,4,5,12:i:1,5), Paratyphi A (I 1,2,12:a:1,5), Sandiego
(I 4;5,12:e,h:e,n,z15)
2001 2.6 Newport 6,8:eh:1,2 79 17.7 Tshiongwe (I 6,8:e,h:e,n,z15) (8), Bardo (I 8,e,h:1,2)c (1), Salmonella spp.
(2), Kottbus (I 6,8:e,h:1,5), Paratyphi B (I 1,4,5,12:b:1,2), Rechovot
(I 8,20:e,h:z6), Saintpaul (I 1,4,5,12:e,h:1,2)
2001 2.7 Hadar 6,8:z10:enx 76 23.7 Tshiongwe (I 6,8:e,h:e,n,z15) (8), Salmonella subsp. (4), Istanbul
(I 8:z10:e,n,x)c (1), Chailey (I 6,8:z4,z23:e,n,z15), Hadar (I 6,8:z10:e,n,x),
Hidalgo (I 6,8:r,i:e,n,z15), Mapo (I 6,8:z10:1,5), Quiniela (I
6,8:c:e,n,z15), Rechovot (I 8,20:e,h:z6)
2001 2.8 Enteriditis 9,12:g,m: 76 15.8 Salmonella subsp. (3), Dublin (I 1,9,12;Vi:g,p:) (2), Blegdam
(I 9,12:g,m,q:), Berta (I 1,9,12:f,g,t:), Kottbus (I 6,8:e,h:1,5),
Newport (I 6,8,20:e,h:1,2:z67), Seremban (I 9,12:i:1,5), Typhimurium
(I 1,4,5,12:i:1,2), II Kuilsrivierb
2000 1.1 Typhimurium 4,5,12:i:1,2 36 8.3 Farsta (I 4,12:i:e,n,x), Lagos (I 1,4,5,12:i:1,5), Tumodu (I 1,4,12:i:z6)
2000 1.2 Typhimurium 1,4,5,12:i:1,2 36 11.1 Gloucester (I 1,4,12,27:i:l,w) (2), Lagos (I 1,4,5,12:i:1,5), Saintpaul
(I 1,4,5,12:e,h:1,2)
2000 1.3 Bredeney 1,4,12:l,v:1,7 37 29.7 Typhimurium (I 1,4,5,12:i:1,2) (3), Arechavaleta (I 4,5,12:a:1,7) (2),
Fyris (I 4,5,12:l,v:1,2) (2), Derby (I 1,4,5,12:f,g:1,2), Gloucester
(I 1,4,12,27:i:l,w), Paratyphi B (I 1,4,5,12:b:1,2), ():eh:1,5b
2000 1.4 Newport 6,8:eh:1,2 36 22.2 Tshiongwe (I 6,8:e,h:e,n,z15) (3), Bardo (I 8,e,h:1,2),b Braenderup
(I 6,7,14:e,h:e,n,z15), Kottbus (I 6,8:e,h:1,5), Larochelle (I 6,7:e,h:1,2),
I ():eh:1,2,b I 6,7:eh:b
2000 1.5 Saintpaul 1,4,12:eh:1,2 36 30.6 Chester (I 1,4,5,12:e,h:e,n,x) (3), Kaapstad (I 4,12:e,h:1,7) (2), Sandiego
(I 4;5,12:e,h:e,n,z15) (2), Kisangani (I 1,4,5,12:a:1,2), Saintpaul
(I 1,4,5,12:e,h:1,2), Tsevie (I 4,12:i:e,n,z15), I 4:e,h:e,nb
2000 1.6 Schwarzengrund 1,4,12,27:d:1,7 36 33.3 Stanley (I 1,4,5,12,27:d:1,2) (3), Schwarzengrund (I 1,4,12,27:d:1,7) (2),
Canada (I 4,12,27:b:1,6), Derby (I 1,4,5,12:f,g:1,2), Eppendorf
(I 1,4,12,27:d:1,5), Gloucester (I 1,4,12,27:i:l,w), Grumpensis
(I 13,23:d:1,7), Cairo,b I 4:d:b
2000 1.7 Heidelberg 1,4,12:r:1,2 35 31.4 Typhimurium (I 1,4,5,12:i:1,2) (2), Derby (I 1,4,5,12:f,g:1,2), Kisangani
(I 1,4,5,12:a:1,2), Kottbus (I 6,8:e,h:1,5), Paratyphi B (I 1,4,5,12:b:1,2),
Remo (I 1,4,12,27:r:1,7), Saintpaul (I 1,4,5,12:e,h:1,2), Schwarzengrund
(I 1,4,12,27:d:1,7), Stanley (I 1,4,5,12,27:d:1,2), I ():eh:1,2b
2000 1.8 Enteritidis 9,12:g,m: 37 10.8 Berta (I 1,9,12:f,g,t:), Blegdam (I 9,12:g,m,q:), Bournemouth
(I 9,12:e,h:1,2), Ndolo (I 1,9,12:d:1,5)
a Underlining indicates somatic factors determined by phage conversion (present only when the culture was lysogenized by the corresponding converting phage).
b Serotype submitted with no ofﬁcial name or antigenic formula.
c Not considered an error, since the serovar is subject to colonial form variation by the minor O antigen (O:61).
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The overall percentage of correctly serotyped isolates dif-
fered by region. The highest numbers of errors were observed
in Central Asia and the Middle East, where little improvement
was seen during the seven iterations (50% in 2001 and 55% in
2007). The number of participants in the Oceanic region has
been consistent (n  4), and all four laboratories correctly
serotyped all eight strains in both 2001 and 2007. In Southeast
Asia, the percentage of correctly serotyped isolates increased
TABLE 2. Numbers of laboratories producing deviating results per year and regiona
Region Yr No. oflaboratories
No. of
strains
serotyped
% of strains
correctly
serotyped
Countries participating in any iteration
Africa 2001 6 37 73.0 Botswana, Cameroon, Central African Republic, Democratic Republic of Congo,
Ivory Coast, Mauritania, Madagascar, Mauritius, Morocco, Senegal, South
Africa, Sudan, Tunisia, Uganda
2002 9 62 87.1
2003 11 70 71.4
2004 9 51 62.7
2006 16 95 71.6
2007 11 73 80.8
Asia and Middle
East
2001 10 60 50.0 Egypt, India, Israel, Jordan, Kuwait, Lebanon, Oman, Saudi Arabia, Syria
2002 5 30 83.3
2003 5 35 54.3
2004 5 33 54.5
2006 5 35 74.3
2007 5 40 55.0
Caribbean 2001 0 0 0 Barbados, Guatemala, Honduras, Jamaica, Suriname, Trinidad and Tobago
2002 0 0 0
2003 3 18 61.1
2004 2 8 87.5
2006 3 14 78.6
2007 2 9 77.8
China 2001 4 32 96.9 China
2002 3 24 100.0
2003 8 60 75.0
2004 7 46 78.3
2006 6 48 85.4
2007 10 80 91.3
Europe 2001 43 323 80.5 Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland,
Ireland, Italy, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Republic of
Moldova, The Netherlands, Norway, Poland, Romania, Serbia and
Montenegro, Slovak Republic, Slovenia, Spain, Turkey, United Kingdom
2002 50 384 90.0
2003 60 401 84.8
2004 57 392 84.7
2006 52 403 86.4
2007 54 415 89.4
North America 2001 4 32 87.5 Canada, United States
2002 2 16 100.0
2003 6 41 95.1
2004 8 55 81.8
2006 10 80 96.3
2007 12 94 97.9
Oceania 2001 4 30 100.0 Australia, New Caledonia, New Zealand, Papua New Guinea
2002 6 43 93.0
2003 6 46 93.5
2004 5 38 97.4
2006 5 37 94.6
2007 4 32 100.0
Russia 2001 1 8 12.5 Belarus, Georgia, Russia, Ukraine.
2002 1 8 62.5
2003 1 7 14.3
2004 4 26 69.2
2006 5 40 80.0
2007 8 51 80.4
Latin America 2001 11 78 57.7 Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Ecuador, Mexico,
Panama, Paraguay, Peru, Uruguay, Venezuela2002 11 82 87.8
2003 13 83 75.9
2004 15 88 79.5
2006 13 84 84.5
2007 15 107 88.8
Southeast Asia 2001 15 113 54.0 Cambodia, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri
Lanka, Taiwan, Thailand, Vietnam2002 12 90 92.2
2003 15 100 81.0
2004 17 130 81.5
2006 15 117 84.6
2007 19 140 91.4
a No data are available for 2000.
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signiﬁcantly (P  0.01), from 54% in 2001 to 92% in 2002, and
remained consistently over 80% through 2007. In Latin Amer-
ica, performance increased signiﬁcantly (P  0.01), from 58%
in 2001 to 89% in 2007. Europe had the highest number of
participating laboratories, and the percentage of correctly se-
rotyped isolates ranged from 81% in 2001, when 43 laborato-
ries participated, to 89% (P 0.01) in the 2007 iteration, when
54 laboratories participated (Table 2).
DISCUSSION
Through training, reference testing services, technical sup-
port, and hosting of scientists, WHO Global Salm-Surv has
been working to improve the laboratory capacity and thereby
the data quality of WHO member states. The EQAS is one of
the tools the program uses to assess the impact of its capacity-
building efforts and to pinpoint areas for improvement.
The results from the ﬁrst seven iterations of the WHO
Global Salm-Surv EQAS, which to our knowledge is the largest
external quality assurance program for the serotyping of Sal-
monella species, indicate that the majority of participating lab-
oratories worldwide are capable of correctly serotyping Sal-
monella species. The number of participating laboratories
increased consistently from 2000 to 2007, demonstrating an
increased interest in quality assurance and an increased global
capacity for Salmonella serotyping. However, ﬂuctuations in
the performance of some laboratories were observed. Some
laboratories still do not meet the WHO Global Salm-Surv goal
of performing serotyping on all eight strains with no more than
one incorrect result. Efforts at building laboratory capacity for
serotyping should focus on those laboratories in the future and
should be directed at common difﬁculties.
Since test strains differ from year to year, an improvement in
the performance of participating laboratories can be evaluated
only on the basis of the internal quality controls. The results of
quality control have remained fairly consistent during the
seven iterations despite a large increase in the number of
participants. The selection of a common serovar (Salmonella
serovar Enteritidis) may have biased the results: this serovar is
frequently encountered, and many laboratories are proﬁcient
at its identiﬁcation. Additionally, this is a monophasic serovar.
We have shown that most incorrect results appear to be caused
by errors in the identiﬁcation of phase two ﬂagellar antigens.
These factors might have contributed to the consistently high
performance observed for the Salmonella serovar Enteritidis
strain. Selection of a diphasic serovar may reduce this bias in
the future.
Our data suggest that several factors contributed to the
observed errors. Unpublished data from a needs assessment in
the EQAS 2007 iteration, where 82 laboratories (56%) com-
pleted the survey, showed that nearly 1 out of 3 (30%) labo-
ratories have limited access to high-quality antisera. Addition-
ally, less-common serovars were included in some iterations
(e.g., Salmonella enterica serovar Vinohrady [I 28:m,t:]), and
the same needs assessment found that 26% of laboratories had
difﬁculty serotyping rare and unusual Salmonella strains. Fi-
nally, there are important regional differences in laboratory
capacity. The needs assessment found that institutions in Af-
rica, Asia and the Middle East, and Southeast Asia were more
likely to report difﬁculty obtaining antisera, especially for se-
rotyping unusual Salmonella strains, than were institutions in
other regions.
The decline in the proportion of serotypes correctly identi-
ﬁed in 2003 and 2004 was likely due to the selection of the
Salmonella isolates (Table 3). In 2003 and 2004, laboratories
needed less-common antisera in order to fully serotype all of
the EQAS isolates. After 2004, only more-common serovars
were included. The subsequent overall improvement in perfor-
mance suggests that many laboratories have access only to
commonly available antisera. WHO Global Salm-Surv has
demonstrated that the predominant Salmonella serotypes dif-
fer between regions (3). Therefore, a broad selection of anti-
sera for Salmonella surveillance is needed globally. WHO
Global Salm-Surv continues to provide information to partic-
ipants on where to purchase high-quality antisera and to sup-
port many laboratories with antisera for surveillance purposes.
Many of the incorrect serotyping results were due to incor-
rect identiﬁcation of phase two ﬂagellar antigens (Table 1).
For example, common incorrect results included misidentiﬁ-
cation of Salmonella serovar Typhimurium (I 4,5,12:i:1,2) as
Salmonella enterica serovar Farsta (I 4,5,12:i:e,n,x), Lagos (I
4,5,12:i:1,5), or Tumodu (I 4,5,12:i:z6). All four serovars share
the same O and phase one ﬂagellar antigens but differ in their
phase two ﬂagellar antigens.
Colonial form variation (the variable expression of minor
antigens by different single-colony picks from the same strain)
may occur with the expression of the O:61 antigen by some
serogroup C2 serovars (10). Therefore, although the current
Kauffmann-White scheme regards O:6,8 and O:8 serovar pairs,
such as Salmonella serovars Newport (I 6,8:e,h:1,2) and Bardo
(I 8:e,h:1,2), as distinct serovars, we allowed for colonial form
variations. We considered correct identiﬁcations for Salmo-
nella serovars Newport, Kottbus, Hadar, Manhattan, and Bo-
vismorbiﬁcans on the basis of the serogroup alone and ac-
cepted as correct for those serovars, respectively, Salmonella
serovars Bardo, Ferruch, Istanbul, Yovokome, and Hind-
marsh.
The results from the WHO Global Salm-Surv EQAS also
demonstrate important regional differences in the serotyping
results for Salmonella species. Particular efforts should focus
on Central Asia and the Middle East, but also on Africa,
Russia, and the Caribbean, where a large proportion of the
TABLE 3. Numbers (and percentages) of participating laboratories
that correctly serotyped all eight Salmonella isolates in EQAS
(2000 to 2007) and total number of isolates correctly
serotyped per iteration
Yr
No. (%) of laboratories per
iteration that correctly
serotyped all eight isolatesa
Total no. (%) of isolates
correctly serotyped per
iterationb
2000 34 (92) 165 (76)
2001 79 (82) 513 (72)
2002 80 (81) 668 (91)
2003 69 (54) 692 (80)
2004 78 (61) 701 (81)
2006 105 (81) 808 (85)
2007 109 (78) 920 (88)
Overall 554 (76) 4,467 (82)
a Does not include laboratories that serotyped fewer than eight isolates.
b Includes all correctly serotyped isolates, disregarding the fact that some
participants attempted to serotype fewer than eight test strains.
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laboratories do not correctly serotype many of the strains.
Addressing the regional differences will involve additional
training courses in selected regions.
WHO Global Salm-Surv is a platform that can assist WHO
member states to strengthen their core public health capacities
under the International Health Regulations (IHR, 2005) for
disease surveillance and response, which will in turn strengthen
international public health security. WHO Global Salm-Surv
promotes intersectoral collaboration among human health,
veterinary, and food-related disciplines in food safety and
other issues that arise at the human-animal interface. As the
program continues to expand, it increasingly addresses re-
gional training and support needs.
Conclusion. This study showed that there is a continuing
need to improve Salmonella serotyping and that this need
appears to be greater in speciﬁc regions. Detection of the
phase two ﬂagellar antigen is one of the more profound bar-
riers to obtaining a satisfactory serotyping result. Future train-
ing efforts should be aimed at enhancing the ability to charac-
terize the phase two ﬂagellar antigen and disseminating
information on where to purchase high-quality antisera.
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Article II 
Global monitoring of Salmonella serovar distribution based on quality assured data 
from  the WHO Global Salm-Surv Country Data Bank; 2001 – 2007. 
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Antimicrobial Resistance and Molecular Epidemiology
of Salmonella Rissen from Animals, Food Products,
and Patients in Thailand and Denmark
Rene S. Hendriksen,1 Aroon Bangtrakulnonth,2 Chaiwat Pulsrikarn,2 Srirat Pornreongwong,2
Henrik Hasman,1 Si Wook Song,3 and Frank M. Aarestrup1
Abstract
Recently we reported increases in both the number of Salmonella infections due to Salmonella Rissen in
Thailand and the isolation of this serovar from pork products in Thailand. The objectives of the present study
were to determine the genetic diversity and antimicrobial resistance of Salmonella Rissen isolates recovered
from humans, food products, and animals in Denmark and Thailand. Additionally, risk factors due to travel
and consumption of speciﬁc food products were analyzed and evaluated. A total of 112 Salmonella Rissen
isolates were included in this study from Thailand andDenmark. Thai isolates were recovered from humans,
uncooked food, and ready-to-eat food. Danish isolates were obtained from humans (with and without a
history of travel to Thailand prior to the infection), Danish pig or pork products, imported pig or pork
products, turkeys, and animal feed. A total of 63 uniqueXbaI PFGEpatternswere observed. The predominant
pattern was shared by 22 strains. Limited antimicrobial resistance was observed in the Danish strains, and a
higher degree of resistance was observed in strains originating from Thailand. Virtually all isolates were
resistant to tetracycline. The tetA gene was detected in tetracycline-resistant isolates. Statistical analysis and
molecular subtyping identiﬁed the combination of travel to Thailand and consumption of imported pig or
pork products as well consumption of as pig or pork products produced in Denmark as risk factors for
Salmonella Rissen infection among the Danish patients. The outcome of this study might be used as a sup-
plement for future Salmonella Rissen investigations and outbreak detection.
Introduction
Salmonella enterica is a common cause ofhuman gastroenteritis and bacteremia and a
wide variety of animals, particularly food ani-
mals, have been identiﬁed as reservoirs for non-
Typhi Salmonella (Coyle et al., 1988; Humphrey
et al., 1988, 2000). Although 2587 serovars of Sal-
monella enterica have been identiﬁed, most hu-
man infections are caused by a limited number
of serovars. In developed countries, Salmonella
enterica serovars Typhimurium and Enteritidis
are the most common causes of human salmo-
nellosis, although other serovars have been re-
ported to be more prevalent in speciﬁc regions
(Humphrey et al., 2000; Olsen et al., 2001; Her-
ikstad et al., 2002; Bangtrakulnonth et al., 2004b;
Galanis et al., 2006). Shifts in prevalence of spe-
ciﬁc strain types and serovars can be due to
international travel, human migration, and a
1WHO Collaborating Centre for Antimicrobial Resistance in Foodborne Pathogens and EU Community Reference Laboratory for
Antimicrobial Resistance, National Food Institute, Technical University of Denmark, Copenhagen, Denmark.
2WHO International Salmonella and Shigella Centre, National Institute of Health, Department of Medical Sciences, Ministry of Public
Health, Bangkok, Thailand.
3The National Veterinary Research and Quarantine Service, Anyang, Korea.
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global food and livestockmarket. Knowledge of
the prevalence and molecular epidemiology of
different serovars in speciﬁc regions may facili-
tate the recognition and control of new and
emerging pathogens.
We recently reported an increase in Salmonella
infections due to Salmonella enterica serovar Ris-
sen in Thailand. The reported number of human
Salmonella infections due to Salmonella Rissen in
Thailand has increased from 54 cases in 1993 to
334 in 2002. During that same time period, a 10
percentage point increase (4.7% to 14.7%) in the
isolation of Salmonella Rissen from speciﬁc food
products was also observed (Bangtrakulnonth
et al., 2004b).While this serovar is rarely reported
elsewhere in the world, it is among the top three
Salmonella serovars found in pigs and pork
products in Thailand, other Southeast Asian
countries, and Spain (Bangtrakulnonth et al.,
2003, 2004a, 2005; Angkititrakul et al., 2005;
Vaeteewootacharn et al., 2005; VAV, 2005; In-
thavong et al., 2006; Padungtod and Kaneene,
2006; Riano et al., 2006; Vo et al., 2006; Astorga
et al., 2007).
In recent years, increased antimicrobial resis-
tance has been reported in several serovars of
S. enterica. However, only limited data on the
prevalence of antimicrobial resistance of Salmo-
nella Rissen is available. In 2005, Angkititrakul
reported tetracycline, streptomycin, and sul-
phonamide resistance among Salmonella Rissen
isolates recovered from pork and chicken in
Thailand. The isolates recovered fromporkwere
however susceptible to ciproﬂoxacin, gentami-
cin, chloramphenicol, amoxicillin, and sulpha-
methoxazoleþ trimethroprim (Angkititrakul
et al., 2005). In contrast, multidrug-resistant iso-
lates of Salmonella Rissen have been reported
from Spain. Previous studies have shown these
isolates to be resistant to ampicillin, amoxy-
cillin, streptomycin, neomycin, sulphonamides,
sulphanamidesþ trimethoprim, chlorampheni-
col, and tetracycline (Riano et al., 2006; Astorga
et al., 2007). One study (Riano et al., 2006) also
described the identiﬁcation of the blaSHV-12
gene in a cefotaxime and ceftazidime resistant
isolate.
Antimicrobial susceptibility proﬁles and mo-
lecular subtyping are useful epidemiological
toolswhich can be used to determine the sources
of an outbreak. To our knowledge, only one
molecular study of Salmonella Rissen has previ-
ously been undertaken. In this earlier study 19
Portuguese isolates of Salmonella Rissen were
characterized bypulsed-ﬁeld gel electrophoresis
(PFGE). Three unique XbaI patterns were ob-
served, with the predominant pattern being
shared by 17 isolates (Vieira-Pinto et al., 2006).
The objectives of the present study were to
determine the genetic diversity and antimicro-
bial resistance of Salmonella Rissen isolates re-
covered from humans, food products, and
animals in Denmark and Thailand.
Microbiological ﬁndingswere correlatedwith
epidemiological data, and risk factors for infec-
tion with Salmonella Rissen were calculated.
The outcome of this study might be used as a
supplement for future Salmonella Rissen inves-
tigations and outbreak detection.
Methods
Bacterial isolates
The WHO National Salmonella and Shigella
Centre in Bangkok receives all presumptive
positive Salmonella isolates from all diagnostic
laboratories throughout Thailand. In 2004, 300
isolates were identiﬁed as SalmonellaRissen. The
isolates originated from 9 of 12 districts and
Bangkok.
In addition to human isolates, The WHO Na-
tional Salmonella and Shigella Centre also re-
ceives isolates recovered from food products. In
2004, the centre received 295 isolates, originating
from various food sources. The majority of the
isolates originated from pork products. These
samples were further characterized as ‘‘raw
food’’ (n¼ 128) or ‘‘ready-to-eat food’’ (n¼ 92).
The raw food isolates were submitted from dis-
tricts 1, 3, and 4 and Bangkok over a 1-year pe-
riod, excluding the months of February to April
and October to December. The isolates origi-
nating from ready-to-eat food were collected
over a 9-month period (April–December) from
districts 1 and 10 and Bangkok.
The 23 human isolates from Denmark were
collected between 2000 and 2005 by theNational
Reference Laboratory for Enteropathogenic
Bacteria, Statens Serum Institut (SSI) in Den-
mark. These isolates were recovered from pa-
tients suffering from gastrointestinal infections
caused by Salmonella Rissen. Four cases were
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acquired in Denmark. Six patients had traveled
to Thailand prior to becoming ill. Travel history
was unavailable for the remaining 13 cases. An
additional 155 isolates were identiﬁed by the
National Food Institute,Copenhagen,Denmark.
These isolates were obtained from pig or pork
products of Danish origin (n¼ 61), imported pig
or pork products (n¼ 19), turkey (n¼ 19), and
animal feed (n¼ 24). The remaining 32 isolates
were either from an unknown source or origi-
nated from caged birds, chickens, the environ-
ment, horses, cattle, or bone meal. All isolates
were collected between 1996 and 2005.
The isolates were initially identiﬁed as Sal-
monella spp. according to internationally recog-
nized procedures. Isolates were then serotyped
using slide agglutination in the countryof origin.
Selection of isolates
Usingastratiﬁedrandomsampling technique,
33 of the 300 human isolates fromThailandwere
selected for additional characterization. Isolates
were from both male and female patients resid-
ing in districts 1, 4, 5, 7, 8, and 12 and Bangkok.
Patients ranged in age from 1 to 42 years. A re-
view of the sample collection date was used to
insure that the isolateswere representative of the
study period. The isolates from the raw food and
ready-to-eat food were selected from the same
time period as the Thai human isolates. The
majority of the food isolates were recovered in
May and June.
Thirteen of the 128 raw food isolates were se-
lected for additional characterization. The se-
lected isolates were from districts 1, 3, and 4 and
Bangkok. Ten of the ninety-two isolates from
ready-to-eat food were selected for additional
characterization. The selected isolateswere from
district 1 and Bangkok.
All 23 human isolates from Denmark were
included in the study. A stratiﬁed random
sampling technique was used to select isolates
from the NFI collection for additional charac-
terization.
Isolates selected for additional characteriza-
tion were obtained from: Danish pigs and pork
products collectedbetween2002 to 2005 (n¼ 10);
imported pig or pork products (Spanish origin
n¼ 5, German origin n¼ 1, unknown origin
n¼ 3) submitted to Danish import control au-
thorities between 2002 and 2005 (n¼ 9); turkey
collected between 2000 and 2002 (n¼ 6); and
animal feed collected between 2001 and 2005
(n¼ 8).
Risk factors
SAS version 9.1.3 (SAS Institute Inc., Cary,
NC) was used to calculate the relative risk using
a Fisher’s Exact test. The risk of disease for con-
sumption of imported pork from Spain and the
risk factor of travel to Thailand among the
Danish patients infected with Salmonella Rissen
were evaluated.
Serotyping
O and H antigens were characterized by
agglutination with hyperimmune sera and sero-
type was assigned according to the Kauffmann–
White scheme (Popoff and Le Minor, 2001).
Antimicrobial susceptibility testing
Susceptibility to antimicrobial agents was
performed at the NFI on all selected isolates as
minimum inhibitory concentration determina-
tions using a commercially prepared, dehy-
dratedpanel (Sensititre) fromTREKDiagnostic
Systems Ltd. (East Grinstead, England).
The following antimicrobials and resistance
cut-off values or breakpoint were used in the
study: ampicillin, AMP (R> 4 mg=mL); amoxi-
cillinþ clavulanic acid, AUG (R> 4 mg=mL);
apramycin, APR (R> 16mg=mL); cefalothin,
CEF (R> 16mg=mL); cefpodoxime, POD (R> 1
mg=mL); ceftiofur, XNL (R> 2 mg=mL); chlor-
amphenicol, CHL (R> 16mg=mL); cipro-
ﬂoxacin, CIP (R> 0.06mg=mL); colistin COL
(R> 8 mg=mL); ﬂorfenicol, FFN (R> 2 mg=mL);
gentamicin, GEN (R> 2 mg=mL); nalidixic acid,
NAL (R> 16mg=mL); neomycin, NEO (R> 8
mg=mL); spectinomycin, SPE (R> 64 mg=mL);
streptomycin, STR (R> 16 mg=mL); sulpha-
methoxazole, SMX (R> 256 mg=mL); tetracy-
cline, TET (R> 8 mg=mL); and trimethoprim,
TMP (R> 2mg=mL).
Epidemiological cut-off values were inter-
preted according to current eucast (http:==
www.eucast.org) and European Food Safety
Authority (EFSA) recommendations. Exceptions
weremade for interpretationofAPR,AUG,CEF,
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COL, FFN, POD, SPE, and XNL, where Clinical
and Laboratory Standards Institute (CLSI, 2002,
2006a, 2006b)guidelinesandclinicalbreakpoints
were utilized. NEO and STR were interpreted
according to research conduced at NFI. Quality
control using E. coliATCC 25922was conducted
on a weekly basis according to CLSI.
Detection of resistance genes
Resistant and intermediate strains were fur-
ther characterized through the use of a poly-
merase chain reaction (PCR) assay with primers
speciﬁc for 25 antimicrobial resistance genes
(Table 1).
All PCR ampliﬁcations were performed with
buffer supplied by the manufacturer, 20 pmol=
mL of each primer and 0.5 U of Amplicon Taq
Polymerase (Ampliqon,Copenhagen,Denmark).
The ﬁnal reaction volume was (50mL), The fol-
lowing cycling conditions were used for all re-
actions: 3minutes at 948C; 35 cycles of 1minute at
948C, 1 minute at the appropriate annealing
temperature, and 1minute at 728C; 10minutes at
728C. Primer names and sequences, resistance
genes, primer position, annealing temperature,
control strains, amplicon sizes, and references are
listed in Table 1.
Amplicons produced by the seven CIP-
resistant strains and the single blaCTX amplicon
generated,were selected for sequencing. Prior to
sequencing, the amplicons were puriﬁed using
the GFX PCR DNA kit (Amersham Bios-
ciences, Piscataway, NJ), The DNAwas shipped
to Macrogen Inc. (Seoul, Korea) for sequencing
using the same primers as in the PCR analysis.
Sequence analysis and alignment was per-
formedusingVectonNTI suite 9 (InforMax, Inc.,
Bethesda, MD) software. The resulting nucleo-
tide sequences were compared to sequences
obtained from the GenBank database (http:==
www.lahey.org =studies=webt.html).
Pulsed-ﬁeld gel electrophoresis
The selected isolateswere analyzed for genetic
relatedness by PFGE usingXbaI according to the
Centers for Disease Control and Prevention
(CDC) PulseNet protocol (Ribot et al., 2002). The
electrophoresis was performedwith a CHEFDR
III System (Bio-Rad Laboratories, Hercules,
CA) by using 1% SeaKem agarose in 0.5Tris-
borate-EDTA at 180 V. Running conditions
consisted of 1phase from2.2 to 63.8 seconds for a
run time of 22 hours.
PFGE following digestion with BlnI was uti-
lized to further differentiate the 22 isolates
which exhibited the predominant XbaI pattern
(TEEX01.0017.DK). Comparison of the PFGE
proﬁles was performed by using Bionumerics
software version 4.6 (Applied Maths, Sint-
Martens-Latem, Belgium) and the dice correla-
tion for band matching with a 1.0% position
tolerance andanoptimization at 1.0%usingboth
XbaI and BlnI.
Results
Risk factors
Available travel histories suggested that six
Danish patients (5%) may have acquired their
infection abroad and four patients (4%) may
have obtained the infection in Denmark. All six
patients (5%) who traveled to Thailand shared a
common PFGE pattern with a Thai isolate. Six
(5%) of the remaining 17 patients (15%) did not
share a common PFGE pattern. Among the
Danish patients, there did not appear to be a
statistically signiﬁcant connection using Fisher’s
Exact test ( p¼ 0.1438) between travel to Thai-
land (exposure) and sharing a common PFGE
proﬁle with a Thai source (outcome).
Nine isolates (8%) included in the study
originated from imported pig or pork products.
Six of these isolates (5%) shared a common
PFGE pattern with a Danish patient. Three (3%)
of the ten Danish pig or pork product samples
(9%) included in this study shared a common
PFGE pattern with a Danish patient. The risk of
consuming imported pig or pork (exposure)
was estimated between pork or pig and shar-
ing a common PFGE proﬁle with Danish pa-
tients who had not traveled prior to the onset
of infection (outcome). No statistical signiﬁ-
cance was observed using Fisher’s Exact test
( p¼ 0.3469).
Antimicrobial resistance
All eight (7%) isolates from animal feed orig-
inating from Denmark were fully susceptible to
all antimicrobials tested. A similarly low fre-
quency of resistance was observed in six (5%)
608 HENDRIKSEN ET AL.
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isolates from turkey slaughtered in Denmark
and 10 (9%) isolates from pig or pork products
produced in Denmark (Table 2).
Danish-produced pig or pork product isolates
and isolates from imported pig or pork products
had a higher frequency of resistance to TET
(80.0 %).
Ahigher frequencyof resistancewasobserved
in the six isolates (5%) cultured from Danish
patients with a history of travel to Thailand
compared to the 17 isolates (15%) from Danish
patients. Resistance to CHL, CIP, NAL, NEO,
SPE, SMX, and TMP ranged from 17% to 33%. A
higher frequency of resistancewas seen toAMP,
STR, and TET with 50%, 50%, and 100% resis-
tance observed, respectively.
The human isolates from Thailand showed
high resistance to AMP (36%), CHL (27%), SPE
(33%), STR (27%), SMX (30%), and TMP (27%).
The majority of isolates (88%) were fully resis-
tant to TET.
The isolates from raw food and ready-to-eat
food showed similar trends in the frequency of
resistance. High level of resistance was seen
against TET (77–80%) (Table 2). One human
isolate from Denmark found to be multidrug
resistant: AMP, CEP, POD, XNL, CHL, SPE,
STR, SMX, TET, and TMP. However, this strain
was recovered from a premature infant who
most likely had received treatment with anti-
microbials.
Identiﬁcation of resistance genes
TetA speciﬁc amplicons were produced by all
TET-resistant isolates (18%) obtained from
Danish patients; including those with a history
of travel to Thailand (8%), pork imported from
Spain or Germany (7%), ready-to-eat food (9%),
and raw food from Thailand; and ﬁve isolates
from Danish pig or pork products (4%). The
three isolates (3%) from Danish pig or pork
products, and one isolate (1%) from turkey also
yielded tetB speciﬁc amplicions (Table 3).
All SMX-resistant isolates (2%) obtained from
Danish patients produced amplicons speciﬁc to
sul1. The SMX-resistant isolate (1%) fromDanish
patient with a history of travel to Thailand pro-
duceda sul3 speciﬁc amplicon. Two isolates (2%)
from Danish pig or pork product samples pro-
duced sul1 and sul2 speciﬁc amplicons, respec-
tively. The three isolates (3%) from imported pig
or pork products and the ready-to-eat (3%) and
raw food (4%) samples from Thailand produced
amplicons to sul1 and sul3 (Table 3).
A single base-pair substitution in the gyrA
gene was identiﬁed in seven CIP-resistant
strains (7%). Five of these strains (4%) originated
from Thai patients and two (2%) from Danish
patients, one (1%) of whom had travelled to
Thailand. Isolates from three of the Thai patients
(3%) and one of the Danish patients (1%) had a
mutation at codon 83 (TCC [Ser]?TTC [Phe]).
The two remaining Thai patients (2%) and the
Danish patient (1%) (who had travelled to
Thailand) had a mutation at codon 87 (GAC
[Asp]?AAC [Asn]). (Mutated bases are shown
in bold.)
The isolate from the Danish patient which
produced a positive amplicon to blaCTX was se-
quenced and showed 100% similarity to strains
in the GenBank encoding for blaCTX-M-14.
PFGE typing
A total of 63 unique XbaI patterns; were ob-
served among the 112 isolates (Fig. 1). These 63
patterns formed 10 distinct clusters. All isolates
from Danish patients with a history of travel to
Thailand (n¼ 6) shared XbaI patterns with iso-
lates recovered in Thailand. Five of these isolates
matched patterns obtained from isolates recov-
ered from raw food or ready-to-eat food sam-
ples in Thailand. The predominant pattern
TEEX01.0017.DK belonged to PFGE cluster 4
and consisted of 22 (20%) isolates. This XbaI
cluster included: ﬁve isolates (4%) from Thai
patients; three isolates (3%) from ready-to-eat
food; two isolates (2%) from raw food; six iso-
lates (5%) from Danish patient, two (2%) of
whom had traveled to Thailand; four isolates
(4%) from imported pig or pork products (n¼ 3
from Spain and n¼ 1 from Germany), and two
isolates (2%) originating from Danish pig or
pork products. When pattern TEEX01.0017.DK
was further subtyped using the BlnI enzyme, six
patterns (TEEA26.0001.DK–TEEA26.0006.DK)
were obtained (Fig. 2). The predominant pattern
TEEA26.0001.DK was shared by 17 isolates
(15%) including: six isolates (5%) from Danish
patients, two (2%) of whom had traveled to
Thailand; one pig or pork product isolate (1%)
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fromDenmark; two isolates (2%) from imported
pig or pork products; four isolates (4%) from
patients in Thailand; two isolates (2%) from raw
food; and two isolates (2%) from ready-to-eat
food. With the exception of one isolate (1%) ob-
tained from Spanish pork products, antimicro-
bial resistance within this cluster was limited to
tetracycline.
FIG. 1. Dendrographic analysis of the representative XbaI pulsed-ﬁeld gel electrophoresis patterns of Salmonella
Rissen isolates from Denmark and Thailand.
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A similarity of approximately 82% was
observed among PFGE cluster 1 strains. This
cluster of isolates originated from Denmark and
was pan-susceptible.
In PFGE cluster 6; the predominant pattern,
TEEX01.0026.DK was shared by six isolates
(5%): four from Thai patients (4%), one isolate
(1%) from ready-to-eat food and one isolate (1%)
from a Danish patient with a history of travel to
Thailand prior to the infection. All of the isolates
(5%) were resistant to AMP, CHL, NEO, SPE,
STR, SMX, TET, and TMP (data not shown)
(Fig. 1).
Discussion
The majority of Salmonella Rissen isolates in-
cluded in this study exhibited resistance to tet-
racycline and displayed limited resistance to
other antimicrobials. A previous study from
Thailand found almost all porcine isolates to be
fully resistant to TET, STR, and SMX (Angkiti-
trakul et al., 2005). Thai isolates and isolates from
Danish patients with a history of travel to Thai-
land were more likely to be resistant to AMP,
CHL, STR, SMX, and TMP than isolates origi-
nating from Denmark.
Almost all ampicillin-resistant isolates con-
tained a sequence similar to blaTEM-1b. blaTEM
genes have also been widely found among Sal-
monella isolates in other studies (Gallardo et al.,
1999; Olesen et al., 2004). Chloramphenicol re-
sistance was mediated by the catA1 or the cmlA
gene, which has also been observed previously
(Guerra et al., 2002; Zhao et al., 2007), but is also
widespread among other gram-negative bacte-
ria. Florfenicol resistance is normally encodedby
the ﬂogene,which speciﬁes nonenzymatic cross-
resistance to both ﬂorfenicol and chloramphen-
icol. However, none of the ﬂorfenicol-resistant
isolates tested contained the ﬂo gene. It has pre-
viously been suggested that several of isolates
may possess an unknown chromosomal ﬂo gene
(White et al., 2000). Tetracycline resistance was
primarily mediated by tetA. However, the tetB
gene was identiﬁed in one turkey isolate and
three of the eight Danish pig or pork isolates.
tetA is commonly found on transposons such as
Tn1721, this gene has been identiﬁed in many
gram-negative bacteria including Salmonella
(Frech and Schwarz, 2000).
Sulphonamide resistance in Enterobacteriaceae
is typicallymediated by the resistance genes sulI
(encoded on aClass I integron), sul2 (encodedon
a nonconjugative plasmid), or sul3 (putatively
associated with both an integron system and
a conjugative plasmid) (Radstrom et al., 1991).
sul1-, sul2-, and sul3-mediated resistance was
identiﬁed among the sulphamethoxazole-
resistant isolates.
The aph(3’’)-II gene was identiﬁed in all
neomycin-resistant isolates. This gene has pre-
viouslybeen identiﬁed in several other species of
gram-negative bacteria. Streptomycin resistance
was encoded by aadA, strA, and strB. This ge-
notype is also commonly observed in Denmark
among streptomycin-resistant isolates of Salmo-
nella Typhimurium (Madsen et al., 2000).
Seven ciproﬂoxacin-resistant isolates con-
tained a single mutation in gyrA at codons 83
(Ser?Phe) or 87 (Asp?Asn). Mutations at
these positions, located within the quinolone
resistance–determining region of gyrA, have
been associated with ciproﬂoxacin resistance in
several bacterial species, including high-level
ciproﬂoxacin resistance in Salmonella spp. (Chiu
et al., 2002; Casin et al., 2003; Ling et al., 2003).
To our knowledge, this is the ﬁrst study uti-
lizing PFGE to demonstrate the molecular di-
versity of Salmonella Rissen. This appears to be a
genetically diverse serotype, with 112 strains
producing a total of 63 unique XbaI pat-
terns (Fig. 1). The predominant pattern was
TEEX01.0017.DK which consisted of 22 isolates
andwas shared betweenThai patients, ready-to-
eat food, raw food, Danish patients with and
without a history of travel, and imported and
Danish pig or pork. Several other patterns were
shared by isolates from different sources which
could support a link between the reservoirs.
The biological analysis strongly suggests that
Thai patients acquire Salmonella Rissen infec-
tions by consumption of Thai-produced pig or
pork products. These data also suggest that tra-
vel to Thailand and consumption of imported
and Danish-produced pig or pork products are
potential risk factors for infection with Salmo-
nella Rissen infection among Danish patients.
Previous studies have also indicated that Danish
patientsmight acquire infectionswith Salmonella
serotypes Corvallis or Schwarzengrund from
Thailand through a combination of travelling
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and the import of different food products
(Archambault et al. 2006; Aarestrup et al. 2007).
Source attribution analysis in Denmark has also
shown the increased importance of imported
foodproducts as a source ofSalmonella infections
(Hald et al., 2007). With increases in tourism and
international trade, Salmonella subtypes which
had been conﬁned to speciﬁc regions may
emerge elsewhere. These studies emphasise the
need to view Salmonella epidemiology from a
global perspective.
It should be noted that some degree of
selection and statistical bias may have inﬂu-
enced the results of the present study. The ma-
jority of Thai isolates were collected between
May and June 2004 and only isolates collected
during this time period were selected for mo-
lecular characterization. In contrast, the Danish
isolates were collected over a period of several
years. Comparing isolates from different time
periods may reduce the chances of ﬁnding
clones with identical antibiogrammes or indis-
tinguishable PFGE patterns. Additionally, the
limited number of isolates included in the study
might have inﬂuenced the statistical analysis of
speciﬁc risk factors, particularly the consump-
tion of imported pork. It should also be noted
that travel histories could only be obtained for
nine of the 23 Danish patients. No information
regarding travel prior infectionwas available for
14 patients.
Conclusion
This study suggest that travel to Thailand and
the consumption of pig or pork products (Dan-
ish and imported)were risk factors forSalmonella
Rissen infections among the Danish patients in-
cluded in this study. This study also suggests
that the Thai patients included in this studymost
likely became infected with Salmonella Rissen by
the consumption of Thai pig or pork products.
This studymayhavepotential beneﬁts for future
Salmonella Rissen investigations and outbreak
detection.
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Emergence of Multidrug-Resistant Salmonella Concord
Infections in Europe and the United States in Children Adopted
From Ethiopia, 2003–2007
Rene S. Hendriksen,* Matthew Mikoleit, MASCP,† Christian Kornschober, MD,‡ Regan L. Rickert, MPH,†
Susan Van Duyne, MS,† Charlotte Kjelsø, MEd,§ Henrik Hasman, PhD,* Martin Cormican, PhD,¶
Dik Mevius, DVM, PhD,** John Threlfall, PhD,†† Frederic J. Angulo, DVM, PhD,†
and Frank M. Aarestrup, DVM, PhD*
Background: Multidrug-resistant Salmonella serovar Concord infections
have been reported from children adopted from Ethiopia. We interviewed
patients, characterized the isolates, and gathered information about adop-
tions from Ethiopia to assess public health implications.
Methods: Information about Salmonella Concord cases and adoptions
were provided from Austria, Denmark, England (and Wales), Ireland, the
Netherlands and the United States. Patients from Denmark and the United
States were interviewed to determine the orphanages of origin; orphanages
in Ethiopia were visited. Isolates were subtyped by pulsed-ﬁeld gel elec-
trophoresis and antimicrobial susceptibility; speciﬁc antimicrobial resis-
tance genes were characterized.
Results: Salmonella Concord was isolated from 78 persons from 2003 to
2007. Adoption status was known for 44 patients 3 years of age; 98%
were adopted from Ethiopia. The children adopted from Ethiopia were
from several orphanages; visited orphanages had poor hygiene and sani-
tation and frequent use of antimicrobial agents. The number of children
adopted from Ethiopia in the participating countries increased 527% from
221 in 2003 to 1385 in 2007. Sixty-four Salmonella Concord isolates
yielded 53 pulsed-ﬁeld gel electrophoresis patterns including 6 patterns
with 2 indistinguishable isolates; one isolate from an Ethiopia adoptee.
Antimicrobial susceptibility was performed on 43 isolates; 81% were
multidrug-resistant (3 agents). Multidrug-resistant isolates were from
Ethiopian adoptees and were resistant to third and fourth generation
cephalosporins and 14% had decreased susceptibility to ciproﬂoxacin.
Conclusions: Improved hygiene and sanitation and more appropriate use
of antimicrobial agents are needed in orphanages in Ethiopia. Culturing of
stool specimens of children adopted from Ethiopia and appropriate hygiene
may prevent further disease transmission.
Key Words: Salmonella, Ethiopia, adoptees, ESBL, multi-drug
resistance
(Pediatr Infect Dis J 2009;28: 814–818)
Salmonella enterica is a common cause of human gastroenteritisworldwide.1–3 Although most Salmonella infections are self-
limiting, severe infections resulting in bacteremia, meningitis, and
death may occur. Antimicrobial agents may be life-saving in
severe infections. Third generation cephalosporins and ﬂuoro-
quinolones are commonly used for the treatment of Salmonella
infections in children and adults, respectively.4,5 Infections caused
by antimicrobial-resistant Salmonella are more likely to require
hospitalization, and may result in more severe outcomes.6–8
In 2007, infections caused by Salmonella serovar Concord,
a rare Salmonella serotype, were reported in several countries
among children adopted from Ethiopia; the isolates from these
infections were resistant to numerous antimicrobial agents includ-
ing third generation cephalosporins.9,10 To prevent further infec-
tions, we conducted a multinational investigation, in collaboration
with the Ethiopia Ministry of Health, to determine the likely
sources of the infections.
PATIENTS AND METHODS
Epidemiologic Information
Public health institutes in Europe and the United States
which identiﬁed human Salmonella Concord infections in 2003 to
2007 were invited to participate in the study. Participating coun-
tries sent isolates to the National Food Institute (DTU-Food) in
Denmark and provided information about patients including those
3 years of age. Adoption status and country of origin were
provided if available. Patients, or parents of patients 18 years of
age, in Denmark and the United States were interviewed to
determine the orphanage of origin for adopted patients and if the
patient had international travel before illness onset or used anti-
microbial agents before specimen collection. Information about
adoptions from Ethiopia was sought from national agencies in
participating countries. In collaboration with the Ethiopian Nutri-
tion and Health Research Institute, orphanages in Ethiopia were
visited in February 2008.
Laboratory
Isolates were serotyped at public health laboratories and
conﬁrmed at DTU-Food.11 Isolates were subtyped by pulsed-ﬁeld
gel electrophoresis (PFGE) at state public health laboratories in the
United States and DTU-Food according the PulseNet protocol
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using Xba I digestion.12 PFGE patterns were compared using
BioNumerics 4.6 (Applied Maths, Sint- Martens-Latem, Belgium).
Minimum inhibitory concentrations (MICs) to 25 antimicrobial
agents were determined using Sensititre microbroth dilution.13
CLSI interpretive criteria were used for amikacin, ampicillin,
aztreonam, cefazolin, cefepime, cefpodoxime, ceftazidime, ceftri-
axone, cefuroxime, cephalothin, chloramphenicol, ciproﬂoxacin,
gentamicin, imipenem, nalidixic acid, sulfamethoxazole, tetracy-
cline, and trimethoprim14–16; and DTU-Food-deﬁned resistance
breakpoints were used for apramycin (16 mg/L), ceftiofur (4
mg/L) (a third generation cephalosporin used in veterinary medi-
cine), colistin (8 mg/L), ﬂorfenicol (16 mg/L) (a phenicol used
in veterinary medicine), neomycin (8 mg/L), spectinomycin
(64 mg/L), and streptomycin (16 mg/L) (http://www.crl-ar.eu/
_pdf/monitoring_reports/Danmap%202006.pdf).
Decreased susceptibility to ceftriaxone and ciproﬂoxacin was de-
ﬁned as an MIC 2 mg/L and MIC 0.125 mg/L, respectively.
Resistance to 3 antimicrobial agents of different classes was
deﬁned as multidrug-resistant.
Multidrug-resistant strains were further characterized using
a polymerase chain reaction (PCR) assay with primers speciﬁc for
8 antimicrobial resistance genes13 (Table, Supplemental Digital
Content 1, http://links.lww.com/INF/A144). PCR products were
puriﬁed (GFX PCR DNA kit Amersham Biosciences), and sub-
mitted to Macrogen Inc. for sequencing. Sequence analysis and
alignment was performed using Vecton NTI suite 9 (InforMax,
Inc.). Resulting nucleotide sequences were compared with se-
quences obtained from GenBank (available at: http://www.lahey.
org/studies/webt.html). Conjugation of selected multidrug-resis-
tant isolates was performed using previously described meth-
ods.17,18 Transconjugation was veriﬁed by PCR using primers
speciﬁc for blaCTX-M-15 and blaSHV-12. Plasmid analysis was
performed on selected transconjugants and their respective donors
by S1-nuclease digestion and PFGE.
Role of Funding Source
Neither of the grants for this study had any involvement in
design, collection of isolates, analysis, interpretation of data,
preparation of the article or decision where to submit the study for
publication.
RESULTS
Public health institutes in Austria, Denmark, England (and
Wales), Ireland, the Netherlands and the United States reported 78
cases of laboratory-conﬁrmed Salmonella Concord infections from
2003 to 2007. In the United States, Salmonella Concord was
isolated from 48 persons; 3 in 2003, 4 in 2004, 5 in 2005, 12 in
2006, and 24 in 2007. In the 5 participating European countries,
Salmonella Concord was isolated 30 persons; 1 in 2003, 9 in 2004,
10 in 2005, 8 in 2006 and 2 in 2007 (Fig. 1). During the study
period, Salmonella Concord was isolated from 12 persons in
Austria, 3 in Denmark, 9 in England (and Wales), 2 in Ireland, and
4 in the Netherlands. Gender were known for 67 patients; 41 (61%)
were female. Age was known for 75 patients. The median age was
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FIGURE 1. Number of children adopted from Ethiopia (A) and number of reported laboratory-confirmed cases of Salmonella
serotype Concord (B) per year in participating countries in Europe* and the United States, 2003–2007. *No adoption data were
available for Austria. References: http://www.adoptionsnaevnet.dk/; http://travel.state.gov/family/adoption/notices/notices_
473.html; http://www.adoptie.nl/; http://www.adoptionboard.ie/; http://www.dfes.gov.uk/intercountryadoption/general.shtml.
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12 months (range: 2 months–76 years); 56 (75%) were3 years of
age and 11 (15%) were 18 years of age. Adoption status was
known for 44 (79%) of the patients 3 years of age; of these, 43
(98%) were adopted. The patient who was 3 years of age and
was not adopted was a sibling of a child adopted from Ethiopia. All
43 adopted children were from Ethiopia except for 1 child who
was adopted from an unspeciﬁed African country. Of the 43
adopted children, 10 adopted children were brought to Austria and
33 to the other participating countries (29 to the United States, 3 to
Denmark, and 1 to England). Six (54%) patients 18 years of age
were female; of these, 2 were mothers of children adopted from
Ethiopia.
We interviewed patients or parents for 31 (61%) of the 51
patients in Denmark and the United States. Among the 25 inter-
viewed patients 3 years of age, 24 (96%) were adopted from
Ethiopia. For the children adopted from Ethiopia, the median time
in one or more orphanages in Ethiopia was 3 months (range: 1–6.5
months). Stool specimens which yielded Salmonella Concord from
the children adopted from Ethiopia were collected an average of 32
days following adoption (range: 2–185 days). Six (25%) of the
children adopted from Ethiopia were asymptomatic at the time of
adoption and specimen collection; 1 asymptomatic child had a
stool specimen cultured because of an ill sibling, and 5 asymp-
tomatic children had stool specimens cultured resulting from
recommendations by his or her pediatrician. Eighteen (75%) of the
children adopted from Ethiopia were symptomatic at the time of
adoption; all had diarrhea, 7 (39%) had fever; 4 (22%) had bloody
diarrhea, and 3 (17%) were hospitalized. Median duration of
illness was 11 days (range: 5–90 days). One child received anti-
microbial agents after illness onset and before specimen collection.
Information regarding the adoption agency in Ethiopia was re-
ported for 18 (75%) of the adopted children; the children were
adopted from 8 different orphanages in Addis Abba, Ethiopia.
A total of 3419 children were adopted from Ethiopia from
2003 to 2007 and brought to countries participating in this study
(no adoption information was available from Austria); during this
5-year period, the number of children adopted from Ethiopia
increased 527% from 221 adoptions in 2003 to 1385 in 2007. Of
the 2852 children adopted from Ethiopia and brought to the United
States, 1987 (70%) occurred in the last 2 years. Of the 567 children
adopted from Ethiopia and brought to 1 of the 4 European
countries with adoption information participating in this study, 233
(41%) occurred in the last 2 years. During the study period, 188
children adopted from Ethiopia were brought to Denmark, 14 to
England (and Wales), 66 to Ireland, and 299 to the Netherlands
(Fig. 1).
Two orphanages in Ethiopia from where at least 3 patients
were adopted were visited. Children at the orphanages were most
commonly abandoned at police stations shortly after birth. Family
or medical history before arrival at the orphanage was seldom
known. Children typically stayed at the orphanages for at least 3
months before being adopted or sent to another agency. Poor
hygiene and sanitation was observed at the orphanages. Cases of
dehydration and diarrhea were reported among the children in the
orphanages. According to physicians at the orphanages, young
children in the orphanages were typically treated for diarrhea with
ceftriaxone, gentamicin and sulfamethoxazole, or with tri-
methoprim and sulfamethoxazole; older children received cipro-
ﬂoxacin.
Laboratory
Salmonella Concord isolates from 64 (82%) of the 78
patients were subtyped by PFGE. Fifty-three unique XbaI PFGE
patterns were observed (Fig., Supplemental Digital Content 2,
http://links.lww.com/INF/A145). There were 6 PFGE patterns
with 2 indistinguishable isolates. The pattern with the most
indistinguishable isolates included those from 7 children of which
at least 5 isolates were from children adopted from Ethiopia. Each
of the remaining 5 patterns with 2 indistinguishable isolates
included at least 1 isolate from a child adopted from Ethiopia
including 1 pattern with indistinguishable isolates from a child
adopted from Ethiopia and his adopted mother.
Isolates were available for antimicrobial susceptibility test-
ing for 43 (55%) of the 78 patients; 8 (19%) were susceptible to all
agents and 35 (81%) were multidrug-resistant. Travel history was
known for 4 of the patients infected with pansusceptible Salmo-
nella Concord. None reported associations with Ethiopia but all
were adults who traveled to Kenya before illness onset; one adult
also traveled to South Africa, Zambia, and Malawi. Travel or
adoption status was known for 30 of the 35 patients infected with
multidrug-resistant isolates. All were either from or associated
with a child adopted from Ethiopia. All multidrug-resistant isolates
were resistant to ampicillin, aztreonam, cefazolin, cefepime, cef-
podoxime, ceftazidime, ceftiofur, cefuroxime, cephalothin chlor-
amphenicol, streptomycin, sulfamethoxazole, and trimethoprim.
All multidrug-resistant isolates also had decreased susceptibility to
ceftriaxone; 34 (97%) were ceftriaxone-resistant. Of the multi-
drug-resistant isolates, 34 (97%) were resistant to gentamicin, 24
(69%) were resistant to tetracycline, and 6 (14%) showed de-
creased susceptibility to ciproﬂoxacin.
At least 1 isolate was available for antimicrobial suscepti-
bility testing from 3 of the 6 PFGE patterns with2 indistinguish-
able isolates; each of these available isolates was multidrug-
resistant and was from a child adopted from Ethiopia.
All 35 multidrug-resistant isolates harbored a blaTEM gene
and blaCTX gene; sequence analysis of the PCR products showed
100% identity to blaTEM-1b and blaCTX-M-15, respectively. Of the
multidrug-resistant isolates, 13 (37%) also harbored the blaSHV
gene; sequence analysis revealed 100% identity to blaSHV-12. Nine
multidrug-resistant isolates were selected for conjugation studies.
Five transconjugants were successfully recovered yielding the
same susceptibility pattern as the donors. After digestion with S1
enzyme and PFGE, a plasmid of approximately 380 kb. was
observed. Two isolates yielded transconjugants with less resistance
than the donors (resulted in limited resistance to ampicillin, ceph-
alothin, cefpodoxime, and ceftiofur). After digestion with S1 and
PFGE, a single plasmid of approximately 80 kb was observed in
these 2 isolates. PCR conﬁrmed the presence of the genes blaCTX
and the blaSHV in all transconjugants.
The 6 multidrug isolates with decreased susceptibility to
ciproﬂoxacin were characterized. Three isolates were indistin-
guishable by PFGE and contained the plasmid mediated quinolone
resistance gene qnrB; these isolates were isolated from children
adopted from Ethiopia and brought to the United States. Two
isolates with different PFGE patterns contained the quinolone
resistance gene qnrA gene; these isolates were isolated from
children adopted from Ethiopia and brought to Austria. The re-
maining isolate had a single base substitution in the gyrA gene at
codon 83 (TCC {Ser} 3 TTC {Phe}); this isolate was from a
1-year old child in the United Kingdom with an unknown adoption
history.
DISCUSSION
In this multinational study, we demonstrate that multidrug-
resistant Salmonella Concord infections are common among chil-
dren adopted from Ethiopia. We found that from 2003 to 2007, at
least 33 (1.0%) of the 3419 children adopted from Ethiopia and
brought to the United States and 4 European countries had a
laboratory-conﬁrmed Salmonella Concord infection. In the United
Hendriksen et al The Pediatric Infectious Disease Journal • Volume 28, Number 9, September 2009
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States alone the number was 24 cases of 2852 (0.8%) Ethiopian
adoptees. Most of these infected children were symptomatic, some
with severe symptoms. Since only a fraction of Salmonella infec-
tions are laboratory-conﬁrmed, these data suggest a remarkably
high incidence of Salmonella infection among children in orphan-
ages in Ethiopia. It is not known how long this Salmonella strain
has been present in these orphanages, but the diversity of PFGE
patterns (no indication of temporal evolution among the patterns)
among the children adopted from Ethiopia and the adoption of
infected children from at least 8 orphanages in Ethiopia indicates
an endemic problem in Ethiopian orphanages. The increasing
isolation of this strain in the United States and Europe likely
reﬂects that increasing frequency of adoption of children from
Ethiopia. Ethiopia was the fourth most common country of origin
for adoptions in Denmark and the United States in 2007 following
China, Vietnam and South Africa in Denmark (Available at:
http://www.adoptionsnaevnet.dk), and China, Guatemala and Rus-
sia in the United States (Available at: http://travel.state.gov/family/
adoption/stats/stats_451.html).
The highly resistant nature of the Salmonella Concord
isolates from children adopted from Ethiopia makes antimicrobial
treatment difﬁcult. Although antimicrobial agents are not neces-
sary for the treatment of most Salmonella infections, antimicrobial
treatment can be life-saving in severe infections.4,5 All of the
isolates from children adopted from Ethiopia were resistant to 19
antimicrobial agents including all antimicrobial agents commonly
used to treat Salmonella infections in children. Furthermore, some
of the isolates from children adopted from Ethiopia had decreased
susceptibility to ciproﬂoxacin; treatment of such infections with
ﬂuoroquinolones is not advised because such treatment has been
associated with treatment failures.19,20
The highly resistant isolates from children adopted from
Ethiopia illuminates the need for more appropriate use of antimi-
crobial agents in orphanages in Ethiopia. The empiric treatment of
children with diarrhea at the orphanages with a combination of
ceftriaxone, gentamicin, and sulfamethoxazole is particularly wor-
risome. It is not known if other countries have similar endemic
Salmonella problems in orphanages but the transmission of mul-
tidrug-resistant Salmonella has been reported in orphanages in
other countries in Africa; in a similar study of multidrug-resistant
Salmonella Babelsberg and Salmonella Enteritidis infections in
France among children adopted from Mali, the highly resistant
nature of the isolates was thought to be due to the heavy use of
antimicrobial agents in orphanages in Mali.21 Preventing further
infections in orphanages in Ethiopia and elsewhere should focus
on improvements in hygiene and sanitation. The highly resistant
nature of Salmonella Concord in the orphanages in Ethiopia
demonstrates the difﬁculties in controlling such infections using
antimicrobial agents. Treatment of children with diarrhea should
focus on supportive care particularly rehydration. Antimicrobial
agents should be reserved for treatment of patients at risk for
serious infections or with systemic symptoms.
This study provides useful information for parents adopting
children from Ethiopia and perhaps elsewhere. The American
Academy of Pediatrics recommends that a stool specimen be
collected from all adopted children and cultured for bacterial
pathogens including Salmonella.22–24 Adherence to this recom-
mendation identiﬁed Salmonella. Concord infections in several
asymptomatic children adopted from Ethiopia. The utility of this
recommendation was highlighted in this study since we identiﬁed
several instances in which family members were infected with
Salmonella Concord which was apparently introduced into the
family from an adopted child. Furthermore, considering the alarm-
ingly high frequency of antimicrobial resistance among the Sal-
monella Concord isolates from adopted children in this study
including resistance to third and fourth generation cephalosporins
and ciproﬂoxacin, it may be useful to test Salmonella isolates
isolated from adopted children for antimicrobial susceptibility.
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Article V 
Molecular characterization of extended spectrum cephalosporinases (ESC) producing 
Salmonella Choleraesuis from patients in Thailand and Denmark 
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 ABSTRACT  
The objective of this study was to characterize extended spectrum cephalosporinases (ESC) 
producing isolates of 			serovar Choleraesuis recovered from patients in Thailand and 
Denmark.   
 
Twenty-four isolates were included in the study, 13 of which were blood culture isolates. 
Twenty-three isolates were recovered from Thai patients in 2003, 2007, or 2008 and one isolate 
was recovered from a Danish traveller to Thailand. ESC production was confirmed by minimum 
inhibitory concentration testing. Micro-array and plasmid profiling (replicon typing and RFLP) 
were used to characterize the genetic mechanisms of antimicrobial resistance in the ESC 
producing isolates. PFGE was used to compare isolates resistant to third generation 
cephalosporins with susceptible isolates from Thailand during the same period.  
 
MIC determination, micro-array, PCR, plasmid profiling and replicon typing revealed the 
presence of multi-drug resistant isolates harboring either 	CMY-2 containing incA/C or 	CTX-M-
14 containing incFIIA / incFrepB located on plasmids ranging in size from 75–200 kb. The RFLP 
and replicon typing clustered the isolates into four distinct groups. PFGE revealed 16 unique 
patterns and five clusters; each cluster contained two to three isolates. The isolate from the 
Danish patient was indistinguishable from two Thai clinical isolates. 
 
This study revealed the emergence of the 	CTX-M-14 gene among several clones of 			 
serovar Choleraesuis. Numerous plasmids were identified containing up to two different ESC 
genes and four distinct replicons. A “travel associated” spread was confirmed. The findings 
represent a serious threat to public health for the Thai people and tourists.  
 3
 INTRODUCTION
			
 is a common cause of human gastroenteritis and bacteremia worldwide (15, 
29) and a wide variety of animals, particularly food animals, has been identified as reservoirs for 
non-Typhi 			 (11, 19, 20). Although approximately 2,600 serovars of 			

 have been identified, most human infections are caused by a limited number of serovars 
and in general these infections are self-limiting. Some 			 serovars including  
			 Choleraesuis (swine) and 			 Dublin (cattle) which are adapted to a specific 
animal hosts, have a propensity to cause extra-intestinal infections in humans.  When compared 
to other serovars of non-Typhi 			, infections with these serovars are associated with 
higher rates of bacteremia, meningitis, and mortality (4, 5, 21).  For patients with severe 
salmonellosis, antimicrobial chemotherapy may be life-saving. Due to increasing prevalence of 
fluorquionolone resistance third generation cephalosporins are increasingly used for the treatment 
of 			 infections in humans (14, 18, 22) and these compounds have been designated as 
critically important for human health by the World Health Organization (10).
We recently reported that human infections with 			serovarCholeraesuis in Thailand 
increased from 1.5% in 1993 to 9.2% in 2007 (16). The group of people at highest risk for these 
infections was those between 6–40 years of age in the Central region of Thailand (16). A 2007 
study of 			serovarCholeraesuis isolates from Thailand observed an increasing 
resistance to both third generation cephalosporins and fluoroquinolones.  Fifty-four isolates 
obtained between 2003 and 2005 were tested, of which 30% were found to be resistant to third 
generation cephalosporins (22).  
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 To date, only two reports, both from Taiwan, have described mechanisms for third generation 
cephalosporin resistance in 			 serovarCholeraesuis. The first report was published in 
2004 with the discovery of 	CMY-2 AmpC -lactamase gene located on a 140 kb F-like plasmid 
(6). The following year, the same authors detected 	CTX-M-3 in a 			 serovar
Choleraesuis isolate from a patient admitted to a university hospital (28). In 2007, a massive 
increase of flouroquinolone and ceftriaxone resistant 			 serovar Choleraesuis was 
described in Thailand (22).  
In Taiwan, the usage of antimicrobials in veterinary medicine and as growth promoter in animal 
feed may have promoted the emerging of the resistance (5). Likewise, in Thailand, the third 
generation cephalosporin ceftiofur is used extensively in the swine production (22).  
 
The objectives of the present study were to determine the genetic diversity and antimicrobial 
resistance of extended spectrum cephalosporinases (ESC) producing 			 serovar
Choleraesuis isolates from patients in Thailand and Denmark. Additionally, isolates of 
			 serovar Choleraesuis from Thailand which were resistant to third generation 
cephalosporins were compared with susceptible isolates using PFGE.  
METHODS
0
	
	
A total of 24 isolates were included in this study.  Twenty-three isolates were recovered in 
Thailand and one ESC producing isolate was recovered in 2008 at Aalborg Hospital, Aarhus 
University Hospital, Denmark. The WHO National 			 and 
		Center in Bangkok 
receives all presumptive isolates of 			spp.  from all diagnostic laboratories throughout 
Thailand. In 2003, as part of another study, the National Food Institute, Technical University of 
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 Denmark (DTU-Food) received 82 isolates of 			serovarCholeraesuis which were 
recovered from Thai patients. (1). In 2008, this collection was screened for the presence of ESC 
producing isolates and two ESC producing strains, both isolated in 2003, were identified. DTU-
Food received 12 isolates of 			serovarCholeraesuis in 2008, ten isolates were ESC 
producers isolated in 2008 from Thai patients at the Regional Medical Sciences Center in 
Samutsongkhram, Thailand.  
In addition, to assess the genetic diversity of 			serovarCholeraesuis in Thailand, nine 
isolates from Thailand which were susceptible to third generation cephalosporins were included 
in the study. These susceptible isolates were isolated from patients in Bangkok and were 
randomly selected from the collection.  
 


The isolates were serotyped using slide agglutination in the country of origin.  
O and H antigens were characterized by agglutination with hyperimmune sera (S & A reagents 
lab, Ltd, Bangkok, Thailand and Statens Serum Institute, Copenhagen, Denmark) and serotype 
was assigned according to the Kauffmann-White scheme (13).  
 



	

	


Minimum inhibitory concentration testing of the 13 ESC producing isolates was performed at the 
DTU-Food using previously described methods (17). Results were primarily interpreted using 
current European Committee on Antimicrobial Susceptibility Testing (EUCAST) 
(www.eucast.org) and European Food Safety Authority (EFSA) epidemiologic break points (26). 
Due to the absence of some break points in the EUCAST system, exceptions were made for the 
interpretation of cefepime and ceftriaxone where Clinical and Laboratory Standards Institute 
 6
 guidelines and clinical breakpoints were utilised (7, 8, 9). Quality control using '	
 ATCC 
25922 was conducted according to CLSI. 
 
%

Detection of gene-groups associated with the antimicrobial resistance phenotypes was carried out 
using miniaturized microarrays (Identibac Amr-ve Array tubes, New Haw, Addlestore, Surrey, 
UK) containing probes for most relevant Gram-negative antimicrobial gene groups (Identibac). 
Analysis was performed as described by the manufacturer on the 13 ESC producing isolates.  

/


5	

PCR amplification and sequencing of the 	CTX-M-9 group, 	TEM and 	CMY-2 genes were 
performed on the 13 isolates using methods described previously (17, 25).  
Amplicons produced were selected for sequencing. Prior to sequencing, the amplicons were 
purified using the GFX™ PCR DNA kit (GE Healthcare, Chalfont St. Giles, UK) following the 
protocol of the manufacturer. The DNA was shipped to Macrogen Inc., Seoul, Korea for 
sequencing using the same primers as in the PCR analysis. Sequence analysis and alignment was 
performed using Vecton NTI suite 9 (InforMax Inc., Bethesda, Maryland, US) software. The 
resulting nucleotide sequences were compared to sequences obtained from the GenBank database 
(http://www.lahey.org/studies/webt.html).  
 
	

(

Plasmid DNA was extracted using QIAGEN Plasmid Mini Kit (Qiagen, Hilden, Germany). The 
plasmid DNA was transferred into electrocompetent '	
DH10B cells and subjected to S1 
nuclease PFGE as described below to ensure that only one plasmid had been transferred into the 
 7
 competent cells as well as to estimate the approximate size of the plasmids carrying the ESC 
phenotype. The electroporation was followed by selection of transformants on BHI agar 
supplemented with cefotaxime (2 g/ml). The presence of the plasmid in the transformants was 
confirmed by PCR detection of relevant 	 genes as described above. Additionally, testing was 
performed to determine if any non-ESC resistance determinants co-transferred with the ESC 
plasmids.  The 13 transformants were analysed by PCR for all relevant resistance genes based on 
the results of the Array tube analysis described above. Transformants were further subjected to 
replicon PCR and plasmid purification followed by RFLP.  
  
;	

 
Plasmids within transformants were replicon typed as described previously (2).  
 

	
	G

Plate-mating experiments were performed with transformants as donors and plasmid-free, 
rifampicin and nalidixic acid resistant '	
 MT102RN as recipients (2, 25). The strains were 
grown to both late exponential as well as stationary phase, mixed (1:1) and incubated on solid 
blood agar at 37C for 18 h. Transconjugants were selected on BHI medium supplemented with 
50 g/ml rifampicin, 32 g/ml nalidixic acid, and 2 g/ml cefotaxime.  
  
*

	

(

 
PFGE with S1 nuclease (Promega) digestion of whole genomic DNA performed as described 
below was used to estimate sizes of larger plasmids. Following pre-incubation for 10 min. in 1:10 
diluted S1 buffer, 2 mm slices of PFGE plugs made from cultures with an OD620 of 0.6 were 
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 digested with 5 U of S1 (Promega, Madison, US) for 45 min. at 37C. The slices were post-
incubated on ice for 10 min in 200 μL of ice-cold TE-buffer (10:1), loaded on the gel and run on 
a CHEF-DRIII device (Bio-Rad, Hercules, USA) with a pulse time of 6.8 s – 38.4 s at 6 V/cm for 
19 h. Braenderup H9812 digested with &I was used as size marker . 

	
			
  
All 24 isolates included this study were analyzed for genetic relatedness by PFGE using &I 
according to the CDC PulseNet protocol (24). The electrophoresis was performed with a CHEF 
DR III System (Bio-Rad Laboratories, Hercules, CA, USA) using 1% SeaKem agarose in 0.5× 
Tris-borate-EDTA at 180 V. Running conditions consisted of one pulse time of 2.2 - 63.8 s for 22 
h at 6 V/cm on a 120 deg. angle in 14°C TBE buffer. Comparison of the PFGE profiles was 
performed by using Bionumerics software version 4.6 (Applied Maths, Sint-Martens-Latem, 
Belgium) and the dice correlation for band matching with a 0.9 % position tolerance and an 
optimization at 0.9 % using both & . 
 
RESULTS
'

	
	


Twelve of the ESC producing isolates from Thai patients were obtained from blood samples;11 
of the isolates were obtained in Ratchaburi Province and one was from Bangkok. The 12 isolates 
were obtained from 10 patients with two patients each having two positive blood cultures. All 
samples were collected between April and May or between August and October. The patients 
were unevenly distributed by gender, with eight isolates obtained from males and two from 
females.  The age of one patient was unknown. However, the age of the remaining nine patients 
 9
 ranged from 17 to 58 years with a median of 34 years. Data on occupation of the patients were 
not collected. 
 
'

	
	


/


A healthy 37-year old Danish male was on assignment to an industrial company in Bangkok from 
July 27 to August 14 in 2008. He resided in a five star international hotel at Sukhumvit Road in 
the center of Bangkok and worked full time at the Navanakorn Industrial Estate Zone 3 situated 
45 km outside of Bangkok. Meals were primarily served in the hotel and at the work place. 
Typical Thai food (soup and rice dishes) was daily consumed and included either fish or minced 
pork.  
One week before the return to Denmark the patient contracted diarrhoea with an acute onset, but 
without blood. The patient was febrile up to 38.8°C with dizziness, cephalgia, and mild muscle 
pain. Concurrently, the patient noticed flexor paresis of the interphalangeal joint of the left thumb 
accompanied by hypestesia in the C6 dermatome. Except for paresis and hypestesia the 
symptoms abated in a few days and the diarrhoea responded to loperamide. However, symptoms 
recurred several times and the patient was admitted to a Danish hospital on September 10th with a 
weight loss of 11 kg. A blood culture obtained by admission revealed 			serovar
Choleraesuis. Fecal cultures during admission were negative. 
Empirical antimicrobial treatment included ciprofloxacin and pivmecillinam. Treatment with 
meropenem was considered based on the multi-drug resistant phenotype of the isolate, but the 
patient felt well and he declined. Eight months later the patient was in good health though the 
flexor paresis persisted.  




	

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 All of the 13 ESC producing isolates were multi-drug resistant and exhibited resistance to at least 
13 of the tested antimicrobials (eight antimicrobial drug classes) (Figure 1). Resistance was not 
detected to apramycin (only approved for veterinary use), colistin, imipenem, meropenem and 
trimethoprim. All isolates were resistant to ampicillin, cefalothin, cefazolin, cefotaxime, 
cefpodoxime, ceftiofur, nalidixic acid, sulphamethoxazole and tetracycline. Twelve isolates 
(92%) were resistant to chloramphenicol; four (31%) of these strains also were resistant to 
florfenicol (only approved for veterinary use). Resistance to ciprofloxacin was observed in twelve 
(92%) isolates, one isolate had a MIC just below the break point of ciprofloxacin. Eleven (85%), 
four (31%), four (31%), and four (31%) of the isolates were resistant to the ceftriaxone, 
ceftazidime, cefepime, and cefoxitin, respectively (Figure 1). Four isolates (31%) were also 
resistant to amoxicillin and clavulanic acid and another six isolates (46%) to gentamicin. Only 
two isolates (15%) were resistant to neomycin whereas eleven (85%) and ten (77%) isolates were 
resistant to spectinomycin and streptomycin, respectively. 
 
 




Based on Array tube analysis and subsequent sequencing of PCR-generated DNA fragments, 
eight of the 13 ESC producing isolates harbored the extended spectrum  -lactamase gen group 
	CTX – M-9, the chloramphenicol resistance acetyltransferase gen 	A, the sulphonamide 
resistance gen 	3, the aminoglycoside resistance gen A1, and the tetracycline resistance gen 
B. In addition, five (SH2867/08, SH2868/08, SH2871/08, SH2872/08, 08-120226) of the eight 
isolates also harbored the intergase gen 
1.  
Of the remaining five isolates, four contained the 	R gen conferring resistance to florfenicol, the 
sulphonamide resistance gen 	2, the intergase gen 
1 encoding an intergron, the 
aminoglycoside resistance genes A and B, the plasmidic ampC gen 	CMY, and the 
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 tetracycline gen A. In addition, one (SH508/03) of the four isolates also harbored the B and 
	1 genes. Furthermore, three (SH2870/08, SH2874/08, SH508/03) of the four isolates contained 
also the aminoglycoside resistance gen A1. 
One isolate (SH1208/03) was resistant to sulphamethoxazole and tetracycline containing the 	1 
and B genes, respectively. In addition, this isolate harbored the extended spectrum  -
lactamase gen group 	CTX – M-9 and the 	TEM gen.  
 
The isolates which produced amplicons to 	CTX – M-9 group, 	CMY and 	TEM were sequenced 
and showed 100% similarity to strains in the Genbank encoding for 	CTX-M-14 , 	CMY-2 and
	TEM-1b, respectively. 
 
	

(
*	)>'	

;)C
Approximate plasmid sizes were given in Figure 2 and ranged from approximately 75 kb to 200 
kb. Plasmid profiling by RFLP separated the plasmids into three distinct clusters (I, II and III in 
Figure 2). Furthermore, one plasmid profile (from strain SH1208/03) was not associated to any of 
the three main groups. The plasmid with 	CMY-2 genes was associated to cluster I, while 
plasmids harboring the 	CTX-M-14 gene belonged to the two remaining clusters as well as the 
plasmid out of line with the three clusters (Figure 2). Replicon typing identified the incA/C 
replicon in RFLP cluster I, the incFrep in cluster II and incFIIA in cluster III, while the plasmid 
from SH1208/03 was untypable.  
 
$'$


	

	
 
The PCR results revealed that only one (SH2862/08) of the eight ESC producing isolates which 
harbored the extended spectrum -lactamase gen group 	CTX – M-14 successfully transferred non-
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 ESC resistance determinants. In addition to 	CTX – M-14, the transformant contained the 	3, the 
A1 and the B genes.  
The four transformants containing plasmid ampC gen 	CMY-2 seemed to harbor many of the 
non-ESC resistance determinants. All of the four transformants contained the 	R, the 	2, the 
A / B and A genes. In addition, one (SH508/03) of the four transformants also contained 
the 	1 gene and three transformants (SH2870/08, SH2874/08, SH508/03) contained the A1 
gene. 
The transformant of the one isolate (SH1208/03) which harbored the 	CTX – M-14 also contained 
the 	TEM gen.  

$G
5

By conjugation experiments we found the ESC phenotype readily transferable from wild type 
strains carrying plasmids belonging to RFLP cluster I and cluster II as well as from isolate SH 
1208/03. However, the four strains carrying the incFIIA type plasmids of RFLP cluster III did not 
succeed. 
 
)>'

The 24 			 serovar Choleraesuis isolates from 22 patients were subtyped by PFGE. 
Sixteen unique &I PFGE patterns were observed (Figure 1). There were five distinct PFGE 
clusters with >2 indistinguishable isolates. Three clusters contained ESC producing isolates of 
which two included two indistinguishable isolates from different Thai patients (SH2858/08, 
SH2867/08 and SH2870/08, SH2874/08). A second cluster contained three isolates with 
indistinguishable patterns, two isolates from one Thai patient (SH2871-08, SH2872-08) (different 
susceptibility profiles) and the isolate (08-120226) from the Danish traveller to Thailand. The 
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 two remaining clusters only contained isolates susceptible to third generation cephalosporins of 
which one included isolates from both 2003 and 2008.
 
DISCUSSION 
This study provides the first description of	CTX-M-14 in 			serovar Choleraesuis isolates 
and is the first reported isolation of an ESC producing 			 serovar Choleraesuis in an 
international traveller who recovered with sequelae from his infection. In addition, these data 
provide evidence that ESC producing isolates have emerged in Thailand on several plasmids and 
in several clusters of Choleraesuis. 
 
Characterization of the antimicrobial resistance genes indicates some similarity between isolates 
harboring either 	CTX-M-14 or 	CMY-2. The data from the plasmid characterization, conjugation, 
replicon typing and RFLP also suggested that these are not highly clonal strains and further 
grouped the isolates into four distinct replicon clusters. Based on the data of the unknown 
replicon, one could speculate if the plasmid of isolate SH1208/03 was the ancestor to the other 
isolates harboring the 	CTX-M-14 gene and simply evolved rather than spread to other strains. All 
of the analyses indicate multiple clones and multiple plasmids being responsible for the 
resistance to extended spectrum cephalosporinases producing 			 serovar Choleraesuis 
obtained from patients in Thailand and Denmark.  
Several studies have described plasmids carrying 	CMY-2 containing the incA/C replicon along 
with other resistance genes. A recent Canadian study investigated 38 '	
 isolates where all of 
the isolates harbored a plasmid carrying 	CMY-2 containing the incA/C replicon (24). A similar 
association between 	CTX-M14 and incFII has been described previously. Geraldine Marcade 
	 found that the great majority of genes encoding 	CTX-M-14 and 	CTX-M-15 were carried by 
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 IncF replicons. Of 15 '	
 isolates harboring 	CTX-M-14 eight of them contained the replicon 
IncFII (23,. 
 
PFGE patterns revealed a high degree of clonal diversity among the 24 isolates. ESC producing 
and non-ESC producing isolates were generally interspersed although some rare clusters 
comprised solely resistant or susceptible isolates. This indicates that multiple clones are 
circulating in the population and that isolates resistant to third generation cephalosporins most 
likely developed due to a long standing selection pressure from the use of these compounds in a 
veterinary reservoir rather than a recent spread of a single clone. 
 
			 serovar Choleraesuis has been eradicated from the primary production of swine in 
Denmark and many other industrialised countries. The isolate from the Danish traveller shared 
the an identical PFGE pattern with an isolate from a Thai patient infected in the autumn of 2008. 
The isolates were resistant to the same antimicrobials and harbored the same resistance genes 
with exception of two additional resistance traits in the isolate from the Danish patient, namely 
resistance to amoxicillin + clavulanic acid and gentamicin. We have no explanation for this 
discrepancy because the Danish patient did receive only symptomic therapy prior to admission to 
the hospital in Denmark.  
The Danish case was remarkable for neurologic symptoms localized to the left hand which 
coincided with diarrhoeal illness and persisting for at least 9 months. There was no evidence of 
focal infection, but the similarity with mononeuropathy in association with typhoid fever may 
indicate a common pathogenesis (12).  
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 Thailand is a popular tourist destination for Europeans. Thus, in 2008 149.570 Danes visited 
Thailand (http://www.tourism.go.th/). During the same year, 3,022 confirmed cases of 
			 infections in humans were reported to Statens Serum Institute, Denmark. Of these, 
706 (23.3%) were confirmed as travel associated and 95 (13.4%) cases were linked to travelling 
to Thailand (Data not published). These numbers might be underestimated and probably should 
be multiplied with 10 -20 times (30). Taking this underestimation into consideration 0.6% of the 
Danes visiting Thailand might bring back a 			 infection based on these data.  
 
The infections with 			serovar Choleraesuishas recently increased in Thailand and the 
emergence of ESC producing 			 serovar Choleraesuis makes this problem even more 
serious (16). We therefore urge the Thai authorities to take action in order to prevent and control 
the spread of this serovar among animals and the human population. Targeted interventions can 
benefit swine farmers by reducing losses and possible export restrictions. These interventions can 
also reduce the high costs of hospitalization associated with treatment of invasive 			
serovar Choleraesuis infections which include the necessity to use carbapenems which are 
antibiotics of last resort. We recommend enforcing a strict policy on the usage of antimicrobials 
in food animals and a ban on the usage of third generation cephalosporins as growth promoter. 
  
CONCLUSSION 
This study provides for the first time a description of	 CTX-M-14 found in 			 serovar 
Choleraesuis isolates and documents a case of bacteremia with an ESC producing 			
serovar Choleraesuis acquired by a Danish traveller during a stay in Bangkok. The data suggest 
that ESC producing isolates have emerged in Thailand on several plasmids and in multiple clones 
of 			serovar Choleraesuis. 
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 We found two genes and four replicons responsible for the resistance to third and fourth 
generation cephalosporins present in the isolates from both 2003 and 2008. In addition, the 
isolates exhibit a huge diversity among the molecular patterns indicating a variable population 
despite having similar resistance patterns and genes.  
The Thai authorities should initiate immediate actions to control and prevent infections with this 
invasive serovar for the benefit of the Thai people and tourists travelling to Thailand. The first 
step could be specific serovar targeted intervention and limitations in the usage of third 
generation cephalosporins as growth promoters in the primary production of pigs.  
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Risk Factors and Epidemiology of the Ten Most Common
Salmonella Serovars from Patients in Thailand: 2002–2007
Rene S. Hendriksen,1 Aroon Bangtrakulnonth,2 Chaiwat Pulsrikarn,2 Srirat Pornruangwong,2
Gorrawan Noppornphan,2 Hanne-Dorthe Emborg,1 and Frank M. Aarestrup1
Abstract
We conducted a retrospective observational study to assess epidemiological trends and risk factors associated
with the 10 most common Salmonella serovars isolated from humans in Thailand between 2002 and 2007. A total
of 11,656 Salmonella isolates covering all 6 years were included in the study. The top 10 Salmonella serovars
identiﬁed during the course of this study were Enteritidis, Stanley, Weltevreden, Rissen, I [1],4,[5],12:i:,
Choleraesuis, Anatum, Typhimurium, Corvallis, and Panama, which accounted for 8108 (69.6%) of the isolates.
Most isolates were from patients <5 years (33%), were isolated during June (13%), and were recovered from stool
(82%) and from patients in Bangkok (27%). Statistical analysis revealed that S. Enteritidis and S. Choleraesuis
were recovered from blood with a higher frequency than other nontyphoidal serovars. While both serovars
tended to be isolated from patients >5 years; S. Choleraesuis was recovered with a higher frequency from
patients in Bangkok and the central region, whereas S. Enteritidis was recovered predominantly from patients in
the southern region. This study also indicates a shift in prevalence of the most common Salmonella serovars
responsible for human infections in Thailand compared to previous studies. Notably, there was an increase in
human infections with S. Stanley, S. Corvallis, and S. Choleraesuis, three serovars that have previously been
associated with swine, and a decrease in infections due to S. Weltevreden and S. Anatum. The study also
revealed differences in the epidemiology among the different serovars, suggesting that serovar-speciﬁc inter-
ventions are needed. We recommend initiating targeted interventions for the two serovars associated with a high
odds ratio for submitted blood samples, S. Enteritidis and S. Choleraesuis. The authors also recommend addi-
tional epidemiologic studies to investigate the observed increase in swine associated serovars (S. Stanley, S.Corvallis,
and S. Choleraesuis) and determine interventions to reduce the burden of disease from these serovars.
Introduction
Salmonella enterica is a common cause of humangastroenteritis and bacteremia and a wide variety of ani-
mals, particularly food animals, have been identiﬁed as
reservoirs for nontyphoidal Salmonella (Coyle et al., 1988;
Humphrey et al., 1988; Humphrey, 2000). A limited number of
the 2579 currently recognized serovars of Salmonella account
for the vast majority of human infections. In developed
countries, S. Typhimurium and S. Enteritidis are the most
common causes of human salmonellosis, but other serovars
have been reported to be more prevalent in speciﬁc regions
(Humphrey, 2000; Herikstad et al., 2002; Aarestrup et al., 2003;
Bangtrakulnonth et al., 2004; Galanis et al., 2006).
Knowledge of the prevalence and epidemiology of differ-
ent serovars in speciﬁc regions may facilitate the recognition
and control of new and emerging pathogens. Previous studies
have shown that Salmonella serovars Choleraesuis, Dublin,
Virchow, Enteritidis, and Panama tend to cause invasive
disease and are associated with higher mortality rates. These
studies have reported mortality rates of 1.8% and 3.0% for
S. Choleraesuis and S. Dublin, respectively, compared with
0.5% for all nontyphoidal Salmonella and 0.6% for S. Typhi-
murium (Helms et al., 2002; Chiu et al., 2004; Jones et al., 2008).
The explanations for this observed increased virulence have not
been fully elucidated and are most likely multifactoral.
The following retrospective observational cross-sectional
study was conducted to elucidate the epidemiological trends
1World Health Organization (WHO) Collaborating Centre for Antimicrobial Resistance in Foodborne Pathogens and EU Community
Reference Laboratory for Antimicrobial Resistance, National Food Institute, Technical University of Denmark, Copenhagen, Denmark.
2WHO International Salmonella and Shigella Centre, National Institute of Health, Department of Medical Sciences, Ministry of Public
Health, Thailand.
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of the 10 most common Salmonella serovars isolated from
humans in Thailand between 2002 and 2007. Additionally, an
analysis of risk factors for human salmonellosis in Thailand
was performed. Risk factor analysis for infection with 1 of the
10 most common nontyphoidal Salmonella serovars was
compared to other nontyphoidal Salmonella serovars in the
study. Salmonella serovars Typhi, Paratyphi A, and Paratyphi
B were not included in the study based on the relatively low
prevalence in Thailand (2.1%) (Annual Report of Conﬁrmed
Salmonella and Shigella in Thailand, 2006). The following
variables were included in the analysis: age group, season,
sex, specimen type, and geographical region.
The results of this study provide insight into the epidemi-
ology and the speciﬁc factors responsible for human salmo-
nellosis among patients in Thailand. These data may assist
with targeted interventions to control infections by invasive
Salmonella serovars.
Methods
Data source
The World Health Organization (WHO) National Salmo-
nella and Shigella Centre in Bangkok receives all presumptive
isolates of Salmonella from all public health laboratories in
Thailand. Conﬁrmatory identiﬁcation is performed at the
WHONational Salmonella and ShigellaCentre using approved
internationally recognized procedures. Following conﬁrma-
tion, isolates are serotyped by slide agglutination as previ-
ously described (Bangtrakulnonth et al., 2004).
For each isolate, the following clinical and epidemiological
data are electronically recorded in Microsoft Excel 2000
spreadsheets (Microsoft Corporation, Redmond, WA): jour-
nal number, laboratory number, date, given name, surname,
sex, age including age group, origin, geographical zone, ori-
gin of sample, specimen, serogroup, and serotype. There is no
indication in the data source if only one or more samples have
been submitted per patient.
Data set
The data set contained of a total of 11,656 Salmonella isolates
with complete information covering the years from 2002 to
2007 (Table 1). The dependent variables were the 10 most
common serovars in Thailand. Odds ratio of being infected
with each of the 10 serovars were calculated as being infected
with serovar number 1 compared to the rest of the serovars in
the data set, the odds ratio of being infected with serovar
number 2 compared to the rest of the serovars in the data
set, etc.
The qualitative variables—age group, season, and region—
were aggregated into fewer levels due to the number of de-
grees of freedom, which caused problems when running the
algorithm. Originally, age groups were given in intervals of 5
years but were aggregated into only ﬁve levels: 0–5, 6–20, 21–
40, 41–60 and >60 years. Similarly, season and regions were
aggregated from months into four seasonal periods (winter,
spring, summer, and autumn) and from 13 zones into ﬁve
regions (central, northeast, southern, northern, and Bangkok).
Many of the strains were isolated from various parts of the
body and from various materials, thus only specimens origi-
nating from blood and fecal samples (rectal swabs or stool)
were included in the analysis (Table 1).
Statistical analysis
The statistical package SAS version 9.1.3 (SAS Institute
Inc., Cary, NC) was used to perform the logistic analysis. A
preselection of independent variables was initiated using
univariable analysis and all independent variables with a
p-value of <0.05 was included in logistic analysis. A full
model was ﬁtted for each serotype including all independent
variables. Backward selection was performed using p-values.
The criteria for keeping variables in the model was p-values
<0.05. The full model and the reduced model were com-
pared using the log likelihood ratio test to test the contri-
bution of the independent variables in the ﬁnal model. The
ﬁnal models contained several different independent vari-
ables. To understand the meaning of the models, the odds
ratio of being infected with 1 of the 10 most common serovars
compared to the remaining other nontyphoidal Salmonella
serovars was calculated for each level of the independent
variables (Tables 2 and 3). Biological meaningful two-factor
interactions were not analyzed as they were beyond the scope
of this article.
Results
Descriptive data
A total of 11,656 isolates collected from Thai patients with
salmonellosis between 2002 and 2007 were included in this
study. The 10 most common Salmonella serovars in this study
were S. Enteritidis (n¼ 1517 [13%]); S. Stanley (n¼ 1292
[11%]); S. Weltevreden (n¼ 1055 [9%]); S. Rissen (n¼ 969
[8%]); S. I [1],4,[5],12:i: (n¼ 690 [6%]); S. Choleraesuis
(n¼ 681 [6%]); S. Anatum (n¼ 551 [5%]); S. Typhimurium
(n¼ 540 isolates [5%]); S. Corvallis (n¼ 476 isolates [4%]); and
S. Panama (n¼ 337 isolates [3%]), which accounted for 8108
(69.6%) of the isolates (Table 1). We have not received any
information to suggest that these data are biased or dispro-
portionate due to the occurrence of a local or regional out-
break.
The proportion of the nontyphoidal Salmonella serovars
decreased from 49.6% (n¼ 1629) in 1993 to 24.4% (n¼ 1981) in
2007. The proportion of S. Anatum, which peaked at 10.1%
(n¼ 412) in 2000, decreased to 0.3% (n¼ 7) in 2006. Similarly,
by 2006, the proportion of S. Weltevreden, had decreased 13
years in a row to 7.3% (n¼ 151) and continued to decline in
2007, representing 6.6% (n¼ 130) of cases. During this same
period, increases in S. Choleraesuis were observed. The pro-
portion of S. Choleraesuis isolates increased from 2.8%
(n¼ 55) in 2002 to 9.2% (n¼ 190) in 2006. This study also
retrospectively identiﬁed the emergence in 2003 of S. Cor-
vallis, a serovar not recorded in Thailand since 1993. From
2003 to 2007, the level of S.Corvallis remained fairly constant,
representing approximately 4.5% (n¼ 45) of cases. The pro-
portion of S. Rissen remained relatively constant from 1997 to
2004, ranging from 5.9% (n¼ 46) of cases in 1998 to 9.6%
(n¼ 81) of cases in 2004. The proportion of S. Panama de-
creased in 2002 from 6.7% (n¼ 130) of cases to 2.4% (n¼ 33) of
cases in 2003 and remained at this level through 2007. The
proportion of S. Stanley increased since 1993 (1.9%; n¼ 64) to
a maximum level in 2003 (10.1%; n¼ 141). While decreases in
the proportions of S. Enteritidis and S. I [1],4,[5],12:i: were
observed in 2004 and 2005 compared to previous years, sub-
sequent increases were observed in 2007 with S. Enteritidis
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and S. I [1],4,[5],12:i: comprising 16.0% (n¼ 316) and 4.5%
(n¼ 90), of the cases for 2007, respectively (Fig. 1).
Age distribution
The patients’ ages ranged from 1 day to 96 years. The ma-
jority of infections (n¼ 640, 32.6%) were observed in patients
between 0 and 5 years (Fig. 1). The frequency of infections
among the patients rapidly decreased after the ﬁfth year of life
to an average annual level of 3.2–4.4% (n¼ 63–86) among pa-
tients from 6 to 20 years. A higher frequency of infection was
also observed among patients in the second and third decades
of life. This age group on average represented 144 cases (7.5%)
per year. The frequency of infection plateaued through the
sixth decade to an average of 60 cases per year (3.1%) at age 60.
The frequency of infection peaked for the third time among
patients older than 60 years. This age group accounted for an
average of 280 cases (14.0%) per year (Table 1, Fig. 2).
Sex
No differences were observed based on patients’ sex. Over
the 6-year period, 52.1% of patients were female and 47.9%
were male.
Seasonal trends
Infections peaked in June with an average of 1456 cases
(12.5%). Overall, the fewest cases (n¼ 745) were reported
during the month of April. However, S. I [1],4,[5],12:i:
peaked in April with an average 113 cases compared to 65
cases in June (Table 1, Fig. 3).
Specimen source
The majority of isolates (82.2%) were recovered from stool
or rectal swabs whereas the remaining 17.8% of samples were
recovered from blood. Between 2002 and 2005, the percentage
of isolates recovered from blood decreased from 15.2% in 2002
to 8.4% in 2005. However, the percentage of blood isolates
more than doubled in 2006 to 29.3% and remained relatively
unchanged (25.2%) in 2007.
Regional variation
The majority (n¼ 3119) of infections were reported from the
Bangkok region (Table 1). The 10 most common serovars de-
scribed in this study were present in Bangkok; however, the
proportion of S. Enteritidis was the lowest (10%) when com-
pared to the other four regions (Fig. 4). A large number of cases
(n¼ 4057) were also reported in the central region. Similar to
Bangkok, all of the serovars described in the study were pres-
ent in the central region. In addition, the central region had the
highest proportion of S. Choleraesuis (11%), which ranked as
the sixth most common serovar in that region (Fig. 4).
A large number of infections were also observed in the
northern region, speciﬁcally within zones 8 and 10. Salmonella
Kedougou accounted for 5% of the cases in the northern re-
gion. In contrast to other regions, S. Panama was not listed
among the 10 most commonly reported serovars, having been
surpassed by S. Kedougou.
The southern region, which includes both the eastern and
the western peninsulas, accounted for the greatest number of
salmonellosis cases due to S. Enteritidis (19%) and S. Wel-
tevreden (18%) compared to the other regions. A small per-
centage of cases in the southern region were due to swine-
associated serovars: S. Stanley (8%), S. Rissen (4%), and S.
Corvallis (3%). S. Choleraesuis was not among the 10 most
commonly reported serovars in the southern region. How-
ever, in contrast to other regions, SalmonellaAlbany accounted
for 3% of cases and was ranked as the 10th most common
serovar in the southern region (Fig. 4).
Only 1228 cases were observed in the northeastern region
(zones 5, 6, and 7) and were atypical in comparison with the
other regions because neither S.Choleraesuis, S.Corvallis, nor
S. Panama were among the top 10 most common serovars
(Table 1). These serovars were displaced by S. Hvittingfoss
(6%), S. Derby (4%), and S. Virchow (3%) which ranked
eighth, ninth, and tenth, respectively, among the top 10 most
common serovars in the region (Fig. 4).
Risk factors
Blood invasive Salmonella serovars. The statistical anal-
ysis revealed that S. Enteritidis, S. Choleraesuis, and to a
lesser extent S. I [1],4,[5],12:i: and S. Typhimurium were
recovered from blood at a signiﬁcantly increased odds ratio
when compared to other nontyphoidal Salmonella serovars.
The highest odds ratio for isolation of S. Choleraesuis or
S. Enteritidis from blood was observed among patients older
than 5 years, whereas with S. I [1],4,[5],12:i: the highest odds
ratio was observed among patients younger than 6 years.
S. Typhimurium was isolated from blood with a higher odds
ratio in the southern region (zones 1, 2, 3, and 4); however, age
did not appear to be a signiﬁcant predisposing factor for
S. Typhimurium infection.
Seasonal variations were observed among several serovars.
The odds ratio for infection with S. Choleraesuis appeared to
be higher during autumn (Tables 2 and 3, Fig. 3), while
S. Enteritidis cases peaked in winter and S. I [1],4,[5],12:i:
cases increased in spring. Odds ratios for infection with
S. Enteritidis and S. I [1],4,[5],12:i: typically declined during
the summer. S. Anatum cases typically increased during
summer with a lower odds ratio in the remaining part of the
year (Tables 2 and 3, Fig. 3).
In comparison to the other regions, the highest odds ratio
for S. Choleraesuis infection was observed among patients
in Bangkok and the central region. Patients in Bangkok and
the central region also had the lowest odds ratio of S. I [1],4,
[5],12:i: infections. The highest odds ratio of infection with
S. Enteritidis was identiﬁed in the southern region. The
northeastern region had the lowest rate of S. Panama and
S. Corvallis infections (Table 2, Fig. 4).
Diarrhea-associatedSalmonella serovars. Themost com-
mon Salmonella serovars associated with gastrointestinal
infections in Thai patients were S. Stanley, S.Weltevreden, S.
Rissen, S. Anatum, and S. Corvallis (Table 2). The majority of
S. Stanley infections were among patients between 0 and 5
years while S.Weltevreden and S.Anatum primarily infected
patients older than 5 years. S. Panama showed a clear asso-
ciation with patients between 0 and 5 years and was typically
recovered from stool samples.
Geographic trends were also observed among these ser-
ovars. S. Weltevreden cases were reported predominantly
from the southern region and the majority of S. Rissen
cases were reported from the northern region and Bangkok
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(Table 2, Fig. 4). The majority of S. Rissen cases reported over
the course of the study were from the northern region; how-
ever, the majority of cases from the northeastern region were
due to S. Stanley (Table 2 and Fig. 4).
Discussion
Occurrence
When compared to previously published studies showing
the prevalence from 1993 to 2002, the data in this study sug-
gest a shift in the prevalence of the top 10 nontyphoidal ser-
ovars associated with human salmonellosis in Thailand
between 2002 and 2007 (Bangtrakulnonth et al., 2004).
Our data indicate that while rates of S. Weltevreden, S.
Derby, S.Agona, and S.Anatum are decreasing, S. Stanley, S.
Choleraesuis, and S. Corvallis are increasing. Although the
increases in S. Corvallis and S. Stanley are notable, the in-
creased occurrence of more invasive serovars such as S.
Choleraesuis is more worrisome. This increase is particularly
concerning amid recent reports of S. Choleraesuis strains re-
sistant to ﬂuoroquinolone and extended-spectrum cephalo-
sporin. A recent study of 56 S. Choleraesuis isolates reported
approximately 60% of the study isolates to be nalidixic acid
resistant and 15% to be ceftriaxone resistant (Kulwichit et al.,
2007). These reports emphasize the importance of initiating
actions to control the spread of this serovar.
The marked decrease in S. Weltevreden has made S. En-
teritidis the most common serovar associated with human
infections in Thailand. These data contradict a publication
that forecasted a decline in the occurrence of S. Enteritidis
(Bangtrakulnonth et al., 2004). Interestingly, another study
from 2006 failed to ﬁnd any S. Enteritidis in humans from the
northern region (Padungtod and Kaneene, 2006).
Previous studies have described possible reservoirs in
Thailand for many of the serovars described in this study
( Jerngklinchan and Saitanu, 1993; Sakai and Chalermchaikit,
1996; Sasipreeyajan et al., 1996; Bangtrakulnonth et al., 2004;
Vaeteewootacharn et al., 2005; Ponce et al., 2008).
Most studies in Thailand have associated S. Rissen, S. Cor-
vallis, S. I 1, 4, 5, 12:i:, S. Stanley, S. Choleraesuis, and
FIG. 4. Distribution of the top 10 most common serovars in the different regions in Thailand from 2002 to 2007. The
numbers on the pie charts correspond with the numbered serovars in the chart legend to the right of the ﬁgure. Color version
of this ﬁgure is available online at www.liebertonline.com.
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S. Typhimurium with swine and pork products. In 2004, 295
S. Rissen isolates originating from various food sources in
Thailand were investigated and the majority (n¼ 220) of the
isolates originated frompork products (Hendriksen et al., 2008).
These results were supported by a study of swine performed in
Thailand in 2008; 49% of the tested swine harbored S. Rissen.
Additionally, 19% and 12% of the animals also harbored S.
Typhimurium and S. Stanley, respectively (Dorn-In et al., 2008).
S. Corvallis has also been reported from food sources in
Thailand. Publications in 2006 and 2007, described a total of
12 S. Corvallis isolates from food sources in Thailand (beef,
n¼ 2; chickenmeat, n¼ 6; and pork, n¼ 4) (Archambault et al.,
2006; Cavaco et al., 2007). The relationship between 138 iso-
lates of S. Typhimurium and S. I 1, 4, 5, 12:i: in humans and
swine from Thailand has been investigated and swine have
been postulated as a reservoir for both serovars (Pornruang-
wong et al., 2008).
In contrast to the swine-related serovars, S. Enteritidis, S.
Anatum, and S. Panama have been associated with chicken
and poultry products in Thailand. The most predominant
serovar was S. Enteritidis, which was present in 28% of retail
chicken meat in Thailand (Boonmar et al., 1998a). The same
author has also described the spread of a S. Enteritidis clone
among chickens and humans in Thailand (Boonmar et al.,
1998b).
Other studies have also suggested that S. Panama may be
associated with swine and pork in Thailand, while S. Rissen,
S. Corvallis, and S. Stanley may be associated with chicken. A
cross-sectional investigation of retail food in Thailand deter-
mined that S.Anatumwas primarily associated with beef and
pork while S.Corvallis was primarily associated with chicken
(Vindigni et al., 2007).
Several studies have also shown an association between S.
Weltevreden and seafood, environmental sources, or vegeta-
bles. However, this serovar has also been found in both swine
and chicken. Publications describe S.Weltevreden as themost
common serovar associated with Thai frozen shrimp (Boon-
mar et al., 1998c), and it was also found in 22 isolates of 48
isolates recovered from chicken (Padungtod and Kaneene,
2006).
Fermented food has historically been recognized as a po-
tential cause of foodborne disease. Consumption of fermented
pork and seafood products is common across Thailand, and
contamination with Salmonella ssp. has previously been re-
ported with Nham, a traditional Thai fermented ground-pork
sausage (Paukatong and Kunawasen, 2001).
Prior to this study, there have only been limited reports of
S. Choleraesuis in Thailand. Previous reports from Thailand
have shown that S. Choleraesuis was the second most com-
mon cause of septicemia between 1988 and 1996 (Boonmar
et al., 1998c; Chiu et al., 2004). Additionally, one article re-
ported the isolation of S. Choleraesuis from 54 Thai patients
between 2003 and 2005 (Kulwichit et al., 2007).
This study suggests that in the northern region, human
infections with swine-associated serovars are increasing and
human infections with chicken-associated serovars are de-
creasing. Conversely, swine-associated serovars are decreas-
ing and chicken- and seafood-associated serovars are
increasing in southern Thailand. The distribution of animal-
associated serovars may be cultural and could reﬂect reduced
pork consumption and increased poultry consumptionwithin
a large Muslim population in southern Thailand.
Risk factors
Previously published studies have shown that S. En-
teritidis, S. Typhimurium, S. Panama, and S. Choleraesuis are
associated with a higher percentage of extra-intestinal infec-
tions and increased hospitalization rates (Helms et al., 2003;
Jones et al., 2008). The most commonly recovered serovars
from blood samples in Thailand were S. Enteritidis, S. Cho-
leraesuis, S. I [1],4,[5],12:i:, and to a lesser extent S. Typhi-
murium (Tables 2 and 3). Invasive S. Enteritidis infections
have previously been reported in Thailand. Two publications
described increased morbidity associated with S. Enteritidis
and reported that S. Enteritidis, followed by S. Choleraesuis,
were the most common Salmonella serovars recovered from
blood (Boriraj et al., 1997; Boonmar et al., 1998c).
Our analysis indicates that patients submitting rectal swabs
or stool samples had a greater risk for infection with S. Stan-
ley, S. Weltevreden, S. Rissen, and S. Anatum than other
nontyphoidal serovars (Tables 2 and 3). Several publications
also associated these serovars with gastrointestinal infections.
For example, in 2003, S. Rissen and S. Stanley were the two
most common serovars recovered from Thai patients with
diarrhea (Angkititrakul et al., 2005), and S.Weltevreden and S.
Anatum were the leading causes of diarrhea in 1993 to 1996
(Moolasart et al., 1997).
The age distribution of the cases was not unexpected. The
majority of the cases occurred among children and older
adults. This is consistent with the general understanding of
Salmonella epidemiology (de Wit et al., 2000). We found
that children between 0 and 5 years were at higher risk of
being infected with S. Stanley as compared to the other non-
typhoidal Salmonella serovars (Table 2). This is in agreement
with data from a previous study in which 4 out of 15 children
were infected with S. Stanley (Moolasart et al., 1997; Pa-
dungtod and Kaneene, 2006).
S.Anatumhas been reported as a cause of infections among
38% (n¼ 32) of crop farm workers (Padungtod and Kaneene,
2006). This result is also in concordance with our analysis that
shows a higher risk for S. Anatum infection among those
older than 6 years.
Patients older than 6 years were also at a greater risk for
infection with S. Enteritidis and S. Weltevreden. These ﬁnd-
ings are consistent with previous studies (Boriraj et al., 1997).
As these serovars have been associated with speciﬁc reser-
voirs, their association with speciﬁc age groups may reﬂect an
individual’s diet. S. Weltevreden for example has been asso-
ciated with shrimp, a food product not commonly given to
very small children (Boonmar et al., 1998c).
Seasonal variation was observed for most cases in the
summer period (Fig. 3), which is in agreement with what has
been observed elsewhere in the same region (Cho et al.,
2008).
The majority of cases were reported from Bangkok and the
central region (Fig. 2). This large number of cases reported
from Bangkok is most likely due to a combination of popu-
lation density, better reporting, and the high prevalence of
street vendors selling ‘‘ready to eat food.’’ The large number of
cases from zone 4 (within the central region) may simply be
due to logistics, because this area is in close geographic
proximity to Bangkok and samples can easily be collected and
transported. Reasons for the high proportion of cases in the
surrounding districts are uncertain.
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We expected to ﬁnd more human cases in the northern
region based on previous studies where 19% of a total of 403
people sampled tested positive for Salmonella ssp. among the
healthy population in the northeastern region (Vaeteewoo-
tacharn et al., 2005). In another study from the northern region
the prevalence in livestock farmers and slaughterhouse
workers was 36% and 25%, respectively (Padungtod and
Kaneene, 2006). It could be speculated that high prevalence is
associated with working with animals and that the general
population has a much lower prevalence.
The data in this study reveal a high number of infections
caused by nontyphoidal Salmonella serovars in Thailand,
which are potentially preventable. In order to address the
problem, the responsible authorities in Thailand need to take
action to diminish the level of this burden. It is suggested that
a source attribution program be created to reveal the true link
between the different Salmonella serovars. The information
obtained from this attribution study can then be used to con-
trol these infections by launching targeted, serovar-speciﬁc
interventions against the true reservoirs.
Limitations
The epidemiological data from Thailand were based on a
passive monitoring of samples submitted to the WHO Inter-
national Salmonella and Shigella Centre, National Institute of
Health.
Throughout the course of the study, three zones (7, 9, and
11) consistently reported low numbers of cases (data not
shown). It is not known whether this reﬂects actual numbers
or possible data gaps. The authors do not have speciﬁc
knowledge of the capacity for clinical laboratories in these
zones to isolate Salmonella spp. nor do we have any infor-
mation on the local infrastructure needed for a laboratory-
based surveillance system. In addition, habits and local rou-
tines may differ from one part of a country to another with
regard to how often a doctor is consulted.
Conclusion
The outcome of this study indicates a shift in prevalence of
the most common Salmonella serovars responsible for human
infections in Thailand compared to previous studies. Swine-
related serovars in Thailand such as S. Stanley, S. Corvallis,
and S. Choleraesuis are increasing while S. Weltevreden and
S. Anatum are decreasing. Most infections among Thai pa-
tients occur in the age groups 0–5, 31–35, and >60 years. The
majority of cases are reported from Bangkok and surrounding
areas with a peak in reported infections during the summer
months.
Multiple risk factors, which varied by region and serovar,
were identiﬁed in this study. Based on the variability of these
risk factors, the authors recommend initiating interventions
targeted to speciﬁc serovars taking regional, age group, and
seasonal variation into account. We strongly encourage the
Thai authorities to initiate interventions against the two main
invasive serovars, S. Enteritidis and S. Choleraesuis. Inter-
ventions for S. Enteritidis should be focused on patients older
than 5 years in the southern region and interventions for
S. Choleraesuis should be directed towards people older than
5 years in the central region. In addition, studies can be un-
dertaken to elucidate the reasons for the increase in swine-
associated serovars and identify control methods to reduce
the burden of disease associated with these organisms. We
also suggest initiating longer term prevention and control
measures by exploring possibilities to collect data for source
attribution focusing on the reservoirs contributing to salmo-
nellosis among the Thai population.
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